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ABSTRACT 
 
Syringolin A, a plant elicitor, was isolated in 1998 and has been identified as a 
potential anti-cancer compound based on its activity against proteasome. The unique 
structure of this natural product consists of a 12-membered diamide ring, formed by two 
non-proteinogenic amino acids 3,4-dehydrolysine and 5-methyl-4-amino-2-hexenoic acid, 
and a bis(valinyl)urea side chain which is connected to the macrocycle by a peptide bond. 
The construction of this challenging macrocylic core was achieved by a 
macrolactamization reaction using peptide coupling reagents BOP/HOAt, while the two 
(E)-configured double bonds in the ring were introduced by a Johnson‒Claisen 
rearrangement and Wittig olefination respectively.   
Ru(bpy)3Cl2 which is an excellent visible light photoredox catalyst, has been 
extensively applied to organic syntheses in recent years. Although much research has 
focused on the study of the reductive quenching pathway, the oxidative quenching 
 vii 
 
pathway has rarely been explored. Using persulfate as the electron acceptor, we have 
successfully developed a protocol for the oxidative functionalization of dialkylamides 
under mild reaction conditions. Further application has demonstrated a Friedel‒Crafts 
amidoalkylation methodology applying various nucleophilic alcohols and arenes. The 
reaction can also be conducted under thermolysis condition without the photocatalyst, but 
requires elevated temperature. Both of the reactions generate N-acyliminium ion in situ as 
the key intermediate.  
The first example of photocatalytic halogenation has been achieved at room 
temperature using Ru(bpy)3Cl2 and polyhalomethanes (CBr4 and CHI3) as the electron 
acceptors. Excellent yields and high functional group tolerance have been established. 
Mechanistic studies indicate a single electron transfer (SET) pathway and the 
transformation is via a Vilsmeier‒Haack type intermediate. Further expansion of this 
methodology to anhydride formation was achieved, providing a mild avenue for the 
synthesis of symmetric anhydrides. Furthermore, the use of a continuous flow reactor 
enabled the efficient large scale synthesis of anhydrides. 
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CHAPTER 1 
The Total Synthesis of Syringolin A 
 
1 Introduction 
1.1  The Syrbactin Family 
The term ‘syrbactin’ was coined by combining ‘syringolin’ and ‘glidobactin’, each 
of which represents a class of natural products.
1
 Syrbactins share closely related 
molecular structures and biosynthetic pathways. They are characterized by a 
12-membered macrocycle containing an -unsaturated carbonyl moiety and an 
exocyclic N-terminus connecting to a side chain. In addition, glidobactin A (3)
2,3
 has an 
identical structure to cepafungin II, which belongs to another structurally closely related 
natural product family of cepafungins
4
 (Figure 1.1). Glidobactins
5
 and cepafungins
6
 
have shown antifungal and anticancer activities, and research suggests that the acylation 
of the exocyclic threonine moiety by unsaturated fatty acids is crucial for antifungal 
activity.
7
 In contrast, syringolins exhibit no antifungal but only anticancer activity, which 
might be related to the presence of a non-acylated valine moiety.
8
 In 2008, research 
revealed that syringolin A (1) was an irreversible proteasome inhibitor as was the case for 
the natural product epoxomicin which is a known irreversible proteasome inhibitor, in 
2 
  
contrast to the reversible peptide aldehyde inhibitor MG-132.
1
 Studies later showed that 
syringolin B
9
 (2) and glidobactin A
1,9
 (3) exhibited an identical mode of action and they 
both irreversibly inhibited proteasome. Considering that the proteasome has been 
recognized as a potential target for cancer treatment, the investigation of proteasome 
inhibitors, such as the syrbactins, may have implications for the development of novel 
anti-cancer agents.  
 
Figure 1.1 The syrbactin family 
 
 
1.2  The Ubiquitin-Proteasome System  
3 
  
Regulation of various protein levels is crucial to maintain normal cell function. In 
eukaryotic cells, there are two pathways to degrade targeted proteins into small 
peptides.
10
 The lysosomal pathway degrades extracellular proteins taken up by 
endocytosis, phagocytosis and autophagy,
11
 whereas the ubiquitin-proteasome pathway 
degrades intracellular bulky or misfolded proteins.
12
  
The 26S proteasome is a large, multi-subunit complex involved in the proteolytic 
process.
13
 It is assembled by a central 20S proteasome and two 19S regulatory subunits 
at both ends. The 20S proteasome, where the protein hydrolysis takes place,
14
 is a 
cylindrical structure composed of four stacked rings. Each of the two outer rings contains 
seven  subunits, whereas the inner ring contains seven  subunits. 15 The proteolytic 
active sites, which have been identified as N-terminal threonine residues, are located at 
-subunits.
 16
 These three catalytic sites represent three types of proteasome 
activity: the caspase-like activity (β1) which cleaves after acidic residues, the trypsin-like 
activity (β2) which cleaves after basic residues, and the chymotrypsin-like activity (β5) 
which cleaves peptide bonds after hydrophobic residues.
17
 
The targeted protein for proteolysis is attached to a polyubiquitin chain assisted by 
three enzymes E1-E3, which is then recognized by the 19S regulatory particle.
18
 The 
protein binds to the 19S cap and ubiquitin is released and recycled. Since the entry 
4 
  
channel inside 20S core is very narrow, the protein has to undergo unfolding to reach the 
proteolytic active sites.
19
 Both the assembly of the 26S proteasome and the proteolysis 
are ATP-dependent.
20
  
 
1.3  Proteasome Inhibitors and Anticancer Drugs  
The ubiquitin-proteasome system plays a primary role in regulating the protein 
levels in cell growth, cell differentiation, apoptosis and metabolic adaptation. Since 
cancer is a disease involving uncontrolled cell growth or failure to undergo apoptosis, 
manipulation of proteasome activities could be potentially used to treat cancer.
21
  
Proteasome inhibitors can reduce the degradation of proteins, some of which are 
important factors in angiogenesis
22
 and apoptosis.
23
 Thus, treatment of cancer cells with 
proteasome inhibitors could induce apoptosis, inhibit angiogenesis, and circumvent drug 
resistance. In fact, experimental evidence has shown that these new types of anticancer 
agents can target some cancer cells on which conventional chemotherapy has little effect, 
while maintaining low toxicity to the normal cells.
24
 So far, a large number of 
proteasome inhibitors have been discovered (Figure 1.2). Based on their binding 
properties with the proteolytical active sites, they can be grouped as peptide aldehydes, 
vinyl sulfone tripeptides, peptide boronic acids, lactacystin and derivatives, peptide 
5 
  
epoxyketones, and other natural products.
25
 A peptide boronic acid, bortezomib 
(MLN-341), was approved by the FDA in 2003 as the prescriptive drug (Velcade®) for 
the treatment of multiple myeloma and mantle cell lymphoma.
26
 However, laboratory 
and clinical studies are still working on to further increase its anticancer potency. 
Moreover, a requirement for intravenous administration, potentially severe peripheral 
neurotoxicity and selectivity for only one of the three enzymatic functions of the 20S 
proteasome to some extent limited its clinic application.
27
 Further development of new 
proteasome inhibitors with high selectivity for cancer cells and low cytotoxicity to 
normal cells is becoming a fast growing research area. 
 
Figure 1.2 Proteasome inhibitors bortezomib, carfilzomib and salinosporamide A 
 
 
1.4  Syringolins: Isolation and Identification  
Syringolins are secreted by certain strains of bacterium Pseudomonas synringae pv. 
syringae (Pss).
28
 It is known that this pathogen can infect many plants, for example, 
6 
  
causing brown spots disease of beans. The isolation of syringolin A was first reported by 
the Dudler group in 1998.
8
 Structure elucidation showed that syringolin A is a small 
molecule consisted of a macrocyclic core formed by two non-proteinogenic amino acids 
3,4-dehydrolysine and 5-methyl-4-amino-2-hexenoic acid, which are connected by a 
peptide bond to a bis(valinyl)urea side chain. However, the configurations of the four 
stereogenic centers were not assigned until the first chemical synthesis of syringolin A.
1
  
The minor syringolin variants B-F were isolated subsequently from Pss in 1999.29 They 
differ from syringolin A by a lysine instead of 3,4-dehydrolysine moiety in the ring 
system (syringolin B) or an isoleucine instead of valine moiety in the side chain 
(syringolins C, D, F), or both (syringolin E). In particular, the structures of syringolin B 
and E resemble the glidobactin and cepafungin families, which have only one 
(E)-configured double bond in the ring.    
 
1.5  Bioactivity of Syringolin A 
It has been demonstrated that syringolins have no antifungal activity, but they can be 
recognized by the non-host plant O.sativa, and activate host defense responses to protect 
rice from blast fungus P.oryzae. Syringolin A was also reported to induce death of 
hypersensitive cells colonized by powdery mildew in wheat and other cereals.
30
 Further 
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investigation of syringolin A on mammalian cell systems reveal that it inhibits cell 
proliferation and induces apoptosis in neuroblastoma and ovarian cancer cells, with an 
IC50 between 20 and 25 μM for each cell line.
31
  
However, the mode of action of syringolin A remained unknown until 2008. The 
research results published in Nature by Dudler and co-workers revealed that syringolin A 
could function as a proteasome inhibitor and irreversibly inhibit all three catalytic 
activities of eukaryotic proteasomes, with apparent Ki’ values of 843 ± 8.4 nM for 
inhibition of the chymotrypsin-like activity, and 6.7 ± 0.7 μM for inhibition of 
trypsin-like activity. Caspase-like activity was also inhibited although with less efficiency. 
Meanwhile, papain and trypsin proteases were not affected. Crystallography of syringolin 
A in the yeast 20S proteasome indicates a covalent modification of the irreversible 
inhibition: Thr1O
γ
 of the proteasome reacts with the -unsaturated carbonyl moiety on 
the ring of syringolin A via 1,4-addition to form a covalent bond which is facilitated by 
the Gly47N through stabilization of the generated carbonyl anion. The constrained 
structure of the 12-membered ring with two unusual trans-double bonds also contributes 
to the high-affinity binding as it will release the ring strain. On the contrary, a parallel 
experiment showed that glidobactin A, which has similar structure as syringolin A, 
although irreversibly inhibits chymotrypsin-like activity (Ki’ = 49 ± 5.4 nM), is less 
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sensitive to trypsin-like activity (Ki’ = 2.0 ± 0.6 μM) and inactive to chymotrypsin-like 
activity. The lower activities of glidobactin could be explained by the flexible ring in the 
molecule diminished the binding affinity with the proteasome.   
 
2 Biosynthesis of Syringolin A 
In 2004, the Dudler group demonstrated that syringolin A was the product of a 
mixed non-ribosomal peptide synthetase (NRPS) and polyketide synthetase (PK), in 
planta.
32
 There are five genes, sylA-sylE, that were found in the syringolin gene cluster. 
SylA is likely a transcriptional regulator involved in the activation of biosynthetic genes, 
while sylE is involved in secreting sylingolin A. The other three putative genes are: sylB, 
sylC and sylD, which are the biosynthetic genes. SylB is an amino acid desaturase 
involved in the conversion of lysine to 3,4-dehydrolysine. SylC encodes a NRPS module 
possessing a condensation (C), an adenylation (A) and a thiolation domain (T), and is 
involved in activation of valine. SylD encodes two NRPS modules and one PKS module. 
This megasynthase possesses two CAT domains followed by ketosynthase (KS), 
acyltransferase (AT), dehydratase (DH), ketoreductase (KR), thiolation (T) and 
thioesterase (TE) domains, and is involved in the formation and cyclization of the 
macrocycle. The gene sequences encoded on the DNA strand determine the amino acid 
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sequence of the product, and the results from the Walsh group indicated that the 
desaturation of lysine moiety happened before the macrocyclization step (Scheme 1.1).
33
     
 
Scheme 1.1 Biosynthetic genes and formation of syringolin A  
 
 
3 Previous Synthetic Approaches to Syringolin A and Structurally Related 
Glidobactin A 
Syringolin A represents an attractive macrocylic compound with a highly strained 
12-membered diamide ring containing two (E)-configured double bonds and a urea side 
chain. It has also been demonstrated as a promising anticancer agent with novel and 
impressive bioactivities. In order to further investigate its mechanism with proteasomes 
and to assess its clinical value, a large quantity of the available material is demanded. 
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Moreover, attempts to modify the substituents on the structure to achieve higher 
bioactivities require a convergent synthetic route. A biosynthetic analysis of the gene 
clusters of syringolin A indicated that all the stereocenters in the molecule might directly 
come from amino acids, specifically, from L-valine. Thus, the installation of the 
stereogenic centers can be easily solved by taking advantage of the chiral pool synthesis, 
which leaves the most challenging step in the total synthesis of syringolin A to be the 
macrocyclization to form the macrolactam.  
To date, there have been three (including our work) total syntheses of syringolin A 
reported. Regardless of the different approaches and order of introduction of the two 
trans-double bonds and other functional groups in the molecule, the main characteristic 
distinguishing the three syntheses is the strategy to assemble the macrocyclic core 
(Figure 1.3).  
 
Figure 1.3 Different strategies to assemble the macrocyclic core 
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The first total synthesis was achieved by Kaiser and co-workers in 2009 and 
employed ring closing metathesis to furnish the macrocycle.
9
 The synthesis was initiated 
from the preparation of the vinylogous analog 5 of Boc protected L-valine methyl ester 4. 
The first (E)-configured double bond was installed at this stage. Protection of the double 
bond by dihydroxylation followed by protection of the diol to form a dimethoxyacetal 6 
not only circumvented undesired side reactions, but also facilitated the ring closing 
metathesis to some extent. Peptide coupling, followed by selenoxide elimination afforded 
the ring-closing metathesis precursor 8. The macrocyclic core 9 was synthesized using 
Grubbs II catalyst in 49% yield (Scheme 1.2). 
 
 Scheme 1.2 Kaiser's strategy to assemble the key macrocycle 
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Kaiser’s group developed two pathways to complete the total synthesis of syringolin 
A. In their first report, the deprotection of the double bond was carried out at the late 
stage of the synthesis. The urea side chain was installed to the macrocycle to afford 10, 
which was prior to the Corey-Winter elimination of a thiocarbonate intermediate 11 to 
afford the second (E)-configured double bond. Final deprotection provided the desired 
product (Scheme 1.3, top).  
 
Scheme 1.3 Kaiser’s strategies to complete the total synthesis of syringolin A 
 
 
In their second generation report of the synthesis of syringolin A and its derivatives, 
the investigators employed a revised strategy.
34
 Corey-Winter elimination of the 
thiocarbonate intermediate 12 was carried out after the macrocyclization followed by the 
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coupling with the side chain to give 14 and final deprotection to afford syringolin A 
(Scheme 1.3, bottom). The advantage of applying this early-stage completion of the 
macrocyclic core 13 is that it provides a convergent synthetic platform for the 
modification of the side chains in syringolin A derivatives, which can be served for broad 
screening of anticancer agents with higher bioactivities.   
The second total synthesis of syringolin A was reported by the Pirrung group in 
2010.
35
 They assembled the macrocycle at the -unsaturated amide region via a 
Horner–Wadsworth–Emmons (HWE) olefination, meanwhile the second (E)-configured 
double bond was installed with high stereocontrol. The total synthesis began with the 
coupling of 15 with L-valinol (16) to afford 17, followed by cross metathesis using 
Grubbs II catalyst, providing the olefin in 18 exclusively with the (E) configuration. 
Bromide 18 was converted to the corresponding phosphonate followed by oxidation of 
the primary alcohol to the aldehyde, to afford 19, the precursor for the HWE olefination. 
Treatment of 19 with a mixture of Zn(OTf)2, TMEDA and Et3N
36
 afforded the 
macrocyclic core 20 in 55% yield. Further optimization to 81% yield was accomplished 
with slow addition of the aldehyde to the reaction mixture over 8 h (Scheme 1.4). 
Presumably, 2 equivalents of Zn(OTf)2 not only enable the efficient depronation under a 
mild condition by chelating to two carbonyls in the amide-based phosphonate moiety, but 
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also activate the aldehyde towards cyclization. Moreover, the generation of 
triphenylphosphine oxide offers the thermodynamic driving force to provide the alkene 
product in relatively high yields. 
The same ring-closing strategy was also applied to the synthesis of syringolin B, 
albeit in attenuated yield (65%). The moderate to excellent yields of the HWE reaction in 
this report represent a successful example of applying HWE olefination in the total 
synthesis of natural products containing macrolactams.
37
 
 
Scheme 1.4 Pirrung's strategy to assemble the key macrocycle 
 
 
Although the biosynthetic analysis of the gene clusters involved in synthesis of 
syringolin A indicates the macrocylization can be achieved via peptide coupling, there 
was no report showing the chemical application of this approach in the synthesis of 
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syringolin A. However, this approach was utilized in the total syntheses of the related, 
mono-saturated natural products glidobactin A and syringolin B. The first successful 
application was achieved by Oka and co-workers. In their effort to complete the synthesis 
of glidobactin A, the investigators performed the macrolactamization at the last step, with 
the side chain already attached to the precursor 21 of macrocyclization. The yield was 
very low (only 2.3%), indicating that the closure of the strained 12-membered ring at the 
hindered amide site with an -substituted amine and an -substituted carboxylic acid is 
difficult (Scheme 1.5, top).
38
 Schmidt and co-workers chose the less hindered amide site 
to assemble the macrocycle 23, and attached the exocyclic side chain afterwards. Using 
the pentafluorophenol ester to activate the carboxylic acid of 22 for nucleophilic attack 
improved the yield to 20% (Scheme 1.5, middle).
39
 Although the attempt to employ late 
stage macrolactamization to synthesize syringolin A failed, Kaiser and co-workers 
successfully applied this strategy in the total synthesis of the less strained molecule, 
syringolin B. The macrocyclic precursor 24 was closed at the same amide site as in the 
Schmidt’s synthesis, and by using peptide coupling reagents: PyBOP HOAt in 
combination with DIEA in DMF, they obtained the desired product 25 in an enhanced 
yield of 30%. (Scheme 1.5, bottom).
30
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Scheme 1.5 Synthetic application of peptide coupling in the macrocyclization of syrbactins 
 
 
4 Aim of the Project 
After the Dudler group reported syringolin A as an irreversible inhibitor to 
proteasome and promising anticancer agent in 2008, we were attracted by its interesting 
molecular structure and potential bioactivity. The project was prompted in order to 
achieve the first total synthesis of this natural product, which would fill the increasing 
demand for material request for biological studies, meanwhile verifying the original 
structure assignment. We were also hoping, at that time, to enable the library syntheses of 
syringolin derivatives for biological evaluation. In line with this plan, a convergent and 
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flexible approach was designed which required a late-stage installation of the side chain 
on the macrolactam. In addition, different macrocylization strategies of the strained 
12-membered ring were also set up for the investigation. However, during the course of 
our investigation, the first total syntheses of syringolin A and B was reported by the 
Kaiser group in collaboration with the Dulder group, along with the biochemical 
assessment. Following this pioneering work, the Pirrung group reported the second 
independent syntheses of syringolin A and B. Therefore, we decided to focus on the 
completion the synthesis with a different strategy to assemble the molecule.   
 
5 Retrosynthetic Analysis of Syringolin A 
With regard to the convergent and flexible approach to syringolin A mentioned 
before, we planned to utilize commercially available amino acids to introduce all of the 
stereocenters (chiral pool synthesis). Moreover, we also envisioned an introduction of the 
side chain at a late stage, which would expedite the synthesis of other analogs. The key 
12-membered macrocycle core 19 would be formed through an intramolecular peptide 
coupling at the less hindered site as in the synthesis of glidobactin A by the Schmidt 
group
39
 and synthesis of syringolin B by the Kaiser group
9
. Wittig olefination would 
provide the vinylogous analog of the Boc protected L-valine methyl ester 26. The 
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(E)-configured double bond in the 3,4-dehydrolysine moiety 27 could be furnished by 
Johnson-Claisen rearrangement, and its precursor could be generated from commercially 
available, and readily accessible Garner’s aldehyde 28 (Scheme 1.6).40 
 
Scheme 1.6 Retrosynthetic analysis of syringolin A 
 
 
6 The Synthesis of Syringolin A 
6.1  The Synthesis of Vinylogous L-Valine Methyl Ester 
The synthesis of the α,β-unsaturated ester 26 began with Boc protection of L-valine,  
followed by coupling with N,O-dimethylhydroxylamine to afford Weinreb amide 29. 
Reduction of the amide to the corresponding aldehyde with LiAlH4, followed by 
immediate subjection of the crude material to Wittig olefination provided the (E)-olefin 5 
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with a 91% yield and >99% ee.
41,42
 Removal of the N-Boc protecting group provided 
amine 26 which was subjected to a peptide coupling for the generation of the precursor 
for the macrolactamization (Scheme 1.7).  
 
Scheme 1.7 Synthesis of vinylogous L-valine methyl ester 
 
 
6.2  The Synthesis of 3, 4-Dehydrolysine Fragment  
To access the 3,4-dehydrolysine fragment 27, Garner’s aldehyde (28) was prepared 
from D-serine in four steps according the literature protocol,
43
 followed by treatment with 
vinyl magnesium bromide in THF for (30 min at -78 °C, 2 h at rt) to afford allylic 
alcohol 30 in 86% yield. Johnson-Claisen rearrangement employing excess CH3C(OMe)3 
in xylene at reflux temperature provided the desired γ,δ-unsaturated ester 31 in high yield 
and excellent selectivity (E/Z > 95:5).
44
 Hydrolysis of this ester led to the carboxylic acid 
32, which was subjected to Curtius rearrangement using DPPA, Et3N and tert-butanol in 
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the presence of activated 4Å molecular sieves. The use of sieves was found to be crucial 
in this transformation to avoid the formation of the corresponding symmetrical urea. 
Intermediate 33 was obtained in 81% yield and then selectively deprotected using 
p-TsOH to afford alcohol 34.  
 
Scheme 1.8 Synthesis of 3,4-dehydrolisine moiety 
 
 
Oxidation to the corresponding acid using two-step protocols proved to be 
problematic due to the instability of the aldehyde intermediate.
45,46
 Treatment of 34 with 
Dess–Martin reagent or under Swern oxidation conditions followed by Pinnick oxidation 
failed to afford the desired acid product, instead generating a series of decomposed 
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by-products. Direct oxidation using TEMPO/NaClO2/NaOCl
47
 or TEMPO/TCCA
48
 
system which proceeded through an aldehyde intermediate also failed as the two-step 
strategy.
49
 Reactions using mild conditions, such as Heyns’s oxidation50 (Pt/O2), showed 
no conversion even at elevated temperature (70 ̊C). Gratifyingly, after extensive studies 
on the oxidation conditions, we found that the Jones reagent efficiently converted alcohol 
34 to the desired amino acid 27 in 1 h at 0 °C in 78% yield (86% brsm) without any 
observable epimerization of the stereogenic center (Scheme 1.8).
51
  
Other approaches to synthesize the 3,4-dehydrolysine moiety, such as applying 
vinylmetal-sulfinylimine addition method reported by Wipf and co-workers,
52
 were also 
examined. As shown in Scheme 1.9, ethyl gloxylate was condensed with 
(R)-(+)-N-tert-butanesulfinamide in the presence of molecular sieves to afford imine 35.
53
 
The nucleophilic vinylmetal species was obtained from hydrozirconation of terminal 
alkyne followed by transmetallation with zinc or aluminum reagents. A four-membered 
chelate model was proposed to account for the selectivity of this reaction. 
Trimethylaluminium gave the allylic N-sulfinyl amine product 36 in 31% yield with 1.5:1 
diastereoselectivity, while dimethylzinc provided 36 in 35% yield with 4:1 
diastereoselectivity. These results show that the less Lewis acidic dimethylzinc is a better 
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choice for the sulfinylimine 35. However, we were unable to improve the yield and 
selectivity for this transformation at that time.  
 
Scheme 1.9 Other approach to synthesize the 3,4-dehydrolisine moiety 
 
 
6.3  The Synthesis of the Macrolactam 
With both coupling fragments 26 and 27 in hand, the first amide bond formation was 
accomplished using EDCI, HOBt, and 
i
Pr2NEt in dichloromethane over 12 h to afford 37 
in 70% yield. Removal of the C- and N-terminal protecting groups generated the 
macrolactamization precursor 15, which was then treated with peptide coupling reagents 
BOP and HOAt in DMF for 48 h, providing the macrocycle 19 in 15% yield (Scheme 
1.10).
54
 Cyclized dimer and trimer of 15 were observed in MS spectrum of the crude 
reaction. Although the yield of this macrolactamization is low, this approach provides the 
most straightforward synthetic route to syringolin A and its analogues. Similar 
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macrolactamization strategies to syringolin A have previously been reported to be 
unsuccessful by the Kaiser group with the effort to obtain the Boc-protected macrocyclic 
core.
30
  
 
Scheme 1.10 Synthesis of the macrolactam 
 
 
6.4  Completion of the Synthesis of Syringolin A 
The final stage of the synthesis required introduction of the urea side chain 40, 
which was obtained by treatment of benzyl (S)-(‒)-2-isocyanato-3-methylbutyrate55 (38) 
with tert-butyl valine (39) in the presence of DIPEA,
56
 followed by benzyl deprotection 
via hydrogenolysis with 10% Pd/C in methanol (Scheme 1.11).  
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Scheme 1.11 Synthesis of the side chain 
 
 
The removal of Cbz protecting group in macrocyclic core 19 with HBr in acetic acid 
afforded the corresponding free amine in quantitative yield, which was then coupled with 
side chain 40 using BOP, HOAt, and DIPEA to afford 41 in 85% yield. The tert-butyl 
protecting group was cleaved under mild acidic condition using formic acid, affording 
syringolin A in 94% isolated yield (Scheme 1.12).
57
 Data for synthetic syringolin A was 
identical in all respects with those previously reported for the natural product. 
 
Scheme 1.12 Completion of the synthesis 
 
 
7 Conclusion 
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In this chapter, the syrbactin natural product family has been introduced. As an 
important member of this family, syringolin A has been found to irreversibly inhibit all 
three catalytic activities of proteasome. The biosynthetic pathway and the previous 
chemical syntheses of syringolin A have been discussed. Utilizing commercially available 
amino acids, we have developed a convergent synthesis of the syringolin A in 13 steps 
from commercially available Garner’s aldehyde. In addition, we demonstrated that the 
macrolactamization of the 12-membered cycle core can be accomplished via 
macrolactamization in coupling with reasonable yield, which could allow for a facile 
modification of both the macrocycle and the side chain.  
 
8 Experimental Section 
General Information 
All reactions were carried out in oven dried glassware under a nitrogen atmosphere 
employing standard techniques in handling air-sensitive materials. Chemicals were either 
used as received, or purified according to the procedures outlined in Purification of 
Common Laboratory Chemicals. Glassware was dried in a 160 °C oven or flame dried 
under vacuum and cooled under inert atmosphere before use. Unless otherwise noted, 
reactions were magnetically stirred and monitored by thin layer chromatography with 
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Sorbent technologies 0.20 mm silica gel 60 plates. Column chromatography were 
performed with silica gel 60 (particle size 0.032‒0.063 mm) supplied by Sorbent 
Technologies. Yields refer to chromatographically and spectroscopically pure compounds, 
unless otherwise noted.  
1
H- and 
13
C- NMR spectra were recorded using an internal deuterium lock on Varian 
Mercury 300, Varian Unity Plus 400, or a Varian 500 spectrometers. All signals are 
reported in ppm with the internal reference of 7.26 ppm or 77.0 ppm for chloroform, 2.50 
ppm or 39.5 ppm for DMSO, 3.30 ppm or 49.1 ppm for methanol, 7.16 ppm or 128.6 for 
benzene as standard.  Data are presented as follows: multiplicity (s = singlet, d = doublet, 
t = triplet, m = mutiplet, br = broad, ABq = AB quartet, dd = doublet of doublet, dt = 
doublet of triplet), coupling constant (J/Hz) and integration. Infrared spectra were 
recorded on a Nicolet Nexus 670 FT-IR with ATR spectraphotometer. Absorptions are 
given in wavenumbers (cm-1). Optical rotations were recorded on an Autopol III digital 
polarimeter at 589 nm and reported as follows: [𝛼]𝐷
𝑇 , concentration (g / 100 mL) and 
High resolution mass spectra were obtained on a Waters Q-Tof API-US with ESI high 
resolution mass spectrometer. Concentration refers to removal of solvent under reduced 
pressure (house vacuum at ca. 20 mmHg). 
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Compound Preparation and Characterization 
 
 
(S)-tert-Butyl 1-(methoxy(methyl)amino)-3-methyl-1-oxobutan-2-ylcarbamate 
(29): A solution of (Boc)2O (10.2 g, 46.7 mmol, 1.1 equiv) in dioxane (100 mL) was 
added to an ice-cold solution of L-valine (5.00 g, 42.7 mmol, 1.0 equiv) in 1 N NaOH 
(100 mL) with stirring. The mixture was warmed to room temperature after 30 min and 
stirred overnight. The dioxane was evaporated and the aqueous layer was washed with 
Et2O (50 mL) to remove any (Boc)2O. EtOAc (100 mL) was then added to the aqueous 
layer and the mixture was acidified to pH 2-3 by slow addition of cold 1 M HCl solution. 
The resulting mixture was extracted with EtOAc (150 mL × 3). The combined extracts 
were washed with brine, dried (MgSO4), filtered and concentrated to give N-Boc-L-valine 
as a colorless, sticky foam which was used in the next step without further purification. 
The crude product was dissolved in dry CH2Cl2 (150 mL) and cooled to -15 °C 
followed by addition of N,O-dimethylhydroxylamine hydrochloride (4.20 g, 43.1 mmol, 
1.0 equiv) and then NMM (9.40 mL, 85.4 mmol, 2.0 equiv). EDCI (8.28 g, 43.1 mmol, 
1.0 equiv) was then added portion wise as a solid over 15 min. The reaction was stirred 
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for 2 h at room temperature before the ice-cold 1 M HCl solution was added (50 mL). 
The aqueous layer was extracted with CH2Cl2 (100 mL) and the combined organic layers 
were washed with saturated NaHCO3 solution (50 mL), washed with brine, dried 
(MgSO4), filtered and concentrated. The resulting crude product was purified by column 
chromatography (30% ethyl acetate in hexanes) to afford compound 29 as a colorless 
solid (9.98 g, 38.4 mmol, 90%).  
Rf (1:3 EtOAc/hexanes): 0.31; 
[𝛼]𝐷
20 = +5.63 (c 0.87, CHCl3);  
IR (neat): 3336, 2972, 1713, 1659, 1503, 1174 cm
-1
;  
1
H NMR (400 MHz, CDCl3): δ 5.12 (d, J = 9.2 Hz, 1 H), 4.52‒4.62 (m, 1 H), 3.77 (s, 
3 H), 3.21 (s, 3 H), 1.98 (dqq, J = 6.8, 6.8, 6.8 Hz, 1 H), 1.43 (s, 9 H), 0.95 (d, J = 6.8 Hz, 
3 H), 0.90 (d, J = 6.8 Hz, 3 H);  
13
C NMR (100 MHz, CDCl3): δ 173.0, 155.8, 79.4, 61.5, 54.9, 31.9, 31.3, 28.3, 19.4, 
17.5;  
HRMS (ESI) m/z calculated for C12H24N2O4Na [M + Na]
+
: 283.1634; found: 
283.1634. 
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N-(tert-Butoxycarbonyl)-(L)-valine methyl ester (5): N-Methoxy-N-methylamide 
29 (0.260 g, 1.00 mmol, 1.0 equiv) was dissolved in dry THF (10.0 mL) and cooled to 
0˚C. 4.0 M LiAlH4 in THF solution (0.125 mL, 0.50 mmol, 0.5 equiv) was added 
dropwise under nitrogen atmosphere and the mixture was stirred for 30 min at 0 °C. The 
reaction was then cooled further to ‒15 °C and saturated KHSO4 solution (15 mL) was 
added carefully, the solution was diluted with Et2O (50 mL) and stirred vigorously for 30 
min. The organic layer was washed with brine, dried (MgSO4), filtered and concentrated 
to give the crude aldehyde as a colorless oil which was used directly in the next step 
without further purification. 
The crude aldehyde was dissolved in dry CH2Cl2 (10 mL) at room teperature and 
(methoxycarbonylmethylene)triphenylphosphorane (0.368 g,  1.10 mmol, 1.1 equiv) 
was added in one portion under nitrogen atmosphere. After stirring for 12 h, CH2Cl2 (40 
mL) was added and the mixture was successively washed with 10% aq. KHSO4 solution 
(10 ml), saturated NaHCO3 solution (10 ml) and brine. The organic layer was dried 
(MgSO4), filtered and concentrated. The resulting crude product was purified by column 
30 
  
chromatography (25% ethyl acetate in hexane) to afford compound 5 as a colorless solid 
(0.236 g, 0.918 mmol, 92%). 
Rf (1:4 EtOAc/hexanes): 0.43;  
[𝛼]𝐷
20 = ‒4.1 (c 1.0, CHCl3);  
IR (neat): 3357, 2965, 1693, 1518, 1366, 1247, 1165, 985, 865, 764 cm
-1
;  
1
H NMR (500 MHz, CDCl3): δ 6.85 (dd, J = 15.5, 5.5 Hz, 1 H), 5.91 (dd, J = 15.5, 
1.7 Hz, 1 H), 4.48‒4.56 (m, 1 H), 4.12‒4.21 (m, 1 H), 3.72 (s, 3 H), 1.80‒1.90 (m, 1 H), 
1.43 (s, 9 H), 0.92 (d, J = 6.8 Hz, 3 H), 0.89 (d, J = 6.8 Hz, 3 H);  
13
C NMR (100 MHz, CDCl3): δ 166.6, 155.3, 147.6, 121.0, 79.6, 56.6, 51.5, 32.1, 
28.2, 18.8, 17.9;  
HRMS (ESI) m/z calculated for C13H23NO4Na [M + Na]
+
: 280.1525; found: 
280.1526. 
 
 
 
(4R)-Benzyl 4-(1-hydroxyallyl)-2, 2-dimethyloxazolidine-3-carboxylate (30): A 
solution of Garner aldehyde 28 (5.26 g, 20.0 mmol, 1.0 equiv) in dry THF (50 mL) was 
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cooled to -78 °C and treated with 1 M vinylmagnesium bromide in THF (60.0 ml, 60.0 
mmol, 3.0 equiv) under nitrogen atmosphere. The temperature was allowed to rise to 
-15 °C during 2 h. After quenching with the sat. NH4Cl solution (80 mL), the reaction 
mixture was extracted with Et2O (150 × 3 mL). The combined organic layers were 
washed with brine, dried (MgSO4), filtered and concentrated. The resulting crude product 
was purified by column chromatography (25% ethyl acetate in hexane) to afford 30 as a 
colorless oil (5.01 g, 17.2 mmol, 86%).  
Rf (1:3 EtOAc/hexane): 0.19;  
[𝛼]𝐷
20 = +35.2 (c 1.26, CHCl3);  
IR (neat): 3437, 2986, 2939, 2885, 1701, 1410, 1352, 1257, 1096, 766 cm
-1
;  
1
H NMR (500 MHz, benzene-d6, 75 ̊C): δ 7.04‒7.23 (m, 5 H), 5.68‒5.83 (m, 1 H), 
5.22 (dd, J = 44.8, 17.2 Hz, 1 H), 4.96‒5.10 (m, 1 H), 5.03 (s, 2 H), 4.30‒4.38 (m, 1 H), 
3.84‒3.96 (m, 1 H), 3.76‒3.84 (m, 1 H), 3.60 (dd, J = 15.8, 8.8 Hz, 1 H), 1.62 (s, 3 H), 
1.43 (s, 3 H); 
HRMS (ESI) m/z calculated for C16H22NO4 [M + H]
+
: 292.1549; found: 292.1560. 
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(S, E)-Benzyl 4-(5-methoxy-5-oxopent-1-enyl)-2,2-dimethyloxazolidine-3-carbo- 
xylate (31): Vinyl alcohol 30 (4.20 g, 14.4 mmol, 1.0 equiv) was dissolved in xylene (50 
mL) followed by addition of trimethyl orthoacetate (14.5 mL, 0.115 mol, 8.0 equiv) and 
propionic acid (0.02 mL). The reaction mixture was heated to reflux under nitrogen 
atmosphere and stirred for 18 h before evaporation to dryness. The resulting crude 
product was purified by column chromatography using gradient elution (10% to 25% 
ethyl acetate in hexanes) to afford compound 31 as a colorless oil (4.65 g, 13.4 mmol, 
93%).  
Rf (1:4 EtOAc/hexanes): 0.30;  
[𝛼]𝐷
20 = +14.2 (c 0.35, CHCl3);  
IR (neat): 2992, 2951, 1738, 1704, 1407, 1350, 1255, 1095, 736 cm
-1
; 
1
H NMR (300 MHz, benzene-d6, 75 °C): δ 7.05‒7.25 (m, 5 H), 5.35‒5.45 (m, 2 H), 
5.09 (ABq, J = 12.2 Hz, Δ= 35.6 Hz, 2 H), 4.1‒4.2 (m, 1 H), 3.67 (dd, J = 8.8, 6.2 Hz, 1 
H), 3.46 (dd, J = 9.0, 2.2 Hz, 1 H), 3.36 (s, 3 H), 2.16 (t, J = 5.4 Hz, 2 H), 2.05‒2.11 (m, 
2 H), 1.70 (s, 3 H), 1.54 (s, 3 H); 
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HRMS (ESI) m/z calculated for C19H25NO5Na [M + Na]
+
: 370.1630; found: 
370.1645. 
 
 
 
(S, E)-5-(3-(Benzyloxycarbonyl)-2,2-dimethyloxazolidin-4-yl)pent-4-enoic acid 
(32): To a solution of methyl ester 31 (4.58 g, 13.2 mmol, 1.0 equiv) in THF-MeOH-H2O 
(3:1:1) (50 mL) was added LiOH·H2O (2.16 g, 52.8 mmol, 4.0 equiv) at 0 °C. The 
heterogeneous reaction mixture was then warmed to room temperature and stirred 
overnight. Ethyl acetate (50 mL) was added to the mixture and 1 M HCl solution was 
carefully added at 0 °C until pH = 3.0. The aqueous layer was extracted with ethyl acetate 
(3 × 50 mL) and combined organic layers were washed with brine, dried (MgSO4), 
filtered and concentrated. The resulting crude product was purified by column 
chromatography (8% MeOH in CH2Cl2) to afford compound 32 as a colorless solid (4.23 
g, 12.7 mmol, 96%).  
Rf (1:12 MeOH/CH2Cl2): 0.47;  
[𝛼]𝐷
20 = +18.2 (c 0.82, CHCl3);  
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IR (neat): 2985 (br), 1704, 1409, 1351, 1254, 1096, 765 cm
-1
;  
1
H NMR (500 MHz, benzene-d6, 75 °C): δ 7.06‒7.24 (m, 5 H), 5.36‒5.48 (m, 2 H), 
5.09 (ABq, J = 12.5 Hz, Δ= 60.0 Hz, 2 H), 4.10‒4.19 (m, 1 H), 3.69 (dd, J = 8.8, 6.0 Hz, 
1 H), 3.47 (dd, J = 8.8, 2.2 Hz, 1 H), 2.11 (t, J = 6.0 Hz, 2 H), 2.05‒2.06 (m, 2 H), 1.70 (s, 
3 H), 1.54 (s, 3 H);  
HRMS (ESI) m/z calculated for C18H23NO5Na [M + Na]
+
: 356.1474; found: 
356.1480. 
 
 
 
(S, E)-Benzyl 4-(4-(tert-butoxycarbonylamino)but-1-enyl)-2,2-dimethyloxazolid- 
ine-3-carboxylate (33): A flame-dried two-necked round-bottom flask fitted with a reflux 
condenser was charged with acid 32 (1.60 g, 4.80 mmol, 1.0 equiv), triethylamine (0.66 
mL, 4.80 mmol, 1.0 equiv), 4 Å molecular sieves (5.0 g) and toluene (50 mL). To this 
solution was added diphenylphosphoryl azide (1.46 g, 5.28 mmol, 1.1 equiv) dropwise at 
0 °C under nitrogen atmosphere. The reaction mixture was then warmed to room 
temperature and stirred for 2 h. A solution of tert-butanol (4.59 mL, 48.0 mmol, 10.0 
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equiv) and triethylamine (0.66 mL, 4.80 mmol, 1.0 equiv) in toluene (25 mL) was added 
slowly. The reaction mixture was then heated to reflux and stirred overnight.  The 
solvent was removed under reduced pressure and the residue was purified by column 
chromatography using gradient elution (10% to 25% ethyl acetate in hexanes) to afford 
compound 33 as a colorless oil (1.58 g, 3.91 mmol, 81%). 
Rf (1:3 EtOAc/hexanes): 0.25;  
[𝛼]𝐷
20 = +32.8 (c 0.67, CHCl3);  
IR (neat): 3357, 2978, 1704, 1518, 1409, 1350, 1254, 1172, 1098, 762 cm
-1
;  
1
H NMR (500 MHz, benzene-d6, 75°C): δ 7.07‒7.25 (m, 5 H), 5.3‒5.4 (m, 2 H), 
5.11 (ABq, J = 7.5 Hz, Δ= 57.5 Hz, 2 H), 4.08‒4.19 (m, 2 H), 3.68‒3.71 (m, 1 H), 3.46‒
3.48 (m, 1 H), 2.95‒3.03 (m, 1 H), 2.86‒2.93 (m, 1 H), 1.38‒1.65 (m, 2 H), 1.68 (s, 3 H), 
1.53 (s, 3 H), 1.45 (s, 9 H);  
HRMS (ESI) m/z calculated for C22H32N2O5Na [M + Na]
+
: 427.2209; found: 
427.2202.  
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(S, E)-Benzyl 6- tert-butoxycarbonylamino-1-hydroxyhex-3-en-2-ylcarbamate 
(34): To a solution of compound 33 (0.606 g, 1.50 mmol, 1.0 equiv) in methanol (10 mL) 
was added p-toluenesulfonic acid (56.4 mg, 0.300 mmol, 0.2 equiv) and then the mixture 
was stirred overnight at room temperature. Methanol was evaporated under reduced 
pressure. The resulting crude product was purified by column chromatography using 
gradient elution (20% to 50% ethyl acetate in hexanes) to afford compound 34 as a 
colorless oil (0.513 g, 1.41 mmol, 94%).   
Rf (1:1 EtOAc/hexanes): 0.32;  
[𝛼]𝐷
20 = +2.93 (c 0.99, CHCl3);  
IR (neat): 3340, 2977, 2933, 1688, 1523, 1249, 1167, 1053, 970, 754 cm
-1
;  
1
H NMR (500 MHz, CDCl3): δ 7.31‒7.42 (m, 5 H), 5.62‒5.70 (m, 1 H), 5.50 (dd, J 
= 15.5, 5.5 Hz, 1 H), 5.07‒5.18 (m, 3 H), 4.56‒4.65 (m, 1 H), 4.22‒4.30 (m, 1 H), 3.62‒
3.71 (m, 2 H), 3.12‒3.23 (m, 2 H), 2.25 (br s, 1 H), 2.20‒2.23 (m, 2 H), 1.43 (s, 9 H); 
13
C NMR (125 MHz, CDCl3): δ 156.2 (two carbons overlapped), 136.4, 129.9, 129.4, 
128.5, 128.1, 79.4, 66.8, 64.9, 54.3, 39.9, 33.1, 28.4;  
HRMS (ESI) m/z calculated for C19H28N2O5Na [M + Na]
+
: 387.1896; found: 
387.1897.  
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(S, E)-2-(Benzyloxycarbonylamino)-6-(tert-butoxycarbonylamino)hex-3-enoic 
acid (27): To a solution of alcohol 34 (0.400 g, 1.10 mmol, 1.0 equiv) in acetone (15 mL) 
was added freshly made Jones reagent (2.70 M, 1.22 mL, 3.30 mmol, 3.0 equiv) slowly at 
0 °C. The reaction mixture was stirred for 1 h at the same temperature before isopropanol 
(0.50 mL) was added slowly to quench the reaction. The resulting mixture was then 
stirred at room temperature for 30 minutes. Solids were removed by filtration and solvent 
was removed in vacuo. Then water (15 mL) was added and the aqueous layer was 
extracted with ethyl acetate (3 × 50 mL). The combined organic layers were washed with 
brine, dried (MgSO4), filtered and concentrated. The resulting crude product was purified 
by column chromatography (8% MeOH in CH2Cl2) to afford acid 27 as a colorless solid 
(0.324 g, 0.858 mmol, 78%) and 36.0 mg (0.099 mmol, 9%) of starting material was 
recovered. 
Rf (1:10 MeOH/CH2Cl2): 0.23;  
1
H NMR (400 MHz, CD3OD): δ 12.0 (br s, 1 H), 7.26‒7.37 (m, 5 H), 5.76 (dt, J = 
15.5, 7.2 Hz, 1 H), 5.63 (dd, J = 15.5, 6.0 Hz, 1 H), 5.09 (s, 2 H), 4.68 (d, J = 6.0 Hz, 1 
H), 3.07 (t, J = 6.8 Hz, 2 H), 2.21 (dd, J = 13.5, 6.8 Hz, 2 H), 1.41 (s, 9 H). 
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(S, E)-Methyl 4-((S, E)-2-(benzyloxycarbonylamino)-6-(tert-butoxycarbonylami 
no)hex-3-enamido)-5-methylhex-2-enoate (35): To a solution of 5 (0.206 g, 0.802 mmol, 
1.0 equiv) in dichloromethane (6.0 mL) was added trifluoroacetic acid (2.0 mL, 25%) 
slowly at 0 °C and the reaction mixture was stirred at room temperature for 30 minutes. 
The solvent was then removed in vacuo to afford the crude amine 26 as a thick oil which 
was used directly in next step without further purification. 
To a solution of acid 27 (0.300 g, 0.802 mmol, 1.0 equiv), HOBt (0.130 g, 0.962 
mmol, 1.2 equiv), EDCI (0.184 g, 0.962 mmol, 1.2 equiv) and DIPEA (0.22 mL, 1.60 
mmol, 2.0 equiv) in dry dichloromethane (5.0 mL) was added the amine intermediate in 
dry dichloromethane (5.0 mL) at 0 °C. The reaction mixture was stirred overnight at 
room temperature. Then dichloromethane (50 mL) was added and the mixture was 
successively washed with 10% citric acid solution (10 ml), saturated NaHCO3 solution 
(10 ml) and brine. The organic layer was dried (MgSO4), filtered and concentrated. The 
resulting crude product was purified by column chromatography using gradient elution 
(20% to 50% ethyl acetate in hexanes) to afford 35 as a colorless oil (0.290 g, 0.561 
mmol, 70%). 
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Rf (1:1 EtOAc/hexanes): 0.5;  
[𝛼]𝐷
20 = +35.7 (c 1.52, CHCl3);  
IR (neat): 3315, 2966, 1708, 1520, 1248, 1172, 1042, 756 cm
-1
;  
1
H NMR (500 MHz, DMSO-d6): δ 7.96 (d, J = 8.8 Hz, 1 H), 7.53 (d, J = 7.8 Hz, 1 
H), 7.28‒7.40 (m, 5 H), 6.83 (dd, J = 15.8, 5.5 Hz, 1 H), 6.74 (m, 1 H), 5.83 (d, J = 15.7 
Hz, 1 H), 5.73 (dt, J = 15.7, 6.7 Hz, 1 H), 5.06 (dd, J = 15.5, 7 Hz, 1 H), 5.02 (s, 2 H), 
4.63 (t, J = 7.5 Hz, 1 H), 4.24‒4.32 (m, 1 H), 3.64 (s, 3 H), 2.89‒2.97 (m, 2 H), 2.02‒2.17 
(m, 2 H), 1.78‒1.90 (m, 1 H), 1.35 (s, 9 H), 0.85 (d, J = 6.6 Hz, 3 H ), 0.84 (d, J = 6.6 Hz, 
3 H);  
13
C NMR (75 MHz, CDCl3): δ 169.5, 166.5, 156.1, 146.6, 136.1, 133.3, 128.4, 
128.1, 128.0, 127.7, 121.5, 79.1, 66.9, 57.0, 55.9, 51.6, 40.0, 33.2, 31.9, 28.3, 18.9, 18.4;  
HRMS (ESI) m/z calculated for C27H39N3O7Na [M + Na]
+
: 540.2686; found: 
540.2674. 
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Macrocycle core (19): To a solution of methyl ester 35 (0.290 g, 0.561 mmol, 1.0 
equiv) in THF-MeOH-H2O (3:1:1) (20 mL) was added LiOH·H2O (0.0920 g, 2.24 mmol, 
4.0 equiv) at 0 °C. The heterogeneous reaction mixture was then warmed to room 
temperature and stirred overnight. Ethyl acetate (50 mL) was added to the mixture and 1 
M HCl solution was carefully added at 0 °C until pH = 3.0. The aqueous layer was 
extracted with ethyl acetate (3 × 50 mL) and combined organic layers were washed with 
brine, dried (MgSO4), filtered and concentrated. The resulting crude product was purified 
by column chromatography using gradient elution (2% to 8% MeOH in CH2Cl2) to afford 
carboxylic acid as a colorless solid (0.257 g, 0.511 mmol, 91%).  
To a solution of the carboxylic acid (0.269 g, 0.520 mmol, 1.0 equiv) in 
dichloromethane (5.4 mL) was added trifluoroacetic acid (1.8 mL, 25%) slowly at 0 °C 
and the reaction mixture was stirred at room temperature for 30 minutes. The solvent was 
then removed in vacuo to afford the crude product 15 as a thick oil which was used 
directly in next step without further purification. HRMS (ESI) m/z calculated for 
C21H30N3O5 [M + H]
+
: 404.2185; found: 404.2180. 
BOP (0.919 g, 2.08 mmol, 4.0 equiv), HOAt (0.283 g, 2.08 mmol, 4.0 equiv) and 
N,N-diisopropylethylamine (0.18 mL, 1.04 mmol, 2.0 equiv) were dissolved in 
dimethylformamide (150 mL) under nitrogen atmosphere in a 250 mL flame-dried flask. 
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A solution of the intermediate and N,N-diisopropylethylamine (0.18 mL, 1.04 mmol, 2.0 
equiv) in dimethylformamide (50 mL) was slowly added over 8 hours with a syringe 
pump and the reaction mixture was stirred for 2 days. The reaction was quenched by 
addition of 10% aq. citric acid and extracted with ethyl acetate. The organic layers were 
washed with water, brine, dried (MgSO4), filtered and concentrated. The resulting crude 
product was purified by column chromatography using gradient elution (2% to 8% 
MeOH in ethyl acetate) to afford macrocycle 19 as a colorless solid (29.5 mg, 0.0767 
mmol, 15%).  
Rf (1:10 MeOH/CH2Cl2): 0.41;  
[𝛼]𝐷
20 = -29.4 (c 0.08, MeOH);  
IR (neat): 3293, 3054, 2958, 1684, 1638, 1531, 1423, 1345, 1245, 1051, 963 cm
-1
; 
1
H NMR (400 MHz, DMSO-d6): δ 8.06 (d, J = 8.0 Hz, 1 H), 7.58 (d, J = 7.6 Hz, 1 
H), 7.51 (t, J = 7.0 Hz, 1 H), 7.29°C 7.38 (m, 5 H), 6.72 (dd, J = 15.2, 5.4 Hz, 1 H), 6.12 
(d, J = 15.2 Hz, 1 H), 5.66 (dt, J = 15.6, 7.6 Hz, 1 H), 5.36 (dd, J = 15.6, 8.0 Hz, 1 H), 
5.05 (ABq, J = 12.7 Hz, Δ= 16.8 Hz, 2 H), 4.63‒4.69 (m, 1 H), 4.02‒4.16 (m, 1 H), 
3.12‒3.26 (m, 2 H), 2.28‒2.38 (m, 1 H), 1.92‒1.99 (m, 1 H), 1.62‒1.82 (m, 1 H), 0.99 (d, 
J = 6.6 Hz, 3 H), 0.95 (d, J = 6.6 Hz, 3 H);  
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13
C NMR (125 MHz, DMSO-d6): δ 169.4, 166.2, 155.5, 143.3, 137.0, 133.2, 128.3, 
127.7, 127.6, 125.4, 121.5, 65.3, 55.8, 55.5, 42.4, 35.1, 31.4, 19.7, 19.2;  
HRMS (ESI) m/z calculated for C21H27N3O4Na [M + Na]
+
: 408.1899; found: 
408.1880. 
 
 
 
(S)-Benzyl 2-(3-((S)-1-tert-butoxy-3-methyl-1-oxobutan-2-yl)ureido)-3-methyl- 
butanoate (38): Benzyl (S)-(‒)-2-isocyanato-3-methylbutyrate 36 (77.0 mg, 0.330 mmol, 
1.0 equiv) was dissolved under nitrogen atmosphere in dichloromethane (5.0 mL) in a 25 
mL flame-dried flask. A solution of L-valine tert-butyl ester 37 (60.0 mg, 0.346 mmol, 
1.05 equiv) and triethylamine (91.1 µL, 0.660 mmol, 2.0 eq) in dichloromethane (5.0 mL) 
was added and the resulting mixture was stirred overnight at room temperature. The 
reaction was quenched by addition of 10% aq. citric acid solution (5 mL) and the aqueous 
layer was extracted with dichloromethane. The combined organic layers were washed 
with brine, dried (MgSO4), filtered and concentrated. The crude product was purified by 
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column chromatography using gradient elution (10% to 30% ethyl acetate in hexane) to 
afford urea 38 (0.130 g, 0.320 mmol, 97%) as a colorless crystal. 
Rf (1:2 EtOAc/hexanes): 0.62; 
[𝛼]𝐷
20 = +17.4 (c 0.12, CHCl3);  
IR (neat): 3344, 2967, 1737, 1638, 1563, 1144, 762 cm
-1
;  
1
H NMR (400 MHz, DMSO-d6): δ 7.32‒7.40 (m, 5 H), 6.44 (d, J = 8.8 Hz, 1 H), 
6.29 (d, J = 9.4 Hz, 1 H), 5.12 (ABq, J = 12.4 Hz, Δ= 22.6 Hz, 2 H), 4.11 (dd, J = 9.0, 
5.3 Hz, 1 H), 3.94 (dd, J = 9.0, 5.3 Hz, 1 H), 1.96‒2.05 (m, 2 H), 0.81‒0.88 (m, 12 H); 
13
C NMR (75 MHz, CDCl3): δ 173.6, 172.6, 157.6, 135.4, 128.4, 128.2, 81.5, 66.9, 
58.2, 57.9, 31.5, 31.3, 28.0, 19.0, 18.9, 17.5, 17.4; 
HRMS (ESI) m/z calculated for C22H34N2O5Na [M + Na]
+
: 429.2365; found: 
429.2354. 
 
 
(S)-2-(3-((S)-1-tert-Butoxy-3-methyl-1-oxobutan-2-yl)ureido)-3-methylbutanoic 
acid (39): Urea 38 (41.0 mg, 0.101 mmol) was dissolved in methanol (8.0 mL) and then 
10% Pd/C (4.0 mg) was added. The reaction was stirred under H2 atmosphere for 30 
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minutes before filtration to remove the catalyst. The solvent was removed under reduced 
pressure. The resulting residue was purified by column chromatography using gradient 
elution (2% to 10% MeOH in CH2Cl2) to afford acid 39 as a colorless solid (30.5 mg, 
0.0970 mmol, 97%).  
Rf (1:1 EtOAc/hexanes): 0.17; 
[𝛼]𝐷
20 = +30.5 (c 0.37, CHCl3); 
IR (neat): 3369, 2968, 2936, 2876, 1730, 1641, 1563, 1370, 1217, 1148, 763 cm
-1
;  
1
H NMR (400 MHz, DMSO-d6): δ 12.5 (br s, 1 H), 6.31 (d, J = 2.2 Hz, 1 H), 6.29 (d, 
J = 2.4 Hz, 1 H), 4.01 (dd, J = 9.0, 4.8 Hz, 1 H), 3.92 (dd, J = 9.0, 5.1 Hz, 1 H), 1.90‒
2.05 (m, 2 H), 1.40 (s, 9 H), 0.88 (d, J = 4.0 Hz, 3 H), 0.86 (d, J = 4.0 Hz, 3 H), 0.82‒
0.85 (m, 6 H);   
13
C NMR (75 MHz, CDCl3): δ 176.0, 173.1, 158.2, 82.3, 58.5, 31.6, 31.0, 28.0, 19.0, 
18.9, 17.8, 17.6;  
HRMS (ESI) m/z calculated for C15H28N2O5Na [M + Na]
+
: 339.1896; found: 
339.1893. 
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(S)-tert-Butyl 2-(3-((S)-1-((3E,5S,8S,9E)-5-isopropyl-2,7-dioxo-1,6-diazacyclodo- 
deca-3,9-dien-8-ylamino)-3-methyl-1-oxobutan-2-yl)ureido)-3-methylbutanoate (40): 
Macrocycle core 19 (7.5 mg, 0.0195 mmol, 1.0 equiv) was dissolved in acetic acid (20 μL) 
followed by addition of hydrobromic acid (33 wt.% in acetic acid, 20 μL) under nitrogen 
atmosphere. The reaction mixture was stirred at room temperature for 30 minutes before 
evaporation in vacuo to dryness. The resulting orange powder was dissolved in DMF (0.2 
mL) with N,N-diisopropylethylamine (6.8 μL, 0.0390 mmol, 2.0 equiv) at 0 °C, followed 
by addition of carboxylic acid 39 (6.8 mg, 0.0215 mmol, 1.1 equiv), BOP (12.5 mg, 0.0292 
mmol, 1.5 equiv) and HOAt (3.9 mg, 0.0292 mmol, 1.5 equiv) in dry dichloromethane (0.8 
mL) under nitrogen atmosphere. The reaction mixture was stirred overnight at room 
temperature before dilution with dichloromethane/methanol (9:1, 40 mL). The mixture was 
successively washed with 10% aq. citric acid solution (5 mL), sat. NaHCO3 solution (5 mL) 
and brine. The organic layer was dried (MgSO4), filtered and concentrated. The resulting 
crude product was purified by column chromatography using gradient elution (5% to 10% 
MeOH in CH2Cl2) to afford compound 40 as a colorless solid (9.1 mg, 0.0166 mmol, 85%). 
Rf (1:8 MeOH/CH2Cl2): 0.41;  
[𝛼]𝐷
20 = −21.4 (c 0.07, MeOH); 
IR (neat): 3277, 2963, 2874, 1728, 1632, 1547, 1469, 1391, 1368, 1221, 1150 cm
-1
;  
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1
H NMR (400 MHz, DMSO-d6): δ 8.07 (d, J = 7.2 Hz, 1 H), 8.03 (d, J = 8.8 Hz, 1 H), 
7.47 (t, J = 6.8 Hz, 1 H), 6.68 (dd, J = 15.5, 5.5 Hz, 1 H), 6.31 (d, J = 9.0 Hz, 1 H), 6.24 (d, 
J = 9.2 Hz, 1 H), 6.09 (d, J = 15.5 Hz, 1 H), 5.59 (dt, J = 15.5, 7.8 Hz, 1 H), 5.41 (dd, J = 
15.8, 7.6 Hz, 1 H), 4.83‒4.85 (m, 1 H), 4.02‒4.12 (m, 2 H), 3.88 (dd, J = 8.8, 5.1 Hz, 1 H), 
3.08‒3.25 (m, 2 H), 2.23‒2.33 (m, 1 H), 1.86‒2.02 (m, 3 H), 1.69‒1.78 (m, 1 H), 0.94 (d, J 
= 6.9 Hz, 3 H), 0.90 (d, J = 6.9 Hz, 3 H), 0.82‒0.87 (m, 9 H), 0.78 (d, J = 6.9 Hz, 3 H); 
13
C NMR (100 MHz, DMSO-d6): δ 171.7, 171.5, 168.9, 166.3, 157.6, 143.3, 133.1, 
125.9, 121.4, 80.1, 58.3, 57.3, 55.4, 53.6, 42.5, 35.0, 31.5, 31.2, 30.4, 27.7, 19.8, 19.3, 19.2, 
19.1, 17.7, 17.6;  
HRMS (ESI) m/z calculated for C28H48N5O6
 
[M + H]
+
: 550.3605; found: 550.3625. 
 
 
 
Synthetic syringolin A (1): Compound 40 (5.0 mg, 9.11 µmol) was dissolved in 
formic acid (0.4 ml) and the resulting mixture was stirred overnight at room temperature. 
After concentration to dryness, the crude product was purified by column 
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chromatography (2% acetic acid + 15% methanol in dichloromethane) to afford synthetic 
syringolin A (1) as a colorless solid (4.3 mg, 8.56 µmol, 94%). 
Rf (2% acetic acid + 15% methanol in dichloromethane): 0.28;  
1
H NMR (400 MHz, DMSO-d6): δ 12.5 (br s, 1 H), 7.98‒8.06 (m, 2 H), 7.47 (t, J = 7.2 
Hz, 1 H), 6.68 (dd, J = 15.5, 5.5 Hz, 1 H), 6.29 (d, J = 8.6 Hz, 1 H), 6.25 (d, J = 9.0 Hz, 1 H), 
6.09 (d, J = 15.2 Hz, 1 H), 5.59 (dt, J = 15.8, 7.6 Hz, 1 H), 5.41 (dd, J = 15.6, 7.8 Hz, 1 H), 
4.83‒4.85 (m, 1 H), 4.02‒4.12 (m, 2 H), 3.94 (dd, J = 8.8, 4.9 Hz, 1 H), 3.08‒3.25 (m, 2 H, 
overlapped with water), 2.23‒2.32 (m, 1 H), 1.86‒2.02 (m, 3 H), 1.68‒1.78 (m, 1 H), 0.94 
(d, J = 6.7 Hz, 3 H), 0.90 (d, J = 6.7 Hz, 3 H), 0.82‒0.87 (m, 9 H), 0.77 (d, J = 6.9 Hz, 3 H); 
13
C NMR (100 MHz, DMSO-d6): δ 173.5, 171.6, 168.9, 166.3, 157.6, 143.3, 133.0, 
126.1, 121.5, 58.2, 57.6, 55.5, 53.6, 42.5, 35.0, 31.5, 30.9, 30.6, 19.8, 19.4, 19.3, 19.2, 17.8, 
17.6; 
HRMS (ESI) m/z calculated for C24H39N5O6
 
[M + H]
+
: 494.2979; found: 494.3003. 
 
Bioactivity Data of Syringolin A Inhibiting Proteases 
Syringolin A and compound 19 were tested in a single-dose at 30 μM in duplicate by 
the Reaction Biology Corporation (Figure 1.4). The chart below shows that syringolin A 
inhibits the proteases: Cathepsin B, C, Kallikrein 5, 8, 13, and Adam10 strongly. 
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Figure 1.4 Biodata from 70 proteases screening 
 
70 Proteases are: 1. Activated Protein C; 2. ACE1; 3. ACE2; 4. ADAM9; 5. ADAM10; 6. BACE1; 
7. Calpain 1; 8. Cathepsin B; 9. Cathepsin C; 10. Cathepsin D; 11. Cathepsin E; 12. Cathepsin G; 
13. Cathepsin H; 14. Cathepsin K; 15. Cathepsin L; 16. Cathepsin S; 17. Cathepsin V; 18. 
Cathepsin X/Z; 19. CCC1s; 20. Chymase; 21. Chymotrypsin; 22. Caspase 1; 23. Caspase 2; 24. 
Caspase 3; 25. Caspase 4; 26. Caspase 5; 27. Caspase 6; 28. Caspase 7; 29. Caspase 8; 30. 
Caspase 9; 31. Caspase 10; 32. Caspase 11; 33. Caspase 14; 34. DPPIV; 35. DPPVIII; 36. DPPIX; 
37. Elastase; 38. FVIIa; 39. Fxa; 40. FxIa; 41. Granzyme B; 42. HCV NS3/4A; 43. Kallikrein 1; 
44. Kallikrein 5; 45. Kallikrein 8; 46. Kallikrein 12; 47. Kallikrein 13; 48. Kallikrein 14; 49. 
MMP 1; 50. MMP 2; 51. MMP 3; 52. MMP 7; 53. MMP 8; 54. MMP 9; 55. MMP 10; 56. MMP 
12; 57. MMP 13; 58. MMP 14; 59. Papain; 60. Plasma Kallikrein; 61. Plasmin; 62. Proteinase A; 
63. Proteinase K; 64. TACE; 65. Thrombin a; 66. tPA; 67. Trypsin; 68. Tryptase b2; 69. Tryptase 
g1; 70. Urokinase 
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CHAPTER 2 
Visible Light Photoredox Catalyst‒Ru(bpy)3Cl2  
 
1 Introduction 
1.1 Visible Light Photoredox Catalyst 
The development of new means to activate molecules for chemical reactions is a 
fundamental objective in chemistry, both for target-oriented
58
 and methods-driven
59
 
purposes. In particular, the development of new methods in catalysis has opened up new 
reactivity and/or selectivity for synthetic transformations.
60 , 61 , 62
 These selective 
processes on the other hand also enable the synthesis of complex molecules without the 
necessity of protective groups
63
 or unnecessary redox manipulations.
64,65
 In this regard, 
visible light-mediated photoredox catalysis has emerged as an attractive mode of 
selectively activating organic molecules and initiate organic reactions.
66,67,68
 Utilizing 
visible light, a free and abundant energy resource with tremendous environmental 
benefits, can minimize the side reactions often associated with the use of high-energy 
ultraviolet (UV) light, due to the inability of organic compounds to absorb visible light. 
Photocatalysts or photo dyes are generally used to transfer visible light into chemical 
energy in the molecules, and polypyridyl complexes of ruthenium and iridium are the 
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commonly used photocatalysts (Figure 2.1). Among them, tris(2,2’-bipyridine)ruthenium 
dichloride complex, Ru(bpy)3Cl2, is one of the most extensively studied and most wildly 
applied photocatalysts.  
 
Figure 2.1: Representative visible light photoredox catalysts 
 
 
1.2 General Photophysical Properties of Ru(bpy)3Cl2  
Over the past several decades it has been shown that Ru(bpy)3Cl2 (1), a 
commercially available red-orange crystalline photocatalyst, has excellent photochemical 
and electrochemical properties.
69,70,71
 The complex was first reported by Burstall in 1936, 
and two enantiomers were resolved by preparing the diastereomeric tartrates using 
ammonium tartrates.
72
 The octahedral complex has D3 symmetry. In the presence of a 
strong ligand (bpy) field, the 4d
6
 metal center adopts a low-spin electron configuration, 
and the d-orbitals are split into two sets: lower energy orbitals t2g and higher energy 
orbitals eg.
73
 In addition, there are π-bonding and π*-antibonding orbitals on the aromatic 
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rings of the ligands, as well as the σ-bonding orbital on the nitrogen atoms. The 
molecular orbital diagram of Ru(bpy)3
2+
 in the ground state with D3 symmetry indicates 
that the highest occupied molecular orbital (HOMO) a1 (dz
2
) has predominantly metal 
character, while the lowest unoccupied molecular orbital (LUMO) a2 (π
*
) is purely of 
ligand character (Figure 2.2a).
74
 Promotion of an electron to higher energy level results 
in three types of transitions, which are shown in the UV-visible absorption spectrum of 
Ru(bpy)3
2+
: (1) weak metal-centered (MC) transition from t2g (e + a1 in D3 symmetry) to 
eg
*
, also known as d-d transition, which is forbidden in the D3 symmetric system. It is 
observed with ε = 100 M-1 cm-1 in the spectrum, as a benefit of a large spin-orbit 
coupling effect; (2) ligand-centered (LC) transition from π to π*(a2 + e) in the UV region; 
and (3) metal to ligand charge transfer (MLCT), where an electron is excited from a 
metal-centered t2g orbital to the lowest unoccupied ligand-centered π
*
 orbital (Figure 
2.2b). The MLCT transition has the most intense absorption band in the visible light 
region (λmax = 452 nm, and ε = 14000 M
-1
 cm
-1
).
 75
 Therefore, visible light irradiation of 
Ru(bpy)3
2+
 will populate the singlet excited state followed by relaxation to the lowest 
energy 
1
MLCT
*
 singlet excited state, which is characterized by a d
5 
metal center and an 
electron in the aromatic system. This initially generated Franck-Condon excited state is 
believed to resemble the geometry of the ground state. Recent studies have been able to 
55 
  
detect this singlet excited state and estimate its lifetime to be approximately 40 
femtoseconds.
76
 Fluorescence emission, though very weak, was observed with λmax 
around 520 nm. Despite the unresolved experimental data suggesting that the excited 
electron being delocalized over three ligands, it is widely accepted that the electron is 
localized on a single ligand.
77,78
 A large dipole moment (14±6 D) was observed in the 
singlet excited state, pointing from the metal to the center of the bpy (π*) ligand. Solvent 
effect studies on the formation of MLCT
*
 also support a dipolar excited state, which can 
be expressed as [Ru
3+
(bpy) 2(bpy˙
－
)]
2+
.
79,80
  
 
Figure 2.2: Orbital diagram (a) Splitting of the d-orbitals for a RuL6 complex with D3 
symmetry in a strong ligand field (b) three electron transition diagram
81
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The generated singlet excited state undergoes ultrafast decay by intersystem crossing 
(ISC) to the lower-lying excited state with nearly unity quantum efficiency.
82
 The 
lifetime of 
1
MLCT
* 
excited state is determined by the rate of intersystem crossing, and a 
value of 40-100 femtoseconds is estimated for Ru(bpy)3
2+ 
in an acetonitrile solution.
83
 
Direct excitation of the ground state to this triplet state is spin forbidden. However, taking 
advantage of the strong spin-orbit coupling effect in mixing the triplet state and the 
singlet state, the lower energy excited state has about 10% singlet character,
84
 thus 
facilitating the intersystem crossing. The 
3
MLCT
*
 excited state, actually contains a set of 
triplet states which are closely spaced and in thermal equilibrium. For example the lowest 
energy 
3
MLCT
*
 excited state is believed to have at least three degenerated states.
85
 
Therefore, the term ‘3MLCT* excited state’ used herein, refers to a manifold of thermally 
equilibrated triplet excited states. Relaxation from the vibrationally hot triplet state to the 
lowest-energy triplet excited state takes up to 20 picoseconds.86 The 3MLCT* excited 
state has a life time of 890 nanoseconds in acetonitrile and 650 nanoseconds in water at 
25 ̊C, sufficiently long enough with regard to the time-scale of diffusion for bimolecular 
quenching reactions. A dipole moment of 5.8 D is reported for the 
3
MLCT
*
 excited state, 
which also indicates the localization of the excited electron on a single ligand.
87
 The 
electrostatic interaction between the cation with higher oxidation state and the anion 
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localized on the ligand distorts the geometry of the Ru(bpy)3
2+ 
complex from D3 to C2 
symmetry. Theoretical calculation indicates the 
3
MLCT
*
 (C2) state is slightly lower than 
the 
3
MLCT
*
 (D3) state in energy.
88
 
There are three main pathways for the triplet excited state to decay to the ground 
state (Figure 2.3). Two of them are 
3
MLCT
*
 involved radiative and nonradiative 
deactivation pathways. The observed luminescence emission (λmax = 615 nm) from 
Ru(bpy)3
2+
 is dominated by the phosphorescence from this long-lived triplet excited state, 
which is usually used in quenching experiments, by applying the Stern–Volmer equation 
to determine the efficiency of a molecule quenching the emission of the photocatalyst via 
either electron transfer or energy transfer. The third decay pathway involves a crossover 
into the closely spaced MC excited state, 
*
[Ru
2+
(bpy)2(η-bpy)]
2+
. Theoretical calculations 
indicate this 
3
MC
*
 excited state is located in between several 
3
MLCT
* 
degenerated states, 
but above the lowest 
3
MLCT
*
 set state. Meanwhile, the lifetime is measured 
experimentally to be around 80 microseconds.
89
 The 
3
MC
*
 excited state can undergo 
radiationless deactivation to the ground state, or ligand dissociation as a result of placing 
an electron in the dσ* antibonding orbital leading to cleavage of Ru-N bond, to generate 
a four-coordinate complex.
90
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Figure 2.3: Generalized Jablonski diagram of Ru(bpy)3
2+
 undergoing different deactivation 
processes 
 
Since the first report of the luminescence of Ru(bpy)3
2+
 half a century ago, 
numerous attempts, including both experimental studies and theoretical calculations, have 
been made to elucidate the relaxation dynamics and excited states involved.
91
 However, 
the whole process of excitation and relaxation still remains unclear. The development of 
new techniques provides promising opportunities to explore the photophysical properties 
of Ru(bpy)3
2+
. In particular, re-evaluation of the ultrafast transitions in the early process, 
for example the formation of 
1
MLCT
*
 excited state and its involvement in the electron 
and energy transfer,
92,93
 could open more possibilities for the use of photocatalysts for 
organic synthesis and industrial applications. 
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1.3 General Photochemical Properties of Ru(bpy)3Cl2  
As discussed above, irradiation of Ru(bpy)3
2+
 using visible light with maximum 
absorption at 452 nm, populates the singlet excited state (S1) via metal to ligand charge 
transfer. Currently, it is believed that the long-lived triplet excited state (T1) is engaged in 
the intermolecular quenching reactions. Ru(bpy)3
2+
 has been demonstrated to be an 
excellent single electron transfer photocatalyst (Figure 2.4). In competition with its 
inherent radiative decays, the excited state *Ru(bpy)3
2+
 can be reduced to Ru(bpy)3
1+
 by 
reductive quenchers having reduction potential more negative than +0.77 V vs. SCE 
(E1/2
II*/I
 measured in acetonitrile), or oxidized to Ru(bpy)3
3+
 by oxidative quenchers 
having reduction potential more positive than -0.81 V vs. SCE (E1/2
III/II*
 measured in 
acetonitrile).  The generated Ru(bpy)3
1+
 is a strong reductant (E1/2
II/I
 = -1.33 V vs. SCE 
in acetonitrile),  while Ru(bpy)3
3+
 is a strong oxidant (E1/2
III/II
 = +1.29 V vs. SCE in 
acetonitrile).  
From cyclic voltammetry (CV), the excited state energy of Ru(bpy)3
2+ 
is obtained 
with a value of 2.10 V at room temperature in acetonitrile, which approximately matches 
the energy difference of 2.03 V between the ground state and the lowest energy excited 
state 
3
MLCT
*
, which is calculated using the maximum emission at λ = 610 nm.94 The 
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value may differ due to the varying parameters during measurement, such as temperature, 
pH value, solvent concentration etc. 
 
Figure 2.4: Current view of visible light photoredox catalyst Ru(bpy)3
2+
 
 
 
1.4 Kinetics of Electron Transfer Process of Ru(bpy)3Cl2  
An example of an outer-sphere electron transfer process regarding the reductive 
quenching cycle of Ru(bpy)3
2+
 is shown in Figure 2.5. Upon visible light irradiation, the 
ground state Ru(bpy)3
2+ 
excites an electron from the t2g orbital of the metal center into the 
π* orbital localized on a single ligand to generate the excited state. In competition with its 
inherent radiative decay pathway (kr), the excited state can pair with a quencher (Q) in the 
solution (kd), followed by bimolecular charge transfer to generate Ru(bpy)3
+ 
and Q
+ (kq). 
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Previous research shows that the rate of charge transfer is in the range of diffusion with kq 
= 1 × 10
10
 M
-1
s
-1
. Reorganization of the solvent molecules around these two charged 
species creates a solvent cage. As a consequence, release of the products into the solution 
has to undergo diffusional cage escape (kce), while competing with the electron-transfer 
charge recombination reaction (krec) to give back Ru(bpy)3
2+ 
and the quencher which will 
diminish the yield of product.  
Based on the proposed model of charge recombination, after metal to ligand charge 
transfer, the reductive quencher will approach the catalyst from the side opposite to the 
charged ligand and inject an electron into the hole on the metal center. In turn, the 
separation of the oxidized quencher (Q
+
) and the reduced ligand may hinder the charge 
recombination. In order for the charge recombination to occur, efficient orbital overlap by 
reorientation of the molecules is required. There are two possibilities: if kreo > krec, then 
the efficiency of cage escape will be determined by krec and kce; if krec > kreo, then 
re-orientation is the rate-determining step and the efficiency of cage escape should be 
higher than in the previous case.
95
 Electron-transfer charge recombination of the two 
products can also regenerate the original species (krec).  
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Figure 2.5:  Representation of the reductive quenching process of Ru(bpy)3
2+
 with a 
quencher 
 
 
2 Applications of Ru(bpy)3Cl2 in Organic Synthesis 
The excellent stability, photophysical and photoelectrical properties, have made 
Ru(bpy)3
2+
 widely used in water splitting, photovoltaics, organic light-emitting diode and 
solar cell systems. However, the value of utilizing Ru(bpy)3
2+
 in organic synthesis did not 
draw widespread attention until very recently.   
In 1984, Deronzier and co-workers reported a Ru(bpy)3(BF4)2 catalyzed the Pschorr 
reaction.
96
 Using 5 mol% photocatalyst in acetonitrile, aryldiazonium salt 5 was 
converted to phenanthrene product 6 in quantitative yield. This net reaction avoids the 
use of any stoichiometric quencher and is believed to undergo oxidative quenching cycle 
of Ru(bpy)3
2+
 (Scheme 2.1).  
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Scheme 2.1:  Ru(bpy)3
2+
 catalyzed Pschorr reaction by Deronzier in 1984 
 
 
In 1991, Okada and co-workers reported an interesting decarboxylation reaction 
followed by 1,4-addition to give the alkylated product 10.
97
 BNAH (9) was used as 
stoichiometric reductive quencher. N-(acyloxy)phthalimide 7 was efficiently reduced 
under photoredox catalysis conditions to afford an alkyl radical intermediate, which was 
then coupled with methyl vinyl ketone 8 or other-unsaturated species, followed by 
hydrogen atom abstraction from BNAH to complete the transformation (Scheme 2.2). 
The attractive feature of this reaction is that it circumvents the harsh conditions or 
complicated reaction set-ups normally used in the traditional decarboxylation reactions, 
and provides a mild yet robust strategy to obtain the desired product with one carbon 
short.  
Scheme 2.2: Ru(bpy)3
2+
 catalyzed decarboxylation reaction by Okada in 1991 
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In 2008, MacMillan and co-workers successfully demonstrated that photoredox 
catalysis could be merged with other catalytic systems, for instance singly occupied 
molecular orbital (SOMO) organocatalysis, to achieve asymmetric transformations 
under mild conditions.
98
 An enantioselective catalytic -alkylation of aldehydes with 
alkyl halides using a combination of Ru(bpy)3
2+
 and imidazolidinone catalyst 13 was 
reported. The reaction was proposed to undergo reductive quenching cycle, and enamine 
generated by condensation of aldehyde 11 with 13 was the key intermediate engaged in 
the radical coupling reaction (Scheme 2.3). This transformation provided typically high 
levels of enantioselectivity and yields for a range of aldehyde and bromide coupling 
partners. 
Scheme 2.3: Photocatalysis merged with SOMO catalysis by MacMillan in 2008 
 
 
The same year, Yoon and co-workers reported a [2+2] cyclization of bis(enones) 
using visible light photoredox catalysis.
99
 The reaction conditions provided excellent 
yields and diastereomeric ratios (dr) of the cyclobutane products with high functional 
group tolerance. N,N-Diisopropylethylamine (
i
Pr2NEt) was used as the reductive 
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quencher to generate the strong reductant Ru(bpy)3
1+
 which is capable of reducing the 
lithium-activated enone 15 to give a radical anion intermediate followed by 
cycloaddition to give the product 16 (Scheme 2.4).  
 
Scheme 2.4: Photocatalysis mediated [2+2] cycloaddition by Yoon in 2011 
 
 
Further application of visible light-mediated photocatalysis to [4+2] cycloaddition 
was achieved by Yoon and co-workers in 2011.
100
 When bis(enones) 17 tethered by a 
four-carbon linker was treated under the same conditions above for [2+2] cycloaddition, 
the dihydropyran products 18 were observed with high regioselectivity (Scheme 2.5).  
 
Scheme 2.5: Photocatalysis mediated [4+2] cycloaddition by Yoon in 2008 
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In 2009, Stephenson and co-workers reported an efficient visible light-mediated 
reductive dehalogenation.
101
 Utilizing the reductive quenching cycle of Ru(bpy)3Cl2, 
halogens  to an electron-withdrawing group (e.g. carbonyl or aryl group) were 
successfully reduced. Two sets of reaction conditions were provided, while condition B 
proved particularly effective for the less activated halogen substituents (Scheme 2.6). 
The reaction is highlighted by high yields with excellent chemoselectivity and high 
functional group tolerance. Moreover, the avoidance of toxic tin reagents as used in 
traditional dehalogenation reactions makes this mild transformation synthetically 
appealing.  
 
Scheme 2.6: Photocatalysis mediated dehalogenation by Stephenson in 2010 
 
 
The dehalogenation of α-halocarbonyls was further applied to ATRA reaction by 
Stephenson and co-workers in 2011. Various terminal alkenes 22, cyclic internal alkenes 
and terminal alkynes were subjected to undergo radical addition (Scheme 2.7).
102
 Both 
radical-polar crossover and radical propagation mechanisms were seemed to amenable 
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for this transformation and the extent to which pathway is favored over the other is 
likely depends on the nature of the substrate itself.  
 
Scheme 2.7: Photocatalysis mediated ATRA by Stephenson in 2011 
 
 
Li and co-workers reported the synthesis of benzothiazoles 25 from 
thiobenzanilides 24 using oxidative photoredox catalysis. Oxygen was used as the 
oxidative quencher to convert Ru(bpy)3
2+
 to Ru(bpy)3
3+
. There was no conversion if DBU 
was not added indicating the deprotonation of 24 occurred. The generated anion was 
oxidized by Ru(bpy)3
3+ 
to provide sulfur centered radical, which underwent the 
cyclization followed by hydrogen atom removal provided the desired benzothiazole 
product (Scheme 2.8).
103
  
 
 Scheme 2.8: Photocatalysis mediated synthesis of benzothiazoles by Li in 2012 
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The convergence of photoredox catalysis with organometallic catalysis for the 
C-CF3 bond formation was reported by Sanford and co-workers in 2012.
104
 CuOAc was 
used as both reductive quencher and transition metal catalyst. Trifluoromethyl iodide 
(CF3I, 27) was reduced via photoredox catalysis and an active “Cu-CF3” complex was 
generated, followed by transmetallation with boronic acid 26 to provide the coupling 
product 28 in high yield (Scheme 2.9).   
 
Scheme 2.9: Photocatalysismerged with transition metal catalysis by Sanford in 2012 
 
 
Rovis and co-workers reported an asymmetric carbon-carbon bond formation using 
dual catalysis approach, combining photoredox catalysis and nucleophilic heterocyclic 
carbene (NHC) catalysis, in 2012.
105
 With meta-dinitrobenzene (32) as the sacrificial 
oxidative quencher, N-aryltetrahydroisoquinoline 29 was proposed to undergo oxidation 
to give the iminium intermediate by Ru(bpy)3
3+
, which was ready for the nucleophilic 
addition of an acyl anion generated via NHC catalysis. The high enantioselectivity was 
controlled by the chiral NHC catalyst 31 (Scheme 2.10). 
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Scheme 2.10: Photocatalysis merged with NHC-catalysis by Rovis in 2012 
 
3 Conclusion 
In this chapter, the generation and general features of Ru(bpy)3
2+
, including 
photophysical and photochemical properties, were introduced. Although further 
exploration of this photoredox catalyst is still undergoing and a number of areas need to 
be re-investigated, Ru(bpy)3
2+
 has shown excellent physical characteristics. Moreover, the 
unique single electron transfer property along with the strong reducing and oxidizing 
abilities of the quenched species (Ru
+ 
and Ru
3+
), has made Ru(bpy)3
2+
 a powerful 
photoredox catalyst in organic synthesis. Applications in organic transformations were 
also briefly discussed. After the seminal publications of the Mamillan, Yoon, and 
Stephenson groups, the re-ermergence of photoredox catalysis has led to a wide variety of 
new synthetically efficient processes. 
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CHAPTER 3 
Friedel‒Crafts Amidoalkylation Using Oxidative Photocatalysis 
 
1 Introduction  
1.1 Applications of the Oxidative Photocatalysis 
As mentioned in Chapter 2, photoredox catalysis has emerged as a powerful tool for 
organic synthesis and extensive studies demonstrated that photocatalysts, such as 
Ru(bpy)3Cl2, can initiate single electron transfer (SET) processes under visible light 
irradiation, therefore providing a new means to selectively activate molecules and 
promote chemical transformations.
106
 Our group has been particularly interested in 
utilizing the reductive quenching pathway of photoredox catalysts to activate chemical 
bonds, which has successfully been applied to the activation of carbon-halogen bonds 
using Ru(bpy)3Cl2 for reductive dehalogenation via carbon-centered radical intermediates. 
On the other hand, the exploration and application of the oxidative quenching pathway of 
Ru(bpy)3Cl2 still remain as challenging goals, with only a few examples reported in the 
literature. 
Several quenchers are known to oxidize 
*
Ru(bpy)3
2+
 (E1/2
III/II*
 = -0.81 V vs SCE) or 
its derivatives and generate the corresponding strong oxidants, such as Ru(bpy)3
3+
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(E1/2
III/II
 = +1.29 V vs SCE). In early studies of photoredox catalysis, 4,4’-bipyridinium 
salts (viologens) were extensively explored as the oxidative quenchers of Ru(bpy)3
2+
. The 
well-known dimethyl viologen (MV
2+
) undergoes a single electron reduction at E1/2
red
 = 
-0.4 V vs SCE to provide the radical cation species (MV˙+), which can be further reduced 
at E1/2
red
 = -0.8 V vs SCE to the neutral dihydrobipyridyl species (MV). Taking 
advantage of the facile electron transfer to viologens from photocatalysts, Willner and 
co-workers performed the reduction of 1,2-dibromostilbenes (1) using 
Ru(bpy)3
2+
/viologen system to obtain trans-stilbenes (2) in high yields. 
N,N’-Dioctyl-4,4’-bipyridinium (C8V
2+
), having oxidation state dependent solubility, 
served as a phase-transfer electron shuttle and its two electron-reduced species, C8V, was 
believed to be the key reducing agent in the debromination, while (NH4)3EDTA was used 
as the stoichiometric reductant to turn over Ru(bpy)3
2+
 (Scheme 3.1).
107
 
 
Scheme 3.1 Debromination using the Ru(bpy)3
2+
/C8V
2+
 system 
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The same Ru(bpy)3
2+
/ C8V
2+
 system was applied by Tomioka and co-workers to the 
reduction of nitroalkenes 3 to oximes 4 along with a small amount of the corresponding 
ketones 5. In this case, it was proposed that either the radical cation species (MV˙+), or 
the neutral species (MV) was responsible for the reduction of nitroalkenes (Scheme 
3.2).
108
  
 
Scheme 3.2 Reduction of nitroalkenes using the Ru(bpy)3
2+
/MV
2+
 system 
 
 
A more recent example illustrating the utility of the Ru(bpy)3
2+
/ MV
2+
 system was 
shown by Yoon and co-workers in the [2+2] cycloaddtion of bis(styrenes) 6 to give the 
cyclobutane products 7 in high yields and with good diastereoselectivities. Ru(bpy)3
3+ 
generated by reaction with MV
2+
, was proposed to be the oxidant of the electron-rich 
olefin partner of the bis(styrene) to give a radical cation intermediate, which then coupled 
with the pendent styrene partner bearing either the electron-rich or electron-deficient 
olefin to give the intramolecular cyclized product (Scheme 3.3).
109
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Scheme 3.3 [2+2] Cycloaddtion using the Ru(bpy)3
2+
/MV
2+
 system 
 
 
Cano-Yelo and Deronzier used aryldiazonium salt 8 (E1/2 = –0.1 V vs SCE for 
phenyldiazonium tetrafluoroborate)
110
 as the sacrificial oxidative quencher, for the 
oxidation of alcohol 9 to aldehyde 11.
111
 Photocatalyst 10, a derivative of Ru(bpy)3
2+
, 
facilitated this transformation. The electron-withdrawing group on the bipyridine ligand 
increased the potential of the catalyst (E1/2
III/II
 = +1.59 V vs SCE) for oxidation of 
alcohols. Benzophenone (12) and fluorenone (13) formed via the Pschorr reaction from 8 
were the stoichiometric by-products (Scheme 3.4).
112
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Scheme 3.4 Oxidation of alcohols using the Ru(bpy)3
2+
/diazonium system 
 
 
Ohkubo and co-workers synthesized a chiral complex △-[Ru(menbpy)3]
2+
 (15), to 
investigate the enantioselective radical transformations induced by photocatalysts.
113
 In 
this case, Co(acac)3 (E1/2
red
 = –0.34 V vs SCE) served as the stoichiometric oxidative 
quencher of △-*[Ru(menbpy)3]
2+
 (E1/2
III/II*
 = -0.45 V vs SCE in acetonitrile) to generate 
△-[Ru(menbpy)3]
3+
 (E1/2
III/II
 = +1.55 V vs SCE in acetonitrile), which was sufficient to 
oxidize naphthols 14 to undergo the asymmetric biaryl coupling reaction and gave 
(R)-(+)-1,1'-bi-2-naphthols 16 as the favored products. The authors suggest that the low 
enantioselectivity is due to the van der Waals interactions between the chiral 
photocatalyst and the substrate (Scheme 3.5).
114
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Scheme 3.5 Biaryl coupling using the Ru(bpy)3
2+
/Co(acac)3 system 
 
 
In the atom transfer radical addition (ATRA) reactions, Barton and co-workers used 
Se-phenyl p-tolueneselenosulfonate (17) as both the substrate and the oxidative quencher. 
Reduction by Ru(bpy)3
2+ 
gave phenylselenolate and sulfonyl radical, which added to a 
range of electron-rich olefins 18 to give ATRA products 19 in high yields (Scheme 
3.6).
115
 
 
Scheme 3.6 ATRA reaction using the Ru(bpy)3
2+
/selenosulfonate system 
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Other applications of the oxidative quenching pathway of Ru(bpy)3
2+
 and its 
derivatives include: cross-linking of proteins using persulfate as the oxidant by Kodadek 
and co-workers;
116,117,118
 oxidation of sulfides to sulfoxides on the Nafion membrane 
containing both Ru(bpy)3
2+
 and lead ruthenate pyrochlore catalyst (Pyc) which served as 
the oxidant in the presence of H2O2, by Zen and co-workers;
119
 and the Meerwein–
Ponndorf–Verley-type reductions of the carbonyl compounds to alcohols in iPrOH using 
the Ru(bpy)3
2+
/MV
2+
 system by Garcia and co-workers.
120
  
 
1.2 Friedel-Crafts Aminoalkylation via N-Acyliminium Ions 
The Friedel-Crafts reaction represents a fundamental method of electrophilic 
aromatic substitutions, in which a new C-C bond is introduced into the arenes and 
heteroarenes.
121,122
 The remarkable power of this transformation to assemble highly 
functionalized aromatic compounds has been recognized by both academic and industrial 
communities, thus remaining as one of the most versatile methods applied in total 
synthesis, pharmaceutical, dye and agrochemical industry.
123
 Initial research was focused 
on alkylation from alkyl halides or acylation from acyl chlorides using stoichiometric 
amounts of Lewis acids (such as AlCl3, BF3, FeCl3, TiCl4 and SnCl4) or strong 
Brønsted-acids (such as HF, H2SO4 and HF·SbF5). Further investigation on the catalytic 
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Friedel–Crafts reaction led to the development of lanthanide trifluoromethanesulfonates 
[such as Sc(OTf)3]
124
 or molybdenum complexes [such as Mo(CO)6]
125
 catalyzed 
systems. Recently, a stereoselective Friedel–Crafts reaction was also reported using chiral 
metal complexes
126
 or chiral Brønsted-acids.
127
 In this context, various alkylating 
species have been studied including epoxides, alcohols, olefins, nitro compounds, 
carbonyl compounds, imines and azodicarboxylates.  
Amidoalkylation of arenes which is normally conducted using N-alkyl or 
N-arylimines as the electrophiles, can also be achieved employing more reactive 
N-acyliminium ions, and thus open to a broader range of functionalizations.
128,129
 The 
importance of N-acyliminium ions in organic synthesis has been well documented, 
especially in the synthesis of alkaloid natural products,
130
  such as gelsemine,
131
 
(±)-jamtine,
132
 epiquinamide
133
 and (‒)-lepadiformine.134  Conventionally, these highly 
reactive N-acyliminium ions were generated in situ through acid-promoted elimination of 
-oxyalkylamides, or single electron oxidation of -(tributylstannyl)alkylamides,135 or 
direct anodic oxidation of -(trimethylsilyl)alkylamides. 136  Among these methods, 
-oxyalkylamides are the most commonly used precursors to give N-acyliminium ions. 
The general methods to synthesize -oxyalkylamide include acylation of imines followed 
by addition of alkoxides, direct reduction of acyclic acylcarbamates using DIBAL-H or 
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cyclic imides using NaBH4, DABCO-catalyzed condensation of -aminoaldehydes with 
acrylamides, TMSOTf-catalyzed addition of N,N-bis(trimethylsilyl)formamide (BSF) to 
aldehydes or pyruvates, Pb(OAc)4 oxidation of L-serine derivatives, condensation of 
aldehydes with amides and benzotriazoles followed by replacement of the benzotriazolyl 
group by alkoxides, and heating of N-sulfonyloxy amides in 2-propanol.
137,138,139
 In order 
to circumvent the pre-synthesis of -oxyalkylamides, an in situ generation of 
-oxyalkylamides followed by Lewis acid catalyzed Friedel-Crafts reaction has also 
been reported using alkylamides with FeCl3/
t
BuOO
t
Bu
140
 and Cu/
t
BuOOCOPh.
141
 
Although these approaches avoid the need for pre-functionalization, elevated 
temperatures are required to homolyze the O-O bond in the peroxides. Meanwhile, 
Ru/
t
BuOOH affords the -(tert-butyldioxy)alkylamides at room temperature.142 The 
generation of N-acyliminium ions from these -oxyalkylamides is reversible as a result 
of the presence of counterions in the reaction. Irreversible generation of N-acyliminium 
ions via direct anodic oxidation of amides has also been reported.
143,144,145
 However, 
amides have a significantly more positive reduction potential (2.0 V for primary amides, 
1.8 V for secondary amides and 1.2-1.5 V vs SCE for tertiary amides)146 than the 
corresponding amines, making them far less susceptible to direct oxidation, including 
photocatalyst-mediated oxidation.  
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2 Aim of the Project 
In line with our investigative pursuit into the dearomatization of phenols towards 
C-C or C-O bond formations via intramolecular cyclization,147 we were searching for 
proper oxidants which could oxidize para-substituted phenols. By comparing the redox 
potential of phenol (E1/2
red
 = +0.65 V vs Ag/AgCl) and Ru(bpy)3
3+
 (E1/2
III/II
 = +1.29 V vs 
SCE), we envisioned that the oxidative dearomatization could be achieved via the 
oxidative quenching pathway of Ru(bpy)3
2+ 
(Scheme 3.7).    
 
Scheme 3.7 Dearomatization of phenols towards intramolecular cyclization  
 
 
Various oxidative conditions were tested and unfortunately none of them gave the 
desired cyclized product. However, when persulfate (S2O8
2-
) was used as the oxidative 
quencher of Ru(bpy)3
2+ 
in DMF, we observed DMF functionalized product 24 in low 
yields instead of the product of phenolic dearomatization (Scheme 3.8).    
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Scheme 3.8 Functionalization of DMF via oxidative photocatalysis  
 
 
It is well precedented that persulfate (S2O8
2‒
) is an effective oxidative quencher of 
*
Ru(bpy)3
2+
,
148 , 149 , 150
 and the generated sulfate radical anion (SO4˙
-
) is a reactive 
intermediate known to abstract activated hydrogen atoms and also be a strong 
oxidant.
151 ,152 ,153
 In view of this property, we reasoned that the -amido radicals 
generated via H-atom abstraction by sulfate radical anion are strongly reducing, 
potentially allowing for the in situ generation of the corresponding N-acyliminium ions 
with subsequent trapping by the nucleophilic alcohols. Given that visible light 
photocatalysis requires mild reaction conditions and provides outstanding functional 
group tolerance, we anticipated the generalization of this approach would offer 
significant advantages compared with current methods. Therefore, we planned to apply 
oxidative photoredox catalysis to the formation of N-acyliminium ions in situ from 
dialkylamides, which would enable the development of the first Ru(bpy)3
2+
 catalyzed 
Friedel-Crafts amidoalkylation reaction when arenes or heteroarenes are used as the 
nucleophiles (Scheme 3.9).  
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Scheme 3.9 Functionalization of dialkylamides via oxidative quenching pathway  
 
 
3 Development of the Friedel-Crafts Amidoalkylation  
3.1 Initial Results and Condition Optimization 
When 3-phenyl-1-propanol (25) or 3-(4-methoxyphenyl)-1-propanol (26) was 
treated with Ru(bpy)3Cl2 (1.0 mol %), Na2S2O8 (5.0 equiv) and 2,6-lutidine (2.0 equiv) in 
DMF, upon visible light irradiation for 12 h at room temperature, formation of the 
N,O-aminal product (27 or 28) was observed (Scheme 3.10).  
 
Scheme 3.10 Formation of N,O-aminals using persulfate   
 
 
Despite complete consumption of the starting material, the isolated yields were 
relatively low (30−66%), presumably due to the lability of the N,O-aminals during the 
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aqueous work-up and subsequent chromatographic purification. However, these results 
demonstrated that N-acyliminium ions could be generated via the visible light-mediated 
reduction of persulfate at room temperature. 
Other oxidative quenchers were also tested. Among them, N-chlorosuccinimide 
(NCS) worked very well in combination with Ir(ppy)2(dtb-bpy)PF6 [also Ru(bpy)3Cl2] 
and substrate 25 providing the desired N,O-aminal product 27 in 76% isolated yield. 
While the reaction was running without degassing but opened to air, the isolated yield 
was slightly attenuated to 66% (Scheme 3.11). However, when substrate with 
electron-rich moiety (such as 26) was treated under the same condition, the reaction 
became complicated and generated several products with around 50% overall conversion.    
  
Scheme 3.11 Formation of N,O-aminals using NCS 
 
 
The NCS/Ir(ppy)2(dtb-bpy)PF6 system was also examined in THF. When alcohols 
25 and 26 were used as nucleophiles, -functionalization of THF was observed and acetal 
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products 29 and 30 were isolated (Scheme 3.12). Interestingly, reactions without 
degassing provided much higher yields (81% of 29 and 84% of 30) than the degassed 
ones (46% of 29 and 58% of 30), due to the suppression of byproduct formation in the 
presence of air. 
 
Scheme 3.12 Formation of acetals using NCS 
 
 
The Friedel−Crafts reaction was further explored using the electron-rich aromatics 
as nucleophiles to form more stable C−C bonds, allowing for facile isolation of the 
products. At the outset, electron-rich 1,3,5-trimethoxybenzene (31) was chosen as the 
nucleophile (Table 3.1). Full consumption of 31 was observed when treated with 
Ru(bpy)3Cl2 and 5.0 equiv of persulfate in DMF after 12 h under the visible light 
irradiation at room temperature (entry 1). Little or no conversion was observed in the 
absence of the catalyst or light, and rigorous degassing was required to achieve optimal 
results, presumably as a consequence of undesired and unproductive excited state energy 
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transfer with oxygen (entries 2−4). Persulfate was found to be essential for the 
transformation, requiring 5.0 equiv for optimal results (entries 5−6).  
 
Table 3.1 Formation of N,O-aminals  
 
Entry Condition
a)
 Conversion
b)
 
1 catalyst, persulfate (5.0 equiv) 99% 
2 no catalyst, persulfate (5.0 equiv) <5% 
3 
catalyst, persulfate (5.0 equiv),  
no blue LEDs 
0 
4 
catalyst, persulfate (5.0 equiv), 
no degassing 
59% 
5 catalyst, no persulfate 0 
6 catalyst, persulfate (4.0 equiv) 86% 
a)
Except for entry 4, the reactions were rigorously degassed. 
b)
Determined by crude 
1
H NMR. 
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3.2 Substrate Scope for the Friedel−Crafts Amidoalkylation Using Photocatalysis 
With the optimized conditions in hand, various electron-rich aromatic and 
heteroaromatic substrates were examined with dialkylamides 33
154
 in the presence of 
persulfate under the photocatalytic conditions (Table 3.2). Treatment of 
1,3,5-trimethoxybenzene (31) with Ru(bpy)3Cl2 and (NH4)2S2O8 in DMF (33a) at room 
temperature afforded mono-substituted product 32 exclusively (entry 1). Switching to 
DMA (33b), both mono-substituted and di-substituted products, 35 and 36 respectively, 
were obtained in a 3.9:1 ratio (entry 2). A differentiated dialkylamide, such as 
1-methyl-2-pyrrolidinone (33c), afforded a mixture of regioisomeric, mono-substituted 
products 37 and 38 (entry 3). Surprisingly, when 1,2,3-trimethoxybenzene (39) was 
treated with the same conditions in the presence of 33a or 33b, the reaction failed to 
provide either of the desired products. Prolonged reaction time or higher temperature did 
not improve the conversion (entry 4). Less nucleophilic substrates, such as 40 and 43, 
needed higher temperatures and longer reaction times under photocatalytic conditions 
(entries 5−8). Substrates bearing multiple nucleophilic sites, such as 43, provided 
mixtures of regioisomers. Furthermore, 1,4-dimethoxybenzene (48) also failed to provide 
the desired products (entry 9). Highly reactive substrates, such as indole (49, entry 10) 
and N-methylindole (51, entry 11), performed poorly in this oxidative coupling reaction. 
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The low yields were presumably due to the oxidative decomposition of the highly 
electron-rich substrates themselves or the loss of the products 50 and 52 by oxidation at 
the methylene carbon adjacent to the amide nitrogen. When switching to N-phenyl indole 
(53, entry 12) and N-benzyl indole (55, entry 13), the reactions gave moderate yields of 
the desired products. In all cases, substitution at the C2 position of the indoles was not 
observed.  
 
Table 3.2 Oxidation of dialkylamides and coupling with arenes
 
using photocatalysis 
 
Entry Substrate 33 T(°C) Hour Product
a)
 Yield
b)
 
1 
 
a 25 12 
 
89% 
only 32 
2 31 b 25 12 
 
72% 
35:36=3.9:1
c)
 
3 31 c 25 12 
 
85% 
37:38>25:1
c)
 
4 
 
a/b 25 12 NR NR 
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5 
 
a 30 36 
 
66% (82%)
d)
 
6 40 b 30 36 
 
68% (85%)
d)
 
7 
 
a 30 60 
 
44% (67%)
d)
 
44:45=12:1
c)
 
8 43 b 30 60 
 
40% (51%)
d)
 
46:47=9.5:1
c)
 
9 
 
a/b 30 60 NR NR 
10 
 
a 25 12  10% 
11 
 
a 25 2 
 
23% 
12 
 
a 25 12 
 
56% 
13 
 
a 25 12 
 
52% 
a)
The reaction was degassed (freeze-pump-thaw) and carried out under argon atmosphere using a 
nucleophile (0.5 mmol) and ammonium persulfate (2.5 mmol) in the presence of Ru(bpy)3Cl2 (1.0 
mol%) in dialkylamides (33, 5.0 mL). 
b)
Isolated yields. 
c)
Determined by crude 
1
H NMR. 
d)
Yields 
are based on the recovered starting materials. 
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However, when N-CO2Me and N-Cbz substituted indoles (57 and 58, respectively) 
were treated under the standard photocatalytic condition, only trace amount of the 
C3-substituted products were generated. Instead, C2-acylated products (59 and 60, 
respectively) were observed with moderate conversions (Scheme 3.13). Prolonged 
reaction time did not help to improve the yield. The mechanism for this transformation is 
not very clear. Possibly acyl- and alkyl-radicals both exist in the reaction, with the 
N-alkyl radical being the favored species. Therefore electron-rich indoles would prefer 
the C3-aminoalkylation, while mild electron-deficient indoles would undergo the 
C2-acylation with modest conversions.  
 
Scheme 3.13 C2-Acylation of N-CO2Me and N-Cbz indoles using photocatalysis 
 
 
N-Sulfonylated indole 61 showed no reactivity under the photocatalytic condition, 
and it failed to provide either the C3-alkylated product 62 or the C2-acylated product 63 
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(Scheme 3.14). It may be due to the fact that electron-withdrawing group (-SO2Ph) tunes 
the reactivity of indole from nucleophilic to electrophilic. 
 
Scheme 3.14 N-Sulfonylated indole under photocatalytic condition 
 
 
3.3 Substrate Scope for the Friedel−Crafts Amidoalkylation Using Thermolysis 
A metal-free thermal decomposition of persulfate was also observed upon heating of 
1,3,5-trimethoxybenzene (31) and persulfate to 55 °C in the absence of the photocatalyst, 
which led to the same amide oxidation product 32 in 2 h (Scheme 3.15), indicating that 
the Friedel−Crafts amidoalkylation could be achieved via thermolysis.  
 
Scheme 3.15 Friedel−Crafts amidoalkylation using thermolysis 
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In order to compare with the photocatalytic transformation, the same substrate scope 
was tested under the identical conditions, except using higher temperature (55 °C) instead 
of Ru(bpy)3Cl2. For all the substrates, the same Friedel−Crafts products were obtained 
and the same trend of reactivity of the substrates was observed, albeit with attenuated 
yields and selectivities (Table 3.3). 
 
Table 3.3 Oxidation of dialkylamides and coupling with arenes
 
using thermolysis 
 
Entry Substrate 33 T(°C) Hour Product
a)
 Yield
 b)
 
1 
 
a 55 12 
 
75% 
32:34=12:1
c)
 
2 31 b 55 12 
 
64% 
35:36=3.9:1
c)
 
3 31 c 55 12 
 
86% 
37:38=11:1
c)
 
4 
 
a/b 55-85 12 NR NR 
5 
 
a 55 36 
 
45% (57%)
d)
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6 40 b 55 36 
 
35% (53%)
d)
 
7 
 
a 55 60 
 
42% (66%)
d)
 
44:45=10:1
c)
 
8 43 b 55 60 
 
31% (48%)
d)
 
46:47=8.1:1
c)
 
9 
 
a/b 55-85 60 NR NR 
10 
 
a 55 12 
 
8% 
11 
 
a 55 2 
 
28% 
12 
 
a 55 2 
 
45% 
13 
 
a 55 2 
 
44% 
a)
The reaction was carried out under argon atmosphere using a nucleophile (0.5 mmol) and 
ammonium persulfate (2.5 mmol) in dialkylamides (33, 5.0 mL) at 55 °C. 
b)
Isolated yields. 
c)
Determined by crude 
1
H NMR. 
d)
Yields are based on the recovered starting materials. 
 
 
3.4 Proposed Mechanism  
Plausible mechanisms for the oxidation of dialkylamides, using DMF as an example, 
are shown in Scheme 3.16. Under the photocatalytic conditions, persulfate is reduced by 
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*
Ru(bpy)3
2+
 to give sulfate and sulfate radical anion 64. Alternatively, under thermal 
conditions persulfate may decompose homolytically to generate two equivalents of 64. 
The sulfate radical 64 then abstracts a H-atom from N-methyl group in DMF to give the 
-amido radical 65. Direct oxidation of 65 by Ru3+ (+1.27 V vs SCE) or via electron 
transfer of persulfate can lead to N-acyliminium ion 66 (Pathway A), which can also be 
obtained via a radical chain process (Pathway B) to give oxyalkylamide 67 followed by 
elimination of the sulfate. Either way, the generated acyliminium ion 66 is susceptible to 
nucleophilic trapping by various electron-rich arenes to afford the desired products 68. 
  
Scheme 3.16 Proposed mechanism  
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Initially, a direct oxidation of dialkylamide followed by intramolecular H-atom 
abstraction pathway was proposed for the generation of -amido radical 65 (Scheme 
3.17), based on an incorrect determination of the ratio of regioisomeric products from 
reaction of trimethoxybenzene (31) with 1-methyl-2-pyrrolidinone (33c).  
 
Scheme 3.17 Possible intramolecular H-atom abstraction?  
 
 
In order to distinguish the intra- and intermolecular H-atom abstractions, an isotopic 
labeling experiment was carried out using a 1:1 mixture of DMF/DMF-d7 as solvent with 
31. The observed product distribution (32H : 32D
*
 = 2.3:1) from this competition 
experiment suggests that the intermolecular H-atom abstraction may be the rate-limiting 
step (Scheme 3.18, top). Surprisingly, a very small amount (7%) of deuterium 
incorporation in the aromatic ring of the product also occurred. This might be the result 
of a reversible oxidation of trimethoxybenzene during the course of the reaction (Scheme 
3.18, bottom). 
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Scheme 3.18 Isotopic labeling experiment  
 
 
4 Conclusion 
In conclusion, by utilizing the oxidative quenching pathway of Ru(bpy)3Cl2, we 
have developed a protocol for the oxidative functionalization of dialkylamides and 
further applications to the Friedel‒Crafts reaction in the presence of various 
nucleophiles.
155
 Persulfate was found to be an inexpensive and efficient reagent for this 
transformation, and is operative under either thermal or photochemical reaction condition. 
Electron-rich species, such as alcohols and arenes served as suitable nucleophiles. In 
most cases, photocatalysis provided higher yields and better selectivities for the Friedel‒
Crafts reactions compared with the thermolytic conditions. Both methods are highlighted 
by their operational simplicity and mild reaction conditions.  
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5 Experimental Section 
General Information 
Glassware was dried in a 170 °C oven or flame dried under vacuum and cooled 
under inert atmosphere before use. Chemicals were either used as received or purified 
according to the procedures outlined in Purification of Common Laboratory Chemicals. 
All reactions were performed using common dry, inert atmosphere techniques. 
1
H and 
13
C 
NMR spectra were recorded on Varian Mercury 300, Varian Unity Plus 400 or a Varian 
500 spectrometers, using an internal deuterium lock. 
 
General Procedure A for the Oxidation of Alkylamides Using Ru(bpy)3Cl2 (Table 
3.2) 
A flame dried 10 mL Schlenk flask with a rubber septum and magnetic stir bar was 
charged with tris(2,2’-bipyridyl)ruthenium(II) chloride hexahydrate (5.0 μmol), the 
corresponding substrate (0.5 mmol) and ammonium persulfate (2.5 mmol). Then 5.0 mL 
of dry dimethylformamide (DMF), dimethylacetamide (DMA), or 
1-methyl-2-pyrrolidinone (DMP) was added via syringe. The mixture was degassed by 
the freeze-pump-thaw procedure (3x) and placed in a 250 mL beaker with blue LEDs 
wrapped inside. The reaction mixture was stirred at room temperature (or 30 ˚C using a 
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100 mL beaker) under argon atmosphere for the time specified in Table 3.2. Then the 
mixture was poured into a separatory funnel containing 100 mL of ethyl acetate and 50 
mL of sat. NaHCO3 solution. The layers were separated and the aqueous layer was 
extracted with ethyl acetate (50 mL). The combined organic layers were washed with 
H2O (2 x 50 mL), brine and dried over Na2SO4. Solvent was evaporated under reduced 
pressure and the residue was purified by chromatography on silica gel to afford the 
desired product. 
 
General Procedure B for the Oxidation of Alkylamides Under Thermolysis (Table 
3.3).  
To a solution of substrate (0.5 mmol) in 5.0 mL of dimethylformamide (DMF), 
dimethylacetamide (DMA), or 1-methyl-2-pyrrolidinone (DMP) in a 10 mL round bottom 
flask was added ammonium persulfate (2.5 mmol). The mixture was then heated to 55 °C 
and stirred at that temperature for the time specified in Table 3.3. Then the reaction 
mixture was poured into a separatory funnel containing 100 mL of ethyl acetate and 50 
mL of sat. NaHCO3 solution. The layers were separated and the aqueous layer was 
extracted with ethyl acetate (50 mL). The combined organic layers were washed with 
H2O (2 x 50 mL), brine and dried over Na2SO4. Solvent was evaporated under reduced 
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pressure and the residue was purified by chromatography on silica gel to afford the 
desired product. 
 
Compound Preparation and Characterization 
 
N-Methyl-N-((3-phenylpropoxy)methyl)formamide (27): According to general 
procedure A, 25 (83.0 mg, 0.50 mmol), ammonium persulfate (0.57 g, 2.5 mmol), 
2,6-lutidine (117 L, 1.0 mmol) and Ru(bpy)3Cl2 (3.7 mg, 5.0 mol) in DMF (5.0 mL) 
afforded 27 as a colorless oil. Yields varied from 34 to 66%. 
Rf (EtOAc/hexanes 1:1): 0.15; 
IR (neat): 2928, 2866, 1679, 1390, 1252, 1100, 1036, 748, 701 cm
-1
;  
Observed as two rotamers in a 82:18 ratio: 
1
H NMR (500 MHz, CDCl3) δ 8.15/8.15 (s, 1 H), 7.31–7.27 (m, 2 H), 7.21–7.16 (m, 
2 H), 4.82/4.66 (s, 2 H), 3.45/3.34 (t, J = 6.4 Hz, 2 H), 2.98/2.93 (s, 3 H), 2.71-2.66 (m, 2 
H), 1.94-1.87 (m, 2 H); 
98 
  
13
C NMR (75 MHz, CDCl3) δ 163.4, 162.8, 141.7, 141.3, 128.4 (two overlapped 
signals: 128.41, 128.37), 128.3, 126.0, 125.8, 80.3, 73.6, 67.7, 66.6, 33.0, 32.3, 32.2, 31.1, 
30.9, 29.0;  
HRMS (ESI) m/z calcd for C12H18NO2 [M + H]
+
: 208.1338; found: 208.1345. 
 
 
 
N-((3-(4-methoxyphenyl)propoxy)methyl)-N-methylformamide (28): According 
to general procedure A, 26 (83.0 mg, 0.50 mmol), ammonium persulfate (0.57 g, 2.5 
mmol), 2,6-lutidine (117 L, 1.0 mmol) and Ru(bpy)3Cl2 (3.7 mg, 5.0 mol) in DMF (5.0 
mL) afforded 28 as a colorless oil. Yields varied from 33 to 55%. 
Rf (EtOAc/hexanes 1:1): 0.11; 
IR (neat): 2943, 2866, 2836, 1683, 1513, 1391, 1247, 1100, 1037, 842, 711 cm
-1
;  
Observed as two rotamers in a 81:19 ratio: 
1
H NMR (400 MHz, CDCl3) δ 8.16/8.16 (s, 1 H), 7.10–7.06 (m, 2 H), 6.85–6.81 (m, 
2 H), 4.82/4.65 (s, 2 H), 3.79/3.79 (s, 3 H), 3.44/3.33 (t, J = 6.4 Hz, 2 H), 2.98/2.93 (s, 3 
H), 2.65–2.59 (m, 2 H), 1.90–1.83 (m, 2 H); 
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13
C NMR (75 MHz, CDCl3) δ 163.4, 162.7, 157.8 (two overlapped signals 157.85, 
157.76), 133.7, 133.4, 129.2, 113.8, 113.7, 80.3, 73.6, 67.7, 66.5, 55.2, 33.0, 31.3 (two 
overlapped signals: 31.32, 31.29), 31.2, 31.1, 28.9;  
HRMS (ESI) m/z calcd for C13H20NO3 [M + H]
+
: 238.1443; found: 238.1453. 
 
 
 
N-Methyl-N-(2,4,6-trimethoxybenzyl)formamide (32): According to general 
procedure A, 31 (84.0 mg, 0.50 mmol), ammonium persulfate (0.57 g, 2.5 mmol) and 
Ru(bpy)3Cl2 (3.7 mg, 5.0 mol) in DMF (5.0 mL) afforded 32 (106.7 mg, 89%) as a 
colorless solid.  
Rf (EtOAc): 0.41; 
IR (neat): 2943, 2867, 1661, 1608, 1592, 1499, 1419, 1240, 1124, 1058, 950, 825 
676 cm
-1
;  
Observed as two rotamers in a 92:8 ratio: 
1
H NMR (400 MHz, CDCl3) δ 8.25/8.03 (s, 1 H), 6.11/6.11 (s, 2 H), 4.56/4.35 (s, 2 
H), 3.81/3.81 (s, 3 H), 3.80/3.80 (s, 6 H), 2.72/2.66 (s, 3 H); 
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13
C NMR (75 MHz, CDCl3) δ 163.6, 162.0, 161.3, 161.1, 160.0, 159.6, 104.4, 103.8, 
90.3, 90.2, 55.6, 55.5, 55.3, 41.3, 35.3, 33.0, 28.7;  
HRMS (ESI) m/z calcd for C12H17NO4Na [M + Na]
+
: 262.1055; found: 262.1055. 
 
 
 
According to general procedure B, 31 (84.0 mg, 0.50 mmol) and ammonium 
persulfate (0.57 g, 2.5 mmol) in DMF (5.0 mL) at 55 °C afforded 32 (83.0 mg, 69%) and 
34 (8.9 mg, 6%). 
N,N'-((2,4,6-Trimethoxy-1,3-phenylene)bis(methylene))bis(N-methylformamide) 
(34): A colorless solid. 
Rf (EtOAc/methanol 8:1): 0.40; 
IR (neat): 2948, 1668, 1605, 1441, 1399, 1227, 1127, 1107, 737 cm
-1
;  
Each component was observed as a set of 2–4 peaks due to the existence of three 
rotamers: 
1
H NMR (400 MHz, CDCl3) δ 8.25/8.06 (s, 2 H), 6.28/6.28 (s, 1 H), 4.60/4.36 (s, 4 
H), 3.84/3.84 (s, 6 H), 3.72/3.71 (s, 3 H), 2.70/2.69/2.67/2.66 (s, 6 H);  
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13
C NMR (100 MHz, CDCl3) δ 163.4, 163.3, 162.3, 160.3, 160.1, 159.9, 159.8, 
159.7, 109.4, 109.2, 108.9, 91.5, 91.2, 63.2, 62.8, 55.8, 55.7, 55.6, 42.2 (two overlapped 
signals: 42.22, 42.20), 36.0, 33.1, 28.8, 28.7;  
HRMS (ESI) m/z calcd for C15H22N2O5Na [M + Na]
+
: 333.1426; found: 333.1439. 
 
 
 
According to general procedure A, 31 (84.0 mg, 0.50 mmol), ammonium persulfate 
(0.57 g, 2.5 mmol) and Ru(bpy)3Cl2 (3.7 mg, 5.0 mol) in DMA (5.0 mL) afforded 35 
(70.0 mg, 56%) and 36 (27.0 mg, 16%). 
According to general procedure B, 31 (84.0 mg, 0.50 mmol) and ammonium 
persulfate (0.57 g, 2.5 mmol) in DMA (5.0 mL) afforded 35 (64.0 mg, 51%) and 36 (23.0 
mg, 14%). 
N-methyl-N-(2,4,6-trimethoxybenzyl)acetamide (35): A colorless solid.  
Rf (EtOAc/methanol 10:1): 0.48; 
IR (neat): 2943, 2841, 1608, 1456, 1420, 1205, 1151, 1014, 950, 817 cm
-1
;  
Observed as two rotamers in a 80:20 ratio: 
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1
H NMR (400 MHz, CDCl3) δ 6.12/6.12 (s, 2 H), 4.62/4.45 (s, 2 H), 3.82/3.82 (s, 3 
H), 3.80/3.79 (s, 6 H), 2.71/2.71 (s, 3 H), 2.28/2.07 (s, 3 H); 
13
C NMR (75 MHz, CDCl3) δ 170.7, 170.0, 161.1, 160.8, 160.0, 159.6, 105.2, 104.8, 
90.2, 90.1, 55.6, 55.4, 55.2 (two overlapped signals: 55.25, 55.23), 42.1, 37.9, 33.7, 31.1, 
22.1, 21.4;  
HRMS (ESI) m/z calcd for C13H19NO4Na [M + Na]
+
: 276.1212; found: 276.1208. 
N,N'-((2,4,6-Trimethoxy-1,3-phenylene)bis(methylene))bis(N-methylacetamide) 
(36): A colorless solid.  
Rf (EtOAc/methanol 5:1): 0.43; 
IR (neat): 2942, 2841, 1624, 1601, 1439, 1399, 1320, 1216, 1132, 1097, 1017, 969, 
820 cm
-1
;  
Each component was observed as a set of 2–4 peaks due to the existence of three 
rotamers: 
1
H NMR (400 MHz, CDCl3) δ 6.29/6.28 (s, 1 H), 4.67/4.65/4.47/4.46 (s, 4 H), 
3.84/3.83 (s, 6 H), 3.67/3.65 (s, 3 H), 2.71/2.69 (s, 6 H), 2.28/2.08 (s, 6 H);  
13
C NMR (100 MHz, CDCl3) δ 170.7, 170.6, 170.2, 170.1, 160.6, 160.2, 159.8, 
159.7, 159.6, 159.5, 159.3, 110.3, 110.2, 109.9, 109.7, 91.4, 91.2, 63.0, 62.5, 62.1, 55.7, 
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55.6, 55.5, 55.4, 42.9, 38.5, 38.4, 33.7, 33.6, 31.1, 22.0 (two overlapped signals: 21.99, 
21.96), 21.4;  
HRMS (ESI) m/z calcd for C17H26N2O5Na [M + Na]
+
: 361.1739; found: 361.1729. 
 
 
 
According to general procedure A, 31 (84.0 mg, 0.50 mmol), ammonium persulfate 
(0.57 g, 2.5 mmol) and Ru(bpy)3Cl2 (3.7 mg, 5.0 mol) in DMP (5.0 mL) afforded 37 and 
38 (total: 113.3 mg, 85%, >25:1). 
According to general procedure B, 31 (84.0 mg, 0.50 mmol) and ammonium 
persulfate (0.57 g, 2.5 mmol) in DMP (5.0 mL) afforded 37 and 38 (total: 115.1 mg, 86%, 
11:1). 
 1-Methyl-5-(2,4,6-trimethoxyphenyl)pyrrolidin-2-one (37): A colorless solid. 
This product could not be isolated in a pure form; contaminated with 38.  
Rf (EtOAc/methanol 10:1): 0.53; 
IR (neat): 2943, 1668, 1606, 1551, 1457, 1420, 1285, 1226, 1205, 1156, 1115, 1060, 
955, 815 cm
-1
;  
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1
H NMR (400 MHz, CDCl3) δ 6.12 (s, 2 H), 5.23 (dd, J = 9.6, 4.6 Hz, 1 H), 3.81 (s, 
3 H), 3.77 (s, 6 H), 2.63–2.53 (m, 1 H), 2.53 (s, 3 H), 2.47–2.38 (m, 1 H), 2.36–2.25 (m, 
1 H), 2.06–1.97 (m, 1 H);  
13
C NMR (100 MHz, CDCl3) δ 175.3, 160.8, 159.8 (broad), 108.4, 90.5 (broad), 
55.7, 55.2, 53.9, 31.1, 27.3, 23.6;  
Key peaks for 1-(2,4,6-trimethoxybenzyl)pyrrolidin-2-one (38): 
1
H NMR (400 MHz, CDCl3) δ 4.48 (s, 2 H), 3.13 (t, J = 7.0 Hz, 2 H), 1.90-1.82 (m, 
2 H);  
13
C NMR (100 MHz, CDCl3) δ 174.1, 161.0, 159.8, 104.6, 90.2, 55.7, 55.2, 46.0, 
34.4, 31.2, 17.6; 
HRMS (ESI) m/z calcd for C14H20NO4 [M + H]
+
: 266.1392; found: 266.1392. 
 
 
 
N-(2,4-Dimethoxy-5-methylbenzyl)-N-methylformamide (41): According to 
general procedure A, 40 (76.0 mg, 0.50 mmol), ammonium persulfate (0.57 g, 2.5 mmol) 
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and Ru(bpy)3Cl2 (3.7 mg, 5.0 mol) in DMF (5.0 mL) afforded 41 (73.0 mg, 66%) as a 
colorless oil, and recovered 15.1 mg of starting material (brsm 82%).  
According to general procedure B, 40 (76.0 mg, 0.50 mmol) and ammonium 
persulfate (0.57 g, 2.5 mmol) in DMF (5.0 mL) afforded 41 (50.0 mg, 45%) as a colorless 
oil, and recovered 16.0 mg of starting material (brsm 57%).  
Rf (EtOAc): 0.45; 
IR (neat): 2933, 1666, 1615, 1511, 1465, 1396, 1298, 1206, 1113, 1034, 818 cm
-1
;  
Observed as two rotamers in a 75:25 ratio: 
1
H NMR (400 MHz, CDCl3) δ 8.26/8.11 (s, 1 H), 6.97/6.87 (s, 1 H), 6.42/6.42 (s, 1 
H), 4.48/4.28 (s, 2 H), 3.84/3.84/3.83/3.82 (s, 6 H), 2.82/2.74 (s, 3 H), 2.13/2.11 (s, 3 H); 
13
C NMR (100 MHz, CDCl3) δ 163.2, 162.5, 158.3, 157.9, 156.8, 156.7, 131.8, 
131.5, 118.3, 117.8, 115.3, 114.7, 94.8, 94.7, 55.6, 55.4, 48.4, 41.3, 34.1, 28.9, 15.1;  
HRMS (ESI) m/z calcd for C12H17NO3Na [M + Na]
+
: 246.1106; found: 246.1104. 
 
 
 
N-(2,4-Dimethoxy-5-methylbenzyl)-N-methylacetamide (42): According to 
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general procedure A, 40 (76.0 mg, 0.50 mmol), ammonium persulfate (0.57 g, 2.5 mmol) 
and Ru(bpy)3Cl2 (3.7 mg, 5.0 mol) in DMA (5.0 mL) afforded 42 (80.0 mg, 68%) as a 
colorless oil, and recovered 15.0 mg of starting material (brsm 85%).  
According to general procedure B, 40 (76.0 mg, 0.50 mmol) and ammonium 
persulfate (0.57 g, 2.5 mmol) in DMA (5.0 mL) afforded 42 (42.0 mg, 35%) as a 
colorless oil, and recovered 25.0 mg of starting material (brsm 53%).  
Rf (EtOAc): 0.40; 
IR (neat): 2937, 1636, 1511, 1464, 1399, 1298, 1205, 1107, 1033, 885, 817, 750 
cm
-1
;  
Observed as two rotamers in a 62:38 ratio: 
1
H NMR (400 MHz, CDCl3) δ 6.98/6.79 (s, 1 H), 6.43/6.41 (s, 1 H), 4.53/4.40 (s, 2 
H), 3.84/3.83/3.82 (s, 6 H), 2.91/2.88 (s, 3 H), 2.16/2.13/2.12 (s, 6 H);  
13
C NMR (100 MHz, CDCl3) δ 171.1, 170.5, 157.8, 157.6, 156.5, 156.1, 131.5, 
129.4, 118.2, 117.9, 116.7, 115.4, 94.8, 94.7, 55.6, 55.4 (two overlapped signals: 55.44, 
55.37), 55.3, 49.2, 44.1, 35.5, 33.1, 21.8, 21.2, 15.2, 15.1; 
HRMS (ESI) m/z calcd for C13H19NO3Na [M + Na]
+
: 260.1263; found: 260.1251. 
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According to general procedure A, 43 (69.0 mg, 0.50 mmol), ammonium persulfate 
(0.57 g, 2.5 mmol) and Ru(bpy)3Cl2 (3.7 mg, 5.0 mol) in DMF (5.0 mL) afforded 44 
and 45 (total: 45.0 mg, 44%, 12:1), and recovered 24.0 mg of starting material (brsm 
67%).  
According to general procedure B, 43 (69.0 mg, 0.50 mmol) and ammonium 
persulfate (0.57 g, 2.5 mmol) in DMF (5.0 mL) afforded 44 and 45 (total: 44.0 mg, 42%, 
10:1), and recovered 24.8 mg of starting material (brsm 66%).  
N-(2,4-Dimethoxybenzyl)-N-methylformamide (44): A colorless solid.  
Rf (EtOAc/hexane 2:1): 0.50; 
IR (neat): 2955, 2844, 1658, 1593, 1473, 1392, 1256, 1111, 780, 742, 678 cm
-1
;  
Observed as two rotamers in a 75:25 ratio: 
1
H NMR (400 MHz, CDCl3) δ 8.24/8.10 (s, 1 H), 7.13/7.03 (d, J = 8.8 Hz, 1 H), 
6.46–6.43 (m, 2 H), 4.48/4.29 (s, 2 H), 3.80/3.79 (s, 6 H), 2.83/2.73 (s, 3 H);  
13
C NMR (100 MHz, CDCl3) δ 163.3, 162.6, 161.0, 160.4, 158.8, 158.6, 130.7, 
130.4, 116.6, 116.1, 104.2, 103.8, 98.7, 98.4, 55.4, 55.3 (two overlapped signals: 55.35, 
55.29), 48.6, 41.7, 34.2, 29.0;  
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HRMS (ESI) m/z calcd for C11H16NO3 [M + H]
+
: 210.1130; found: 210.1138. 
N-(2,6-Dimethoxybenzyl)-N-methylformamide (45): A colorless solid. This 
product could not be isolated in a pure form; contaminated with 44. The following data 
were obtained from a pure form via an alternative synthetic route, which resemble the 
spectra of the mixture.  
Rf (EtOAc/hexane 2:1): 0.45; 
IR (neat): 2939, 1665, 1611, 1589, 1508, 1457, 1396, 1290, 1208, 1157, 1124, 1033, 
919, 834 cm
-1
;  
Observed as two rotamers in a 91:9 ratio: 
1
H NMR (400 MHz, CDCl3) δ 8.29/8.05 (s, 1 H), 7.25/7.25 (t, J = 8.4 Hz, 1 H), 
6.55/6.55 (d, J = 8.4 Hz, 2 H), 4.65/4.43 (s, 2 H), 3.82/3.81 (s, 6 H), 2.74/2.67 (s, 3 H);  
13
C NMR (75 MHz, CDCl3) δ 163.7, 162.1, 159.3, 158.9, 129.6, 129.3, 111.7, 111.2, 
103.5, 55.7, 55.6, 41.4, 35.5, 33.1, 28.8;  
HRMS (ESI) m/z calcd for C11H15NO3Na [M + Na]
+
: 232.0950; found: 232.0943. 
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According to general procedure A, 43 (69.0 mg, 0.50 mmol), ammonium persulfate 
(0.57 g, 2.5 mmol) and Ru(bpy)3Cl2 (3.7 mg, 5.0 mol) in DMA (5.0 mL) afforded 46 
and 47 (total: 45.0 mg, 40%, 9.5:1), and recovered 14.8 mg of starting material (brsm 
51%).  
According to general procedure B, 43 (69.0 mg, 0.50 mmol) and ammonium 
persulfate (0.57 g, 2.5 mmol) in DMA (5.0 mL) afforded 46 and 47 (total: 34.5 mg, 31%, 
8.1:1), and recovered 24.2 mg of starting material (brsm 48%).  
N-(2,4-Dimethoxybenzyl)-N-methylacetamide (46): A colorless solid. 
Rf (EtOAc/hexane 4:1): 0.40; 
IR (neat): 2938, 1613, 1508, 1463, 1405, 1290, 1262, 1209, 1157, 1033, 936, 835 
cm
-1
;  
Observed as two rotamers in a 62:38 ratio: 
1
H NMR (400 MHz, CDCl3) δ 7.14/6.96 (d, J = 8.8 Hz, 1 H), 6.47–6.43 (m, 2 H), 
4.54/4.42 (s, 2 H), 3.81/3.80/3.79 (s, 6 H), 2.93/2.89 (s, 3 H), 2.15/2.12 (s, 3 H);  
13
C NMR (100 MHz, CDCl3) δ 171.4, 170.8, 160.5, 160.1, 158.5, 158.2, 130.4, 
128.2, 117.9, 116.8, 104.2, 103.8, 98.6, 98.3, 55.4, 55.3 (two overlapped signals: 55.33, 
55.30), 55.2, 49.5, 44.7, 35.8, 33.3, 21.8, 21.2;  
HRMS (ESI) m/z calcd for C12H17NO3Na [M + Na]
+
: 246.1106; found: 246.1113. 
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N-(2,6-Dimethoxybenzyl)-N-methylacetamide (47): A colorless solid.  
This product could not be isolated in a pure form; contaminated with 46. The 
following data were obtained from a pure form via an alternative synthetic route, which 
resemble the spectra of the mixture.  
Rf (EtOAc/hexane 4:1): 0.40; 
IR (neat): 2943, 1630, 1592, 1455, 1393, 1261, 1130, 1099, 1037, 1008, 827, 787, 
756, 720 cm
-1
;  
Observed as two rotamers in a 80:20 ratio: 
1
H NMR (400 MHz, CDCl3) δ 7.25/7.23 (t, J = 8.0 Hz, 1 H), 6.56/6.55 (d, J = 8.0 
Hz, 2 H), 4.71/4.53 (s, 2 H), 3.82/3.81 (s, 6 H), 2.73/2.73 (s, 3 H), 2.31/2.08 (s, 3 H);  
13
C NMR (100 MHz, CDCl3) δ 170.9, 170.1, 159.3, 158.9, 129.4, 129.0, 112.7, 
112.2, 103.5 (two overlapped signals: 103.54, 103.51), 55.7, 55.5, 42.3, 38.2, 33.8, 31.2, 
22.0, 21.3;  
HRMS (ESI) m/z calcd for C12H17NO3Na [M + Na]
+
: 246.1106; found: 246.1099. 
 
 
 
111 
  
N-((1H-Indol-3-yl)methyl)-N-methylformamide (50): According to general 
procedure A, 49 (58.5 mg, 0.50 mmol), ammonium persulfate (0.57 g, 2.5 mmol) and 
Ru(bpy)3Cl2 (3.7 mg, 5.0 mol) in DMF (5.0 mL) afforded 50 (9.3 mg, 10%) as a yellow 
oil.  
According to general procedure B, 49 (58.5 mg, 0.50 mmol) and ammonium 
persulfate (0.57 g, 2.5 mmol) in DMF (5.0 mL) afforded 50 (7.8 mg, 8%) as a yellow oil. 
Rf (EtOAc/hexane 2:1): 0.28; 
IR (neat): 3277, 2925, 1657, 1457, 1394, 1356, 1234, 1081, 744 cm
-1
;  
Observed as two rotamers in a 54:46 ratio: 
1
H NMR (400 MHz, CDCl3) δ 8.42/8.12 (s, 1 H), 8.30–8.17 (br s, 1 H), 7.71/7.54 (d, 
J = 7.6 Hz, 1 H), 7.39 (t, J = 9.0 Hz, 1 H), 7.24–7.17 (m, 3 H), 4.71/4.59 (s, 2 H), 
2.83/2.82 (s, 3 H);  
13
C NMR (100 MHz, CDCl3) δ 162.6, 162.3, 136.6, 136.3, 126.6, 126.3, 124.2, 
123.6, 122.5, 122.3, 120.0, 119.8, 119.1, 118.3, 111.5, 111.2, 110.5, 110.1, 45.4, 38.8, 
33.9, 29.2; 
HRMS (ESI) m/z calcd for C22H25N4O2 [2M + H]
+
: 377.1978; found:377.1965. 
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N-Methyl-N-((1-methyl-1H-indol-3-yl)methyl)formamide (52): According to 
general procedure A, 51 (65.5 mg, 0.50 mmol), ammonium persulfate (0.57 g, 2.5 mmol) 
and Ru(bpy)3Cl2 (3.7 mg, 5.0 mol) in DMF (5.0 mL) afforded 52 (22.9 mg, 23%) as a 
yellow oil. 
According to general procedure B, 51 (65.5 mg, 0.50 mmol) and ammonium 
persulfate (0.57 g, 2.50 mmol) in DMF (5.0 mL) afforded 52 (28.0 mg, 28%) as a yellow 
oil. 
Rf (EtOAc/hexane 2:1): 0.30; 
IR (neat): 3056, 2920, 1660, 1552, 1474, 1396, 1330, 1256, 1130, 1065, 1013, 962, 
741 cm
-1
;  
Observed as two rotamers in a 54:46 ratio: 
1
H NMR (400 MHz, CDCl3) δ 8.41/8.10 (s, 1 H), 7.69/7.52 (d, J = 8.0 Hz, 1 H), 
7.35–7.22 (m, 2 H), 7.17–7.11 (m, 1 H), 7.05/7.00 (s, 1 H), 4.68/4.57 (s, 2 H), 3.79/3.77 
(s, 3 H), 2.83/2.81 (s, 3 H);  
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13
C NMR (100 MHz, CDCl3) δ 162.3, 162.0, 137.1, 136.9, 128.6, 128.0, 127.1, 
126.7, 122.0, 121.8, 119.5, 119.3, 119.2, 118.4, 109.4, 109.1 (two overlapped signals: 
109.13, 109.08), 108.7, 45.1, 38.4, 33.7, 32.6, 32.5, 29.0;  
HRMS (ESI) m/z calcd for C12H14N2ONa [M + Na]
+
: 225.1004; found: 225.1006. 
 
 
 
N-Methyl-N-((1-phenyl-1H-indol-3-yl)methyl)formamide (54): According to 
general procedure A, 53 (96.5 mg, 0.50 mmol), ammonium persulfate (0.57 g, 2.5 mmol) 
and Ru(bpy)3Cl2 (3.7 mg, 5.0 mol) in DMF (5.0 mL) afforded 54 (73.0 mg, 56%) as a 
yellow oil. 
According to general procedure B, 53 (96.5 mg, 0.50 mmol) and ammonium 
persulfate (0.57 g, 2.5 mmol) in DMF (5.0 mL) afforded 54 (59.0 mg, 45%) as a yellow 
oil. 
Rf (EtOAc/hexane 5:1): 0.45; 
IR (neat): 3058, 2920, 2856, 1664, 1596, 1500, 1457, 1396, 1238, 1138, 1076, 910, 
742 cm
-1
;  
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Observed as two rotamers in a 54:46 ratio: 
1
H NMR (400 MHz, DMSO-d6) δ 8.48/8.11 (s, 1 H), 7.73-7.53 (m, 7 H), 7.43–7.38 
(m, 1 H), 7.25–7.11 (m, 2 H), 4.66/4.63 (s, 2 H), 2.84/2.70 (s, 3 H);  
13
C NMR (100 MHz, CDCl3) δ 162.5, 162.2, 139.4, 139.2, 136.5, 136.2, 129.7, 
129.6, 128.0, 127.7, 127.6, 127.0, 126.8, 126.5, 124.3, 124.2, 123.0, 122.9, 120.7, 120.5, 
119.7, 118.8, 111.9, 111.5, 110.9, 110.5, 45.2, 38.6, 33.9, 29.3;  
HRMS (ESI) m/z calcd for C17H16N2ONa [M + Na]
+
: 287.1160; found: 287.1165. 
 
 
 
N-((1-Benzyl-1H-indol-3-yl)methyl)-N-methylformamide (56): According to 
general procedure A, 55 (103.5 mg, 0.50 mmol), ammonium persulfate (0.57 g, 2.5 mmol) 
and Ru(bpy)3Cl2 (3.7 mg, 5.0 mol) in DMF (5.0 mL) afforded 56 (72.0 mg, 52%) as a 
yellow oil. 
According to general procedure B, 55 (103.5 mg, 0.50 mmol) and ammonium 
persulfate (0.57 g, 2.5 mmol) in DMF (5.0 mL) afforded 56 (61.0 mg, 44%) as a yellow 
oil. 
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Rf (EtOAc/hexane 2:1): 0.33; 
IR (neat): 3059, 2920, 2859, 1663, 1467, 1394, 1334, 1267, 1173, 1077, 741, 701 
cm
-1
;  
Observed as two rotamers in a 55:45 ratio: 
1
H NMR (400 MHz, DMSO-d6) δ 8.42/8.07 (s, 1 H), 7.59–7.53 (m, 1 H), 7.54/7.50 
(s, 1 H), 7.45–7.40 (m, 1 H), 7.30-7.17 (m, 5 H), 7.14–7.08 (m, 1 H), 7.06-6.98 (m, 1 H), 
5.40/5.39 (s, 2 H), 4.60/4.57 (s, 2 H), 2.77/2.64 (s, 3 H);  
13
C NMR (100 MHz, DMSO-d6) δ 162.4，162.0，138.2，138.1，136.3，136.2，
128.9, 128.7, 128.5 (two overlapped signals: 128.53, 128.51), 127.3 (two overlapped 
signals: 127.32, 127.30), 127.0, 126.9, 121.6, 121.5, 119.2, 119.1, 119.0, 118.6, 110.4, 
110.2, 109.4 (two overlapped signals: 109.41, 109.39), 49.0 (two overlapped signals: 
48.98, 48.94), 43.8, 37.7, 33.1, 28.4;  
HRMS (ESI) m/z calcd for C18H18N2ONa [M + Na]+: 301.1317; found: 301.1316. 
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CHAPTER 4 
Halogenation Mediated by Oxidative Photoredox Catalysis  
 
1 Introduction 
The conversion of alcohols into the corresponding halides (such as chlorides, 
bromides and iodides) is one of the most widely employed functional group 
transformations in organic synthesis. Based on an industrial survey, it is among the top 
three main transformations used for molecular construction by manipulating different 
functional groups.
156
  
Normally, halogenation of alcohols occurs via the activation of carbon-oxygen bond 
followed by nucleophilic displacement by halides, due to the poor leaving group ability 
of the hydroxyl functional group. In this regard, several methods have been reported in 
the literature employing various stoichiometric reagents, including thionyl chloride,
157
 
phosphonium salt,
158 , 159
 phenylmethylenium salt,
160
 benzoxazolium salt,
161
 
iodotrimethylsilane,
162
 Viehe’s salt, 163  Vilsmeier-Haack reagent, 164  cyanuric 
chloride,
165
 Ghosez reagent
166
 and (chloro-phenylthio-methylene)dimethylammonium 
(CPMA) salt
167
 (Figure 4.1).   
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Figure 4.1 General methods for conversion of alcohols to halides 
 
 
Recent advances on halogenation methodology include the use of cyclopropylium 
ions by the Lambert group
168
 and diethylaminodifluorosulfinium ions by the Paquin 
group
169
. In addition, using the InCl3/HSiMe2Cl/benzil system, preferential halogenation 
of tertiary alcohols over primary alcohols has also been reported by the Baba group.
170
 
Silyl ether intermediate 2 is proposed as the precursor of chlorination, presumably via the 
reaction of alkoxysilyl ether intermediate 1, which is generated from chlorosilylation of 
benzil by HSiMe2Cl, with the indium-activated alcohol (Scheme 4.1).   
These methods often require advanced preparation of the reagents, harsh reaction 
conditions (such as high temperature, highly reactive or acidic reagents), or suffer from a 
limited substrate scope or undesired side reactions caused by the generation of highly 
acidic hydrogen halide (HX). The mildest of these transformations, the Appel reaction, 
uses triphenylphosphine (PPh3) in combination with an electrophilic halogen source such  
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Scheme 4.1 Recent updates on halogenation methods 
 
 
as CCl4, CBr4, or I2 to form the reactive phosphonium halide salt. This reaction has been 
widely applied due to its high efficiency and broad substrate scope. Furthermore, 
triphenylphosphine and related compounds are among the most ubiquitous reagents in 
organic synthesis, generally functioning as two electron reducing agents in the Mitsunobu, 
Wittig, and Staudinger reactions as well as in the conversion of alcohols to halides. 
However, triphenylphosphine is one of the least atom economical reagents,
171
 often 
affecting just a single atom replacement during the course of a reaction. In addition, the 
stoichiometric waste by-product, triphenylphosphine oxide (Ph3PO) is often difficult to 
remove from the reaction mixture. Supported phosphine reagents can be used to alleviate 
the purification issue;
172
 however, these reagents are relatively expensive and the 
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reactions still generate stoichiometric waste by-products. Given the wide variety of 
reactions which can be accessed using these reagents, the innovation of catalytic 
approaches is a primary goal for the development of environmentally friendly chemical 
approaches for the nucleophilic substitution of alcohols.
173
  
A catalytic variant of the Appel reaction was reported in 2011 by Denton and 
co-workers, using oxalyl chloride as the activating reagent to generate the corresponding 
phosphorous halide in situ from substoichiometric amount (15 mol%) of Ph3PO (Scheme 
4.2).
174
 Reaction of the phosphonium salt with the alcohol followed by substitution of the 
activated intermediate by bromide provides the desired brominated product and 
regenerates triphenylphosphine oxide.  
Currently, significant efforts have been continuously put into the discovery of new 
methods for halogenation using mild and economic reagents while avoiding phosphine 
related chemicals.   
 
Scheme 4.2 Catalytic Ph3PO mediated Appel reaction 
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2 Aim of the Project 
Visible light photoredox catalysis represents a mode of selectively activating organic 
molecules towards chemical transformations. By harnessing the reductive quenching 
pathway of Ru(bpy)3Cl2, our group has been able to apply the photoredox catalysis to 
various reactions, particularly for radical carbon-carbon bond formation.
175
 Meanwhile, 
we were interested in exploring the oxidative quenching pathways of different 
photoredox catalysts. Shortly after we successfully demonstrated the oxidation of 
dialkylamides using a combination of Ru(bpy)3Cl2 and persulfates, we began to look for 
other novel oxidative quenchers and expand the scope of oxidative photoredox catalysis 
to carbon-oxygen bond activation, including nucleophilic substitution of alcohols. 
Moreover, by taking advantage of the robust redox properties of photoredox catalysts, we 
were hoping to replace the commonly used phosphine reagents by the visible light 
photocatalysts to develop a new strategy for halogenation (Figure 4.2). 
 
Figure 4.2 Phosphine-free halogenation of alcohols using visible light photoredox catalysis 
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3 Design of the Project 
Recent research has shown that electrochemical reduction of tetrahalomethanes 
(CCl4 and CBr4) in DMF using super stoichiometric quantities of Fe and Cu powder can 
convert alcohols into the corresponding halides via a Vilsmeier‒Haack type reagent 
(Scheme 4.3).
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 As previously mentioned, the oxidative quenching of 
*
Ru(bpy)3
2+
 
(E1/2
III/II*
 = -0.81 V) provides a strong oxidant Ru(bpy)3
3+
 (E1/2
III/II
 = +1.29 V vs SCE). By 
comparing with the reduction potentials of CBr4 (E1/2 = –0.30 V vs. SCE) and CHI3 (E1/2 
= –0.49 V vs. SCE),177 we envisioned that the catalytic generation of Vilsmeier-Haack 
reagents could be achieved under mild reaction conditions via the oxidative quenching of 
*
Ru(bpy)3
2+
 by polyhalomethanes, such as CBr4 or CHI3 in DMF. This in situ generated 
reagent would eventually serve to activate carbon-oxygen bond of an alcohol substrate 
for a nucleophilic substitution reaction. In this case, substitution by a nucleophilic halide 
would provide a phosphine-free direct halogenation of alcohols using commercially 
available and easily handled reagents, which can be manipulated on the bench without the 
need for specialized equipment. In a broad sense, the conversion of alcohols to halides, 
which is a very important reaction in its own right, also serves as a proof of concept for 
this novel mode of catalytic activation of carbon-oxygen bonds. Furthermore, with 
careful choice of the oxidative quenching reagents, this approach should prove to be a 
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general means of activating carbon-oxygen bond towards nucleophilic displacement with 
various nucleophiles.  
 
Scheme 4.3 Léonel's halogenation via reduction of polyhalomethanes by Fe/Cu 
 
 
4 Development of Halogenation Using Photoredox Catalysis 
4.1 Initial Results 
To test our hypothesis, carbon tetrabromide was used as both the halogen source and 
oxidative quencher of the photocatalytic pathway. Upon visible light irradiation (blue 
LED, λmax = 435 nm) of alcohol 3 (0.5 mmol) and CBr4 (2.0 equiv) in DMF in the 
presence of Ru(bpy)3Cl2 (1.0 mol%) at 25 ˚C for 5 h under an argon atmosphere, the 
corresponding bromide 4 was obtained in 70% yield. With further optimization of the 
reaction conditions, we observed that addition of an external halide source, such as NaBr 
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(2.0 equiv) improved both the reaction rate and the overall isolated yield of the desired 
bromide to 90% (Scheme 4.4). 
 
Scheme 4.4 Initial results of Ru(bpy)3Cl2 catalyzed bromination 
 
 
A solvent screen, including CH3CN, THF and CH2Cl2 failed to afford the desired 
product in any appreciable yield, suggesting that DMF was indeed an active reagent in 
the reaction in addition to the solvent. Replacing DMF with other amides (served as 
solvents as well), such as DMA, 1-methylpyrrolidin-2-one and N,N-dimethylbenzamide 
shut down the reactivity completely, while N,N-diphenylformamide (4.0 equiv. in 
acetonitrile) provided the desired product, albeit with much lower reactivity (< 10% 
conversion after 12 h). Meanwhile, control reactions showed that rigorous exclusion of 
light or the absence of Ru(bpy)3Cl2 failed to produce any bromide product at room 
temperature. Low reactivity (< 20% conversion) was observed without Ru(bpy)3Cl2 only 
if the reaction was heated at 80 ˚C for 12 h, presumably due to the slow liberation of HBr 
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by the reaction of alcohol with CBr4.
178
 These results support the necessity of the 
photoredox catalyst in the observed halogenation process. 
 
4.2 Substrate Scope for Bromination and Iodination 
The scope of the bromination reaction under the optimized reaction conditions was 
explored using a set of alcohols (Table 4.1). Primary alcohols (substrates 5 to 25) were 
smoothly transformed to their corresponding bromides in 75 to 98% isolated yields. 
Acyclic, secondary alcohols were also viable substrates for the bromination reaction 
(substrates 27 and 29), despite with a reduced reaction rate compared with primary 
alcohols. The attenuated reactivity of secondary alcohols compared with primary alcohols 
is suggestive of a possible SN2 mechanism for the displacement reaction. The reaction is 
highlighted by outstanding functional group tolerance and can be carried out in the 
presence of ethers (substrates 5 to 9), alkenes (substrates 9 to 13), carbamates (substrates 
13 to 19), alkyne (substrate 21), esters (substrates 15 and 27), phenol (substrates 23) and 
silyl ether (substrate 25). Interestingly, the use of cyclic secondary alcohol 31 resulted in 
the isolation of formate ester 32 as the sole product even after a prolonged reaction time 
(24 h), which provides further insight into the reactive intermediate generated during the 
course of this transformation. 
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Table 4.1 Conversion of alcohols to bromides using photocatalysis 
 
 
Substrate Product Yield
 a)
 Substrate Product Yield
a)
 
  
90% 
  
75%
 b)
 
  
98% 
  
86% 
  
78% 
  
84% 
  
77% 
  
86
 b)
 
  
81% 
  
86% 
  
96% 
  
75% 
  
96% 
  
92%
 c)
 
a)
Isolated yield after purification by chromatography on SiO2. 
b)
2,6-Lutidine (3.0 equiv) was 
added to buffer HBr that was produced in the reaction. 
c)
No bromide product was observed. 
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With the success of bromination of alcohols, we next focused on the complementary 
iodination reaction. To achieve this goal, we simply changed the oxidative quencher from 
carbon tetrabromide to iodoform, and the external halogen source from sodium bromide 
to sodium iodide. Alcohols were converted to their corresponding iodides in similar 
yields to the bromination reactions. Moreover, the wide substrate scope and functional 
group tolerance of this process were also remarkable (Table 4.2).  
 
Table 4.2 Conversion of alcohols to iodides using photocatalysis 
 
 
Substrate Product Yield
a)
 Substrate Product Yield
a)
 
  
91% 
  
65%
 
 
  
86% 
  
72% 
  
91% 
  
78%
 b)
 
a)
Isolated yield after purification by chromatography on SiO2. 
b)
2,6-Lutidine (3.0 equiv) was 
added to buffer HI that was produced in the reaction. 
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As presented in both Table 4.1 and Table 4.2, alkynes, alkenes (including sensitive 
cis-allylic alcohols), acid sensitive trisubstituted alkenes, electron-rich aromatics, 
carbamates, sulfonamides and esters were not affected under the reaction conditions. Acid 
sensitive protecting groups, such as tert-butyl carbamates (such as Boc) and silyl ethers 
(such as TBDPS), were also tolerated if 2,6-lutidine was added. The tolerance of these 
functionalities makes this method very attractive and competitive to the known methods 
for the transformation of alcohols to halides. In addition, this method should be readily 
generalized as a means for the activation of carbon-oxygen bonds for nucleophilic 
displacement by various nucleophiles in complex substrates. Furthermore, it is also 
noteworthy that the halogenations can be conducted on preparative scale (5.0 mmol). In 
this case, tetrabutylammonium bromide was used instead of sodium bromide to improve 
the solubility in DMF. The bromination of alcohol 7 produced bromide 8 in a nearly 
identical yield compared with discovery-scale experiments, further demonstrating the 
efficiency of the Ru(bpy)3Cl2/CBr4 photocatalytic system (Scheme 4.5). 
 
Scheme 4.5 Photocatalytic bromination on large scale 
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4.3 Mechanistic Investigations and Discussion 
A key piece of mechanistic evidence was obtained from the observed formate ester 
product 32 (Table 4.1). Indeed, premature quenching of the reaction of primary alcohols 
also led to the isolation of formate ester by-products. To delineate the source of this 
formate ester, we subjected alcohol 13 to the bromination conditions in DMF-d7 and 
quenched the reaction after 4 h (Scheme 4.6). Together with the unconsumed starting 
material, the reaction provided a mixture of bromide 14 and formate ester 41, with 100% 
deuterium incorporation. This result confirms our hypothesis that DMF is involved in this 
photocatalytic transformation and the reactive intermediate generated may be an iminium 
species derived from the reaction of the alcohol with an in situ generated 
Vilsmeier-Haack reagent.  
 
Scheme 4.6 Isotopic labeling experiment 
 
 
Furthermore, the prolonged reaction time required for secondary alcohols in 
comparison to primary alcohols suggest that the reactions proceed via an SN2 pathway. 
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This hypothesis was also supported by the isolation of formate ester 32 but none of the 
desired bromide, when 31 was exposed to the same reaction conditions. The increased 
steric demand of the cyclic alcohols appears to preclude the SN2 pathway. 
Léonel has proposed a carbene mechanism consistent with their data, to account for 
the halogenation of alcohols using the Fe/Cu/CBr4 system.
179
 However, evidence 
garnered to date for photoredox reactions related to the chemistry in our lab are consistent 
with single electron processes and the generation of the corresponding free radical 
species. Indeed, we have found that CBr4 quenches the Ru(bpy)3
2+
 excited state as 
evidenced by luminescence quenching experiments (Stern-Volmer constant: KSV = 14.4 
M
‒1
), to provide the tribromomethyl radical (·CBr3). To distinguish between the radical 
pathway and a potential carbene mechanism, we conducted additional experiments using 
radical traps (such as -methylstyrene) as substrates with Ru(bpy)3Cl2 (1.0 mol%) and 
CBr4 (2.0 equiv) in both DMF and CH3CN (Scheme 4.7). In CH3CN, the Fe/Cu mediated 
reaction reported by Léonel provides only the corresponding dibromocyclopropane 
product, consistent with the generation of dibromocarbene. However, using Ru(bpy)3Cl2, 
dibromocyclopropane product 44 was not observed in either solvent after 12 h. Instead, 
compound 43 was the only product observed, a consequence of the addition of ·CBr3 to 
styrene to generate 42 followed by oxidation (by Ru
3+
 or CBr4) then elimination.  
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Scheme 4.7 Distinguishing between radical and carbene pathways 
 
 
During the optimization of reaction conditions, we observed about 10-20% 
formation of N,O-aminal by-product 45 when the reactions were running without NaBr 
(see Scheme 4.4 top result). The generation of this product is believed to come from 
nucleophilic addition of alcohol to N-acyliminium ion which was generated via H-atom 
abstraction of DMF by ·CBr3 followed by oxidation (see Chapter 3). This result led to the 
hypothesis that N-acyliminium ion could be a key intermediate involved in this 
transformation. Thus the bromide product could be generated by the bromide 
displacement of intermediate 46, obtained from a second H-atom abstraction of the 
N,O-aminal moiety in 45 by ·CBr3 followed by oxidation.  
Indeed, bromide product 4 was observed by treating 45 with the standard 
bromination conditions. However, when compared to the conversion of alcohol 3 under 
the same conditions, 45 was much less reactive than 3 (Scheme 4.8). These results show 
that bromide can be obtained from the N,O-aminal, but with significant lower reaction 
rate than from the alcohol.   
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Scheme 4.8 Bromination of the N,O-acetal species  
 
The reactivity of alcohol and N,O-aminal towards photocatalyzed bromination can 
be better explained by a competition experiment of 3 and 45 in a 1:1 ratio. After a short 
irradiation time (5 h), 3 was fully consumed to provide bromide 4 (50% conversion of 3) 
and 47 (50% conversion of 3), which was generated by aqueous quenching of the 
iminium species from reaction of 3 with the Vilsmeier-Haack reagent. Meanwhile, only 
30% of 45 was consumed to give bromide 4 (Scheme 4.9). All of these results indicate 
that the generation of N-acyliminium ion may be a competing pathway of the 
photocatalyzed bromination, however the in situ generated Vilsmeier-Haack reagent is a 
more preferred pathway for this transformation. Therefore, the addition of external 
bromide not only suppresses the formation of N,O-aminal by-products by converting 
N-acyliminium ions to less reactive -bromoacetylamides, but also accelerates the 
nucleophilic bromide displacement of the iminium intermediate to give bromide product.  
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Scheme 4.9 Competition of alcohol with N,O-acetal in bromination 
 
 
4.4 Proposed Mechanism 
The results obtained so far support a mechanism of single electron reduction of CBr4 
by Ru(bpy)3Cl2 to initiate the halogenation process and the in situ generated 
Vilsmeier-Haack reagent as the key intermediate. With respect to these results and our 
luminescence quenching experiments, we propose an overall mechanism wherein the 
single electron reduction of CBr4 by 
*
Ru(bpy)3
2+
 forms Ru(bpy)3
3+
 and ·CBr3. Trapping 
of the electron-deficient radical by DMF generates a stabilized radical 48, which can be 
oxidized by Ru(bpy)3
3+
 (1.27 V vs SCE) to form the iminium intermediate 49 and 
regenerate Ru(bpy)3
2+
. Alternatively, 48 can be oxidized by reaction with another 
molecule of CBr4 as observed in atom-transfer radical chain reactions.
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 At this stage, 
two reasonable pathways may be considered for the formation of bromide product. The 
first proceeds with direct addition of the alcohol to iminium 49 to form intermediate 51 
which can undergo SN2 displacement by bromide to provide the final product (Path A). In 
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the second pathway, addition of the bromide ion to 49 produces the Vilsmeier-Haack 
reagent 50, which reacts with the alcohol to afford the intermediate 51 (Path B). In 
addition, COBr2 is generated as a by-product in both pathways and it has been shown to 
react with DMF to produce 50 with liberation of CO2,
181
 funneling both of the reaction 
pathways to the common intermediate 51. Consistent with this proposal is the observation 
that the undesired formate ester by-product is formed upon premature hydrolysis of the 
reactive intermediate 51 (Scheme 4.10). 
 
Scheme 4.10 Proposed single electron transfer (SET) mechanism 
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5 Investigations on Racemization of Chiral Alcohol 
Although the data to this point was consistent with an SN2 displacement of the 
activated iminium intermediate 51, treatment of the optically pure alcohol 52 (99% ee) 
under the optimized reaction conditions provided bromide 53 as a racemic mixture 
(Figure 4.3). This unanticipated result provoked a reevaluation of our mechanistic 
hypothesis for the photocatalyzed halogenation reaction. Specifically, we evaluated the 
optical activity of both the bromide at low alcohol conversion and of recovered formate 
ester.  
 
Figure 4.3 Racemization of chiral alcohol under photocatalyzed bromination condition 
 
*The reaction was conducted using optically pure alcohol 52 and treated with 
Ru(bpy)3Cl2 (1.0 mol%), CBr4 (2.0 equiv) and NaBr (2.0 equiv) in DMF for 12 h. 
Racemic bromide product (+/-)-53 was obtained. Highly optically enriched bromide 
53 was isolated at about 35% conversion of 52 under the condition using Ru(bpy)3Cl2 
(1.0 mol%), CBr4 (2.0 equiv) and NaBr (2.0 equiv) in DMF after 5 h. While the 
formate ester 54 was isolated at >80% conversion of 52 under the condition using 
Ru(bpy)3Cl2 (1.0 mol%) and CBr4 (2.0 equiv) in DMF after 7 h.  
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Optical analysis of the isolated bromide 53 (35% conversion of 52) confirmed a 
stereospecific displacement since 53 was isolated in 90% ee. Inversion of configuration 
was confirmed based upon comparison of the sign of optical rotation with an authentic 
sample obtained using the classical Appel reaction (PPh3/CBr4 in CH2Cl2), providing the 
evidence for an SN2 mechanism.  
To further satisfy our hypothesis that an SN1 mechanism was not viable, chiral 
HPLC analysis (Chiralcel OD, 5% hexanes/
i
PrOH) of the recovered alcohol, obtained by 
saponification (K2CO3 in MeOH) of the formate ester 54 (isolated after >80% conversion 
of 52) confirmed that racemization was also not occurring at the stage of our proposed 
reactive iminium intermediate. That is, solvolysis or degenerate displacement of the 
activated intermediate by DMF was not occurring. 
On the basis of these observations, the activated intermediate is configurationally 
stable under the reaction conditions leaving the potential degenerate SN2 displacement of 
bromide in 53 with NaBr as the mechanism for racemization.
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 This displacement and 
subsequent racemization is observed in the time-dependent loss of optical activity during 
the subjection of optically enriched 53 (99% ee) to the reaction conditions (Scheme 
4.11).  
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Scheme 4.11 Time-dependent loss of optical activity of chiral bromide  
 
 
 
6 One-pot Deoxygenation via Combined Quenching Pathways 
Our group has developed a reductive dehalogenation methodology for activated 
halides in 2009, using combination of Ru(bpy)3
2+
 and DIPEA. When switching to a 
stronger reducing photocatalyst, fac-Ir(ppy)3, unactivated iodides were successfully 
reduced in the presence of Bu3N.
183
 Taking advantage of this efficient transformation, we 
conducted the one-pot deoxygenation reaction on flow.
184
 Iodides (such as 36) generated 
from Garegg-Samuelsson reaction were transferred to a 1.34 mL flow reactor (with a 
residence time of 18 min), 1.0 mmol starting materials were reduced at a flow rate of 0.64 
0
0.2
0.4
0.6
0.8
1
0 2 4 6 8 10 12 14
ee
'/
ee
°
 
Time (hour) 
34˚C 28˚C 
138 
  
mmol/h. As an example shown in Scheme 4.12, alcohol 17 was reduced to 55 in 81% 
yield after two steps.     
 
Scheme 4.12 One-pot deoxygenation on flow 
 
 
From this experience, we identified three major issues which prevented the 
successful merger of our Ru(bpy)3
2+
 catalyzed halogenation reaction with our fac-Ir(ppy)3 
catalyzed dehalogenation reaction. First, we had not identified an appropriate 
photocatalyst that was capable of effecting both transformations. Ru(bpy)3
2+
 cannot 
reduce unactivated iodides, while fac-Ir(ppy)3 was not efficient in the conversion of 
alcohols to halides. As shown in Scheme 4.13, substrate 5 was converted to bromide 6 by 
fac-Ir(ppy)3 in 32% conversion after 15 h, in comparison to Ru(bpy)3
2+
 catalyzed 
bromination providing 100% conversion in 5 h. Second, there was no proper solvent that 
could be applied to both reactions. DMF is not a good solvent for our dehalogenation 
while MeCN cannot replace the functional role of DMF in the halogenation. Third, the 
oxidative quenchers (such as CBr4 and CHI3) and by-products (such as Br2, I2, HBr and 
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HI) generated from the halogenation step were observed to have negative impact on the 
dehalogenation reaction. Therefore, finding a powerful photocatalyst with a suitable 
solvent system became the challenge of merging these two reactions.  
 
Scheme 4.13 fac-Ir(ppy)3 catalyzed bromination 
 
 
In 2012, Lee and co-workers reported a dehalogenation methodology for unactivated 
iodides using Ir(ppy)2(dtb-bpy)PF6 and DIPEA.
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 As shown in Scheme 4.14, iodide 56 
was successfully reduced to 57 at room temperature in 11 h. It is noteworthy that the 
reaction was conducted without degassing and oxygen seemed to play a role in this 
transformation, although the mechanism involving the function of oxygen remains 
unclear.  
 
Scheme 4.14 Ir(ppy)2(dtb-bpy)PF6 catalyzed deiodination 
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During the dehalogenation study, we noticed that Ir(ppy)2(dtb-bpy)PF6 can convert 
alcohols to bromides in a slightly faster reaction rate than Ru(bpy)3Cl2, presumably due 
to a faster generation of the Vilsmeier‒Haack reagent. Inspired by this observation, we 
decided to test this catalyst on the dehalogenation of unactivated bromides. Fortunately, 
bromide 17 was reduced to 18 in 15 h with 100% conversion when the reaction was 
heated to 60 ̊C. With this debromination condition in hand, we achieved the first one-pot 
deoxygenation reaction using a single photocatalyst Ir(ppy)2(dtb-bpy)PF6 (Scheme 4.15). 
After the completion of the bromination, DIPEA, NaHCO3 and MeCN/H2O were added 
to the reaction flask. The reaction was stirred at 60 ̊C for 24 h and the reduced product 55 
was isolated in 25% yield after two steps.
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 Although these conditions are unoptimized, 
we have clearly established that the photocatalyzed halogenation and dehalogenation can 
be merged into a one-pot reaction using one catalyst. We have also demonstrated that 
Ir(ppy)2(dtb-bpy)PF6 is capable of sequentially acting in both the oxidative and reductive 
quenching pathways without discernible loss of catalytic activity.  
 
Scheme 4.15 Ir(ppy)2(dtb-bpy)PF6 catalyzed one-pot deoxygenation 
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7 Conclusion 
A catalytic, phosphine-free method was developed for the bromination and 
iodination of alcohols utilizing Ru(bpy)3
2+
.
187
 This is the first example of applying 
visible light photocatalysis to the halogenation of alcohols. The reaction is highlighted by 
the exceptional functional group tolerance, avoidance of stoichiometric oxidized 
phosphine by-products and the generation of the halogenated compounds in high yields 
under mild reaction conditions. Moreover, the cost effective nature of Ru(bpy)3Cl2, low 
catalyst loadings, operational simplicity and activity under visible light irradiation makes 
this transformation industrially valuable. Last, a one-pot deoxygenation reaction by 
combining Ir(ppy)2(dtb-bpy)PF6 catalyzed bromination and debromination reactions was 
shown. This is the first successful example of merging the two quenching pathways of a 
photocatalyst into a one-pot reaction. Further optimization of the reaction condition is 
still undergoing.  
 
8 Experimental Section 
General Information 
Chemicals were either used as received or purified according to the procedures 
outlined in Purification of Common Laboratory Chemicals. Glassware was dried in a 170 
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C oven or flame dried under vacuum and cooled under inert atmosphere before use. All 
reactions were performed using common dry, inert atmosphere techniques. Reactions 
were monitored by TLC and visualized by a dual short wave/long wave UV lamp and 
stained with an ethanolic solution of potassium permanganate or Ceric Ammonium 
Molybdate. Column flash chromatography was performed using 230-400 mesh silica gel. 
Yields refer to chromatographically and spectroscopically pure compounds, unless 
otherwise noted.  
1
H- and 
13
C- NMR spectra were recorded using an internal deuterium lock on Varian 
Mercury 300, Varian Unity Plus 400, or a Varian 500 spectrometers. All signals are 
reported in ppm with the internal reference of 7.26 ppm or 77.0 ppm for chloroform and 
3.31 ppm or 49.0 ppm for methanol as standard.  Data are presented as follows: 
multiplicity (s = singlet, d = doublet, t = triplet, q = quartet, quint = quintet, m = multiplet, 
br = broad, dd = doublet of doublet, dt = doublet of triplet), coupling constant (J/Hz) and 
integration. Infrared spectra were recorded on a Nicolet Nexus 670 FT-IR with ATR 
spectraphotometer. Absorptions are given in wavenumbers (cm
-1
). Optical rotations were 
recorded on an Autopol III digital polarimeter at 589 nm and reported as follows:[𝛼]𝐷
𝑇 , 
concentration (g / 100 mL) and solvent. High resolution mass spectra were obtained on a 
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Waters Q-Tof API-US with ESI high resolution mass spectrometer. HPLC analysis was 
performed on an Agilent 1100 series HPLC System with a diode array detector.  
 
General Procedure A for Bromination 
A flame dried 10 mL Schlenk flask with a rubber septum and magnetic stir bar was 
charged with tris(2,2’-bipyridyl)ruthenium(II) chloride hexahydrate (5.0 μmol, 0.010 
equiv), the corresponding alcohol (0.50 mmol, 1.0 equiv), carbon tetrabromide (1.0 mmol, 
2.0 equiv) and sodium bromide (1.0 mmol, 2.0 equiv). The flask was purged with a 
stream of nitrogen and dry DMF (5.0 mL) was added via syringe. The mixture was 
degassed by the freeze-pump-thaw procedure (3 cycles), and placed in a 250 mL beaker 
with blue LEDs wrapped inside. The reaction mixture was stirred at 25 to 30 ˚C until it 
was complete (as judged by TLC analysis). The mixture was poured into a separatory 
funnel containing 25 mL of Et2O and 25 mL of H2O. The layers were separated and the 
aqueous layer was extracted with Et2O (2 × 25 mL). The combined organic layers were 
washed with sat. Na2S2O3 solution, brine, dried (MgSO4) and concentrated in vacuo. The 
residue was purified by chromatography on silica gel to afford the desired product. 
 
General Procedure B for Iodination 
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A flame dried 10 mL Schlenk flask with a rubber septum and magnetic stir bar was 
charged with tris(2,2’-bipyridyl)ruthenium(II) chloride hexahydrate (5.0 μmol, 0.010 
equiv), the corresponding alcohol (0.5 mmol, 1.0 equiv), iodoform (1.0 mmol, 2.0 equiv) 
and sodium iodide (1.0 mmol, 2.0 equiv). The flask was purged with a stream of nitrogen 
and dry DMF (5.0 mL) was added via syringe. The mixture was degassed by the 
freeze-pump-thaw procedure (3 cycles), and placed in a 250 mL beaker with blue LEDs 
wrapped inside. The reaction mixture was stirred at 25 to 30 ˚C until it was complete (as 
judged by TLC analysis). The mixture was poured into a separatory funnel containing 25 
mL of Et2O and 25 mL of H2O. The layers were separated and the aqueous layer was 
extracted with Et2O (2 × 25 mL). The combined organic layers were washed with sat. 
Na2S2O3 solution, brine, dried (MgSO4) and concentrated in vacuo. The residue was 
purified by chromatography on silica gel to afford the desired product. 
 
Compound Preparation and Characterization 
 
3-(4-(Benzyloxy)phenoxy)propan-1-ol (58):
188
 To a solution of 
4-benzyloxyphenol (3.00 g, 15.0 mmol) in ethanol (50 mL) was added Na (0.345 g, 15.0 
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mmol) in portions under nitrogen atmosphere. After all the Na was added, the mixture 
was stirred at room temperature for 20 min. Then 3-chloro-1-propanol (2.50 mL, 30.0 
mmol) was added and the mixture was refluxed for 20 h. After cooling to room 
temperature, the reaction mixture was poured into cold water (50 mL) and extracted with 
ethyl acetate (3 × 100 mL). The combined organic layers were washed with 5% NaOH 
solution, brine, dried (MgSO4) and concentrated in vacuo. The residue was purified by 
chromatography on silica gel using hexanes/ethyl acetate (1:1) to afford 3.15 g (12.2 
mmol, 81% yield) of the title compound as a colorless powder. 
Rf (EtOAc/hexanes 1:1): 0.43;  
IR (neat): 3279, 2946, 2863, 1509, 1239, 1018, 911, 826, 731cm
-1
;  
1
H NMR (CDCl3, 400 MHz): δ 7.44-7.28 (m, 5 H), 6.92-6.88 (m, 2 H), 6.86-6.82 
(m, 2 H), 5.02 (s, 2 H), 4.08 (t, J = 6.0 Hz, 2 H), 3.87 (t, J = 5.6 Hz, 2 H), 2.10-1.99 (m, 2 
H), 1.83-1.70 (br s, 1 H);  
13
C NMR (CDCl3, 100 MHz): δ 153.0, 137.2, 128.5, 127.8, 127.4, 115.9, 115.8, 
115.4, 70.6, 66.4, 60.5, 32.0; 
MS (ESI) m/z calcd for C16H18O3Na ([M + Na]
+
): 281.1154; found: 281.1147. 
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4-(3-Hydroxypropoxy)phenol (34)：To a solution of compound 59 (2.00g, 7.74 
mmol) in MeOH/THF (100 mL/20 mL) was added 10% Pd/C (200 mg). The reaction 
flask was charged with two balloons of H2 and the mixture was stirred at room 
temperature for 15 h. Then the catalyst was removed by filtration and the filtrate was 
concentrated in vacuo. The residue was purified by chromatography on SiO2 using 
MeOH/CH2Cl2 (1:10) as the eluent to afford 1.20 g (7.14 mmol, 92% yield) of the title 
compound as a colorless powder. 
Rf (MeOH/CH2Cl2 1:10): 0.53;  
IR (neat): 3337, 3098, 2926, 2880, 1514, 1469, 1231, 1068, 991, 825, 753 cm
-1
;  
1
H NMR (CD3OH, 400 MHz): δ 6.78-6.73 (m, 2 H), 6.71-6.66 (m, 2 H), 4.95-4.72 
(br s, 2 H, overlapped with solvent), 4.70-4.50 (br s, 1 H), 3.98 (t, J = 6.4 Hz, 2 H), 3.72 
(t, J = 6.4 Hz, 2 H), 1.98-1.90 (m, 2 H);  
13
C NMR (CD3OH, 100 MHz): δ 153.9, 152.4, 116.9, 116.8, 66.6, 59.6, 33.5;  
MS (ESI) m/z calcd for C9H12O3Na ([M + Na]
+
): 191.0684; found: 191.0488. 
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1-(3-Bromopropyl)-4-methoxybenzene (6): According to the general procedure A, 
the alcohol 5 (83.3 mg, 0.500 mmol) was treated with tris(2,2 -´bipyridyl)ruthenium (II) 
chloride hexahydrate (3.7 mg, 5.0 μmol), carbon tetrabromide (332 mg, 1.00 mmol) and  
sodium bromide (103 mg, 1.00 mmol). After 5 h, the reaction mixture was subjected to 
the workup protocol and purified by chromatography on SiO2 using petroleum ether/Et2O 
(10:1) as the eluent to afford 103 mg (90% yield) of the title compound as a colorless oil. 
Rf (EtOAc/hexanes 1:8): 0.50;  
IR (neat): 2935, 1612, 1511, 1452, 1241, 1177, 1035, 818 cm
-1
;  
1
H NMR (CDCl3, 400 MHz): δ 7.12 (d, J = 8.4 Hz, 2 H), 6.84 (d, J = 8.6, 2 H), 3.80 
(s, 3 H), 3.39 (t, J = 6.5 Hz, 2 H), 2.73 (t, J = 7.2 Hz, 2 H), 2.17-2.10 (m, 2 H);  
13
C NMR (CDCl3, 75 MHz): δ 158.0, 132.5, 129.4, 113.9, 55.2, 34.4, 33.1, 33.0. 
 
 
 
(((5-Bromopentyl)oxy)methyl)benzene (8): According to the general procedure A, 
the alcohol 7 (97.1 mg, 0.500 mmol) was treated with tris(2,2 -´bipyridyl)ruthenium (II) 
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chloride hexahydrate (3.7 mg, 5.0 μmol), carbon tetrabromide (332 mg, 1.00 mmol) and  
sodium bromide (103 mg, 1.00 mmol). After 7 h, the reaction mixture was subjected to 
the workup protocol and purified by chromatography on SiO2 using petroleum ether:Et2O 
(10:1) as the eluent to afford 126 mg (98% yield) of the title compound as a colorless oil. 
Rf (EtOAc/hexanes 1:8): 0.53;  
IR (neat): 3063, 2937, 2858, 1453, 1362, 1246, 1103, 734 cm
-1
;  
1
H NMR (CDCl3, 400 MHz): δ 7.38-7.27 (m, 5 H), 4.51 (s, 2 H), 3.48 (t, J = 6.3 Hz, 
2 H), 3.41 (t, J = 6.8 Hz, 2 H), 1.91-1.86 (m, 2 H), 1.67-1.63 (m, 2 H), 1.57-1.49 (m, 2 
H);  
13
C NMR (CDCl3, 100 MHz): δ 138.5, 128.3, 127.6, 127.5, 72.9, 70.0, 33.7, 32.6, 
28.9, 24.9;  
MS (ESI) m/z calcd for C12H18BrO ([M + H]
+
): 257.0541; found: 257.0534. 
 
 
 
(Z)-(((4-Bromobut-2-en-1-yl)oxy)methyl)benzene (10): According to the general 
procedure A, the alcohol 9 (89.1 mg, 0.500 mmol) was treated with 
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tris(2,2 -´bipyridyl)ruthenium (II) chloride hexahydrate (3.7 mg, 5.0 μmol), carbon 
tetrabromide (332 mg, 1.00 mmol) and sodium bromide (103 mg, 1.00 mmol). After 5 h, 
the reaction mixture was subjected to the workup protocol and purified by 
chromatography on SiO2 using petroleum ether:Et2O (10:1) as the eluent to afford 93.8 
mg (mixture of cis/trans isomers , 78% yield) of the title compound as a colorless oil. 
Rf (EtOAc/hexanes1:10): 0.50;  
IR (neat): 3063, 3030, 2856, 1496, 1453, 1206, 1096, 735 cm
-1
;  
1
H NMR (10:1 mixture of cis/trans isomers, CDCl3, 400 MHz): cis-isomer: δ 
7.38-7.28 (m, 5 H), 5.96-5.87 (m, 1 H), 5.76 (dt, J = 11.2, 6.0 Hz, 1 H), 4.54 (s, 2 H), 
4.15 (d, J = 6.0 Hz, 2 H), 3.99 (d, J = 8.4 Hz, 2 H), trans-isomer (representative signals): 
4.52 (s, 2 H), 4.05 (d, J = 5.2 Hz, 2 H), 3.97 (overlap with 3.99 peak in cis-isomer, 2 H);  
13
C NMR (CDCl3, 75 MHz): δ 137.9, 131.1, 128.5, 128.4, 127.8, 127.7, 72.5, 64.9, 
26.5.  
 
 
 
N-Allyl-N-(2-bromoethyl)-4-methylbenzenesulfonamide (12): According to the 
general procedure A, the alcohol 11
189
 (127 mg, 0.500 mmol) was treated with 
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tris(2,2 -´bipyridyl)ruthenium (II) chloride hexahydrate (3.7 mg, 5.0 μmol), carbon 
tetrabromide (332 mg, 1.00 mmol) and  sodium bromide (103 mg, 1.00 mmol). After 9 h, 
the reaction mixture was subjected to the workup protocol and purified by 
chromatography on SiO2 using dichloromethane/hexanes (2:1) as the eluent to afford 124 
mg (77% yield) of the title compound as a colorless oil. 
Rf (CH2Cl2/hexanes 2:1): 0.55;  
IR (neat): 2921, 1448, 1338, 1154, 1090, 915, 815, 743, 662 cm
-1
;  
1
H NMR (CDCl3, 400 MHz): δ 7.71 (d, J = 8.4 Hz, 2 H), 7.32 (d, J = 8.0 Hz, 2 H), 
5.68 (ddt, J = 17.6, 10.0, 6.4 Hz, 1 H), 5.25-5.17 (m, 2 H), 3.82 (d, J = 6.4 Hz, 2 H), 
3.50-3.39 (m, 4 H), 2.44 (s, 3 H);  
13
C NMR (CDCl3, 100 MHz): δ 143.7, 136.3, 132.9, 129.9, 127.2, 119.7, 52.0, 48.9, 
29.2, 21.5;  
MS (ESI) m/z calcd for C12H17NO2S ([M+H ]
+
): 318.0163; found: 318.0166. 
 
 
 
(R)-Benzyl (1-bromobut-3-en-2-yl)carbamate (14): According to the general 
procedure A, the alcohol 13
190
 (111 mg, 0.500 mmol) was treated with 
151 
  
tris(2,2 -´bipyridyl)ruthenium (II) chloride hexahydrate (3.7 mg, 5.0 μmol), carbon 
tetrabromide (332 mg, 1.00 mmol) and  sodium bromide (103 mg, 1.00 mmol). After 12 
h, the reaction mixture was subjected to the workup protocol and purified by 
chromatography on SiO2 using petroleum ether:Et2O (4:1) as the eluent to afford 106 mg 
(83% yield) of the title compound as a colorless oil. 
[𝛼]𝐷
20 = +24.6 (c 1.30, CHCl3);  
Rf (EtOAc/hexanes 1:4): 0.40;  
IR (neat): 3328, 3032, 2957, 1697, 1510, 1229, 1027, 696 cm
-1
;  
1
H NMR (CDCl3, 500 MHz): δ 7.40-7.32 (m, 5 H), 5.82 (ddd, J = 17.5, 10.5, 5.3 Hz, 
1 H), 5.32-5.27 (m, 2 H), 5.13 (s, 2 H), 5.14-5.04 (br s, 1 H), 4.62-4.50 (m, 1 H), 
3.64-3.58 (m, 1 H), 3.53-3.48 (m, 1 H);  
13
C NMR (CDCl3, 75 MHz): δ 155.5, 136.1, 135.4, 128.6, 128.4, 128.3, 128.2, 117.5, 
67.1, 52.8, 37.1;  
MS (ESI) m/z calcd for C12H15BrNO2 ([M +H]
+
): 284.0286; found: 284.0344. 
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(R)-Methyl 2-(((benzyloxy)carbonyl)amino)-3-bromopropanoate (16): 
According to the general procedure A, the alcohol 15 (126 mg, 0.500 mmol) was treated 
with tris(2,2 -´bipyridyl)ruthenium (II) chloride hexahydrate (3.7 mg, 5.0 μmol), carbon 
tetrabromide (332 mg, 1.00 mmol) and  sodium bromide (103 mg, 1.00 mmol). After 12 
h, the reaction mixture was subjected to the workup protocol and purified by 
chromatography on SiO2 using petroleum ether/Et2O (4:1) as the eluent to afford 128 mg 
(81% yield) of the title compound as a white solid. 
[𝛼]𝐷
20 = +40.0 (c 0.90, CHCl3);  
Rf (EtOAc/hexanes 1:4): 0.30;  
IR (neat): 3322, 3032, 2954, 1716, 1510, 1439, 1339, 1207, 1060, 1012, 739, 697 
cm
-1
;  
1
H NMR (CDCl3, 500 MHz): δ 7.40-7.32 (m, 5 H), 5.66 (d, J = 8.0 Hz, 1 H), 
5.17-5.11 (m, 2 H), 4.82 (dt, J = 8.0, 4.0 Hz, 1 H), 3.84 (dd, J = 10.5, 4.0 Hz, 1 H), 3.81 
(s, 3 H), 3.75 (dd, J = 10.5, 4.0 Hz, 1 H);  
13
C NMR (CDCl3, 75 MHz): δ 169.3, 155.5, 135.9, 67.3, 54.3, 53.1, 33.7;  
MS (ESI) m/z calcd for C12H15BrNO4 ([M+H]
+
): 316.0184; found: 316.0231. 
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Benzyl (3-bromopropyl)carbamate (18): According to the general procedure A, 
the alcohol 17 (104 mg, 0.500 mmol) was treated with tris(2,2 -´bipyridyl)ruthenium (II) 
chloride hexahydrate (3.7 mg, 5.0 μmol), carbon tetrabromide (332 mg, 1.00 mmol) and  
sodium bromide (103 mg, 1.00 mmol). After 5 h, the reaction mixture was subjected to 
the workup protocol and purified by chromatography on SiO2 using petroleum ether/Et2O 
(3:1) as the eluent to afford 130 mg (96% yield) of the title compound as a colorless oil. 
Rf (EtOAc/hexanes 1:3): 0.34;  
IR (neat): 3326, 2947, 1694, 1531, 1454, 1248, 1133, 1002, 697 cm
-1
;  
1
H NMR (CDCl3, 400 MHz): δ 7.38-7.30 (m, 5 H), 5.12-5.08 (m, 2 H), 4.86 (br s, 1 
H), 3.44 (t, J = 6.4 Hz, 2 H), 3.36 (q, J = 6.4 Hz, 2 H), 2.12-2.05 (m, 2 H);  
13
C NMR (CDCl3, 100 MHz) δ 156.4, 136.4, 66.8, 39.4, 32.4, 30.6;  
MS (ESI) m/z calcd for C11H14BrNO2Na ([M + Na]
+
): 294.0106; found: 294.0121. 
 
 
 
tert-Butyl (3-bromopropyl)carbamate (20): According to the general procedure, 
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the alcohol 19 (87.5 mg, 0.500 mmol) was treated with tris(2,2 -´bipyridyl)ruthenium (II) 
chloride hexahydrate (3.7mg, 5.0 μmol), carbon tetrabromide (332 mg, 1.00 mmol), 
sodium bromide (103 mg, 1.00 mmol) and 2,6-lutidine (0.174 mL, 1.50 mmol). After 5 h, 
the reaction mixture was subjected to the workup protocol and purified by 
chromatography on SiO2 using petroleum ether/Et2O (3:1) as the eluent to afford 89.0 mg 
(75% yield) of the title compound as a colorless oil. 
Rf (EtOAc/hexanes1:3): 0.46;  
IR (neat): 3352, 2977, 2932, 1686, 1517, 1366, 1249, 1165 cm
-1
;  
1
H NMR (CDCl3, 400 MHz): δ 4.70-4.60 (br s, 1 H), 3.44 (t, J = 6.4 Hz, 2 H), 3.27 
(q, J = 6.4 Hz, 2 H), 2.08-2.02 (m, 2 H), 1.44 (s, 9 H);  
13
C NMR (CDCl3, 100 MHz): δ 155.9, 79.4, 38.9, 32.6, 30.8, 28.3;  
MS (ESI) m/z calcd for C8H17BrNO2 ([M+H]
+
): 238.0443; found: 238.0524. 
 
 
 
N-(2-Bromoethyl)-4-methyl-N-(prop-2-yn-1-yl)benzenesulfonamide (22): 
According to the general procedure A, the alcohol
 
21 (127 mg, 0.500 mmol) was treated 
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with tris(2,2 -´bipyridyl)ruthenium (II) chloride hexahydrate (3.7 mg, 5.0 μmol), carbon 
tetrabromide (332 mg, 1.00 mmol) and  sodium bromide (103 mg, 1.00 mmol). After 7 h, 
the reaction mixture was subjected to the workup protocol and purified by 
chromatography on SiO2 using petroleum ether/Et2O (4:1) as the eluent to afford 138 mg 
(86% yield) of the title compound as a colorless oil. 
Rf (EtOAc/hexanes 1:3): 0.49;  
IR (neat): 3285, 2976, 1347, 1158, 1091, 907, 660 cm
-1
;  
1
H NMR (CDCl3, 400 MHz): δ 7.74 (dd, J = 8.0, 1.6 Hz, 2 H), 7.32 (dd, J = 8.0, 1.6 
Hz, 2 H), 4.18 (t, J = 2.0 Hz, 2 H), 3.59-3.50 (m, 4 H), 2.43 (s, 3 H), 2.15-2.10 (m, 1 H);  
13
C NMR (CDCl3, 75 MHz): δ 144.0, 135.4, 129.7, 127.6, 74.2, 48.3, 37.9, 29.0, 
21.6;  
MS (ESI) m/z calcd for C12H15BrNO2S ([M+H]
+
): 316.0007; found: 316.0092. 
 
 
 
4-(3-Bromopropyl)phenol (24): According to the general procedure A, the alcohol 
23 (76.0 mg, 0.500 mmol) was treated with tris(2,2 -´bipyridyl)ruthenium (II) chloride 
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hexahydrate (3.7 mg, 5.0 μmol), carbon tetrabromide (332 mg, 1.00 mmol) and  sodium 
bromide (103 mg, 1.00 mmol). After 7 h, the reaction mixture was subjected to the 
workup protocol and purified by chromatography on SiO2 using petroleum ether/Et2O 
(4:1) as the eluent to afford 90.5 mg (84% yield) of the title compound as a white solid. 
Rf (EtOAc/hexanes 1:5): 0.35;  
IR (neat): 3347, 3019, 2935, 2854, 1612, 1512, 1446, 1236, 820 cm
-1
;  
1
H NMR (CDCl3, 500 MHz): δ 7.07 (d, J = 8.6 Hz, 2 H), 6.76 (d, J = 8.3 Hz, 2 H), 
4.56 (s, 1 H), 3.38 (t, J = 6.6 Hz, 2 H), 2.71 (t, J = 7.3 Hz, 2 H), 2.15-2.09 (m, 2 H);  
13
C NMR (CDCl3, 75 MHz): δ 153.8, 132.7, 129.7, 115.3, 34.3, 33.1, 33.0. 
 
 
 
((6-Bromohexyl)oxy)(tert-butyl)diphenylsilane (26): According to the general 
procedure A, the alcohol 25 (178 mg, 0.500 mmol) was treated with 
tris(2,2 -´bipyridyl)ruthenium (II) chloride hexahydrate (3.7 mg, 5.0 μmol), carbon 
tetrabromide (332 mg, 1.00 mmol), sodium bromide (103 mg, 1.00 mmol) and 
2,6-lutidine (0.174 mL, 1.50 mmol). After 6 h, the reaction mixture was subjected to the 
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workup protocol and purified by chromatography on SiO2 using petroleum ether/Et2O 
(10:1) as the eluent to afford 181 mg (86% yield) of the title compound as a colorless oil. 
Rf (EtOAc/hexanes 1:1): 0.41;  
IR (neat): 3071, 2932, 2857, 1727, 1472, 1428, 1110, 701 cm
-1
;  
1
H NMR (CDCl3, 400 MHz): δ 7.66 (d, J = 7.6 Hz, 4 H), 7.45-7.35 (m, 6 H), 3.66 (t, 
J = 6.4 Hz, 2 H), 3.38 (t, J = 6.8 Hz, 2 H), 1.87-1.82 (m, 2 H), 1.60-1.54 (m, 2 H), 
1.46-1.34 (m, 4 H), 1.41 (s, 9 H);  
13
C NMR (CDCl3, 100 MHz): δ 135.6, 134.1, 129.5, 127.6, 63.7, 33.8, 32.8, 32.3, 
27.9, 26.9, 25.0, 19.2;  
MS (ESI) m/z calcd for C22H32BrOSi ([M+H]
+
): 419.1406; found: 419.1499. 
 
 
 
Methyl 2-bromo-2-phenylacetate (28): According to the general procedure A, the 
alcohol 27 (83.1 mg, 0.500 mmol) was treated with tris(2,2 -´bipyridyl)ruthenium (II) 
chloride hexahydrate (3.7 mg, 5.0 μmol), carbon tetrabromide (332 mg, 1.00 mmol) and  
sodium bromide (103 mg, 1.00 mmol). After 12 h, the reaction mixture was subjected to 
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the workup protocol and purified by chromatography on SiO2 using petroleum ether/Et2O 
(10:1) as the eluent to afford 98.2 mg (86% yield) of the title compound as a colorless oil. 
Rf (EtOAc/hexanes 1:10): 0.39;  
IR (neat): 3030, 2953, 1751, 1455, 1435, 1280, 1219, 1146, 1007, 697 cm
-1
;  
1
H NMR (CDCl3, 400 MHz): δ 7.60-7.52 (m, 2 H), 7.40-7.34 (m, 3 H), 5.28 (s, 1 
H), 3.79 (s, 3 H);  
13
C NMR (CDCl3, 75 MHz): δ 168.8, 135.7, 129.3, 128.8, 128.6, 53.4, 46.5.  
 
 
 
(3-Bromobutyl)benzene (30): According to the general procedure A, the alcohol 29 
(75.0 mg, 0.500 mmol) was treated with tris(2,2 -´bipyridyl)ruthenium (II) chloride 
hexahydrate (3.7 mg, 5.0 μmol), carbon tetrabromide (332 mg, 1.00 mmol) and  sodium 
bromide (103 mg, 1.00 mmol). After 12 h, the reaction mixture was subjected to the 
workup protocol and purified by chromatography on SiO2 using petroleum ether as the 
eluent to afford 79.2 mg (75% yield) of the title compound as a colorless oil. 
Rf (hexanes): 0.41;  
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IR (neat): 3027, 2920, 1496, 1453, 1227, 1159, 747, 698 cm
-1
;  
1
H NMR (CDCl3, 500 MHz): δ 7.31-7.28 (m, 2 H), 7.22-7.19 (m, 3 H), 4.12-4.05 
(m, 1 H), 2.90-2.84 (m, 1 H), 2.78-2.72 (m, 1 H), 2.18-2.10 (m, 1 H), 2.09-2.01 (m, 1 
H), 1.74 (d, J = 6.6 Hz, 3 H);  
13
C NMR (CDCl3, 75 MHz): δ 140.9, 128.5, 128.4, 126.1, 50.9, 42.7, 33.9, 26.5.  
 
 
 
Cyclododecyl formate (32): According to the general procedure A, the alcohol 31 
(92.1 mg, 0.500 mmol) procedure A, the alcohol (92.1 mg, 0.500 mmol) was treated with 
tris(2,2 -´bipyridyl)ruthenium (II) chloride hexahydrate (3.7 mg, 5.0 μmol), carbon 
tetrabromide (332 mg, 1.00 mmol) and  sodium bromide (103 mg, 1.00 mmol). After 12 
h, the reaction mixture was subjected to the workup protocol and purified by 
chromatography on SiO2 using petroleum ether/Et2O (20:1) as the eluent to afford 97.0 
mg (92% yield) of the title compound as a colorless oil. 
Rf (EtOAc/hexanes 1:40): 0.20;  
IR (neat): 2929, 2863, 1721, 1470, 1446, 1180, 1151 cm
-1
;  
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1
H NMR (CDCl3, 400 MHz): δ 8.05 (s, 1 H), 5.18-5.11 (m, 1 H), 1.75 (dt, J = 20.8, 
6.8 Hz, 2 H), 1.58-1.50 (m, 2 H), 1.43-1.23 (m, 18 H); 
 
13
C NMR (CDCl3, 100 MHz): δ 161.0, 72.3, 29.1, 24.0, 23.8, 23.4, 23.2, 20.9;  
MS (ESI) m/z calcd for C13H24O2Na ([M+Na]
+
): 235.1674; found: 235.1809. 
 
 
 
1-(3-Iodopropyl)-4-methoxybenzene (33): According to the general procedure B, 
the alcohol 5 (83.0 mg, 0.500 mmol) was treated with tis(2,2 -´bipyridyl)ruthenium (II) 
chloride hexahydrate (3.7 mg, 5.0 μmol), iodoform (394 mg, 1.00 mmol) and sodium 
iododide (150 mg, 1.00 mmol). After 12 h, the reaction mixture was subjected to the 
workup protocol and purified by chromatography on SiO2 using petroleum ether/Et2O 
(10:1) as the eluent to afford 125 mg (91% yield) of the title compound as a pale yellow 
oil. 
Rf (EtOAc/hexanes 1:10): 0.27;  
IR (neat): 2933, 1611, 1512, 1245, 1177, 1036, 824 cm
-1
;  
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1
H NMR (CDCl3, 400 MHz): δ 7.11 (d, J = 8.6 Hz, 2 H), 6.84 (d, J = 8.6 Hz, 2 H), 
3.79 (s, 3 H), 3.16 (t, J = 6.8 Hz, 2 H), 2.67 (t, J = 7.2 Hz, 2 H), 2.13-2.06 (m, 2 H); 
 
13
C NMR (CDCl3, 75 MHz): δ 158.0, 132.4, 129.5, 113.9, 55.2, 35.2, 35.1, 6.5. 
 
 
 
4-(3-Iodopropoxy)phenol (35): According to the general procedure B, the alcohol 
34 (70.0 mg, 0.416 mmol) was treated with tris(2,2 -´bipyridyl)ruthenium (II) chloride 
hexahydrate (3.1 mg, 4.2 μmol), iodoform (328 mg, 0.833 mmol) and sodium iododide 
(125 mg, 0.833 mmol). After 12 h, the reaction mixture was subjected to the workup 
protocol and purified by chromatography on SiO2 using petroleum ether/Et2O (10:1) as 
the eluent to afford 99.7 mg (86% yield) of the title compound as a colorless oil. 
Rf (EtOAc/hexanes 1:3): 0.50;  
IR (neat): 3355, 2920, 1506, 14446, 1209, 1179, 1024, 824 cm
-1
;  
1
H NMR (CDCl3, 400 MHz): δ 6.81-6.74 (m, 5 H), 4.42-4.38 (br s, 1 H), 3.98 (dt, J 
= 6.0, 1.2 Hz, 2 H), 3.37 (dt, J = 6.8, 1.2 Hz, 2 H), 2.28-2.21 (m, 2 H); 
 
13
C NMR (CDCl3, 100 MHz): δ 152.8, 149.6, 116.1, 115.8, 68.1, 33.1, 2.6. 
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Benzyl (3-iodopropyl)carbamate (36): According to the general procedure B, the 
alcohol 17 (104 mg, 0.500 mmol) was treated with tris(2,2 -´bipyridyl)ruthenium (II) 
chloride hexahydrate (3.7 mg, 5.0 μmol), iodoform (394 mg, 1.00 mmol) and sodium 
iododide (150 mg, 1.00 mmol). After 12 h, the reaction mixture was subjected to the 
workup protocol and purified by chromatography on SiO2 using petroleum ether/Et2O 
(4:1) as the eluent to afford 146 mg (91% yield) of the title compound as a pale yellow 
oil. 
Rf (EtOAc/hexanes 1:3): 0.42; 
IR (neat): 3328, 2940, 1693, 1531, 1251, 1028, 736, 696 cm
-1
;  
1
H NMR (CDCl3, 400 MHz): δ 7.40-7.30 (m, 5 H), 5.10 (s, 2 H), 4.88-4.80 (br s, 1 
H), 3.30 (q, J = 6.4 Hz, 2 H), 3.19 (t, J = 6.8 Hz, 2 H), 2.07-2.00 (m, 2 H); 
 
13
C NMR (CDCl3, 75 MHz): δ 156.4, 136.4, 128.5, 128.2, 128.1, 66.8, 41.4, 33.1, 
2.9;  
MS (ESI) m/z calcd for C11H15INO2 ([M+H ]
+
): 320.0148; found: 320.0154. 
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(3-Iodobutyl)benzene (38): According to the general procedure B, the alcohol 37 
(83.1 mg, 0.500 mmol) was treated with tris(2,2 -´bipyridyl)ruthenium (II) chloride 
hexahydrate (3.7 mg, 5.0 μmol), iodoform (394 mg, 1.00 mmol) and sodium iododide 
(150 mg, 1.00 mmol). After 12 h, the reaction mixture was subjected to the workup 
protocol and purified by chromatography on SiO2 using petroleum ether as the eluent to 
afford 89.2 mg (65% yield) of the title compound as a yellow oil. 
Rf (hexanes): 0.72; 
IR (neat): 2915, 1430, 1233, 1168 cm
-1
;  
1
H NMR (CDCl3, 400 MHz): δ 5.16 (s, 1 H), 3.19-3.09 (m, 2 H), 2.57-2.52 (m, 2 
H), 2.37 (dt, J = 8.4, 5.6 Hz, 1 H), 2.29-2.13 (m, 2 H), 2.11-2.06 (m, 1 H), 2.00 (dt, J = 
5.6, 1.4 Hz, 1 H), 1.28 (s, 3 H), 1.18 (d, J = 8.4 Hz, 1 H), 0.84 (s, 3 H);  
13
C NMR (CDCl3, 75 MHz): δ 146.7, 118.7, 45.3, 41.4, 40.6, 38.1, 31.7, 31.3, 26.2, 
21.3, 3.7. 
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(3-Iodobutyl)benzene (39): According to the general procedure B, the alcohol 29 
(75.0 mg, 0.500 mmol) was treated with tris(2,2 -´bipyridyl)ruthenium (II) chloride 
hexahydrate (3.7 mg, 5.0 μmol), iodoform (394 mg, 1.00 mmol) and sodium iodide (150 
mg, 1.00 mmol). After 15 h, the reaction mixture was subjected to the workup protocol 
and purified by chromatography on SiO2 using petroleum ether as the eluent to afford 
93.3 mg (72% yield) of the title compound as a pale yellow oil. 
Rf (hexanes): 0.44; 
IR (neat): 3026, 2916, 1453, 1377, 1134, 746, 697 cm
-1
;  
1
H NMR (CDCl3, 500 MHz): δ 7.31-7.25 (m, 2 H), 7.23-7.17 (m, 3 H), 4.12 (qt, J = 
7.0 Hz, 1 H), 2.85 (ddd, J = 14.0, 9.0, 5.0 Hz, 1 H), 2.73-2.66 (m, 1 H), 2.20-2.15 (m, 1 
H), 1.95 (dd, J = 7.0, 1.0 Hz, 3 H), 1.92-1.85 (m, 1 H);  
13
C NMR (CDCl3, 75 MHz): δ 140.7, 128.5, 128.4, 126.1, 44.4, 35.8, 29.7, 29.0. 
 
 
 
tert-Butyl((6-iodohexyl)oxy)diphenylsilane (40): According to the general 
procedure B, the alcohol 25 (178 mg, 0.500 mmol) was treated with 
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tris(2,2 -´bipyridyl)ruthenium (II) chloride hexahydrate (3.7 mg, 5.0 μmol), iodoform (394 
mg, 1.00 mmol), sodium iododide (150 mg, 1.00 mmol) and 2,6-lutidine (0.174 mL, 1.50 
mmol). After 12 h, the reaction mixture was subjected to the workup protocol and 
purified by chromatography on SiO2 using petroleum ether/Et2O (10:1) as the eluent to 
afford 176 mg (78% yield) of the title compound as a colorless oil. 
Rf (EtOAc/hexanes 1:10): 0.38; 
IR (neat): 3070, 2931, 2857, 1427, 1110, 701 cm
-1
;  
1
H NMR (CDCl3, 400 MHz): δ 7.68-7.64 (m, 4 H), 7.44-7.36 (m, 6 H), 3.65 (t, J = 
6.4 Hz, 2 H), 3.16 (t, J = 7.0 Hz, 2 H), 1.85-1.76 (m, 2 H), 1.60-1.51 (m, 2 H), 1.41-1.35 
(m, 4 H), 1.05 (s, 9 H); 
13
C NMR (CDCl3, 75 MHz): δ 135.5, 134.0, 129.5, 127.5, 63.6, 33.4, 32.2, 30.2, 
26.8, 24.7, 19.2, 7.0;  
MS (ESI) m/z calcd for C22H32IOSi ([M+H ]
+
): 467.1267; found: 467.1461. 
 
Bromination on Preparative Scale  
 
A flame dried 10 mL Schlenk flask with a rubber septum and magnetic stir bar was 
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charged with tris(2,2’-bipyridyl)ruthenium(II) chloride hexahydrate (7.5 mg, 0.010 
mmol), the alcohol 7 (0.971 g, 5.00 mmol), carbon tetrabromide (3.32 g, 10.0 mmol) and 
tetrabutylammonium bromide (3.22 g, 10.0 mmol). The flask was purged with a stream of 
nitrogen and dry DMF (10.0 mL) was added via syringe under the nitrogen atmosphere. 
The mixture was degassed by the freeze-pump-thaw procedure (3 cycles), and placed in a 
250 mL beaker with blue LEDs wrapped inside. After 20 h, the mixture was poured into a 
separatory funnel containing 100 mL of Et2O and 100 mL of H2O. The layers were 
separated and the aqueous layer was extracted with Et2O (2 × 100 mL). The combined 
organic layers were washed with brine, dried (MgSO4) and concentrated in vacuo. The 
residue was purified by chromatography on SiO2 using petroleum ether/Et2O (10:1) as the 
eluent to afford 0.131 g of the alcohol 7 and 1.06 g (83% yield, 96% brsm yield) of the 
desired product 8 as a colorless oil. 
 
Mechanistic Studies 
Part A: Isotopic Labeling Experiment 
 
A flame dried 5 mL round bottom flask with a rubber septum and magnetic stir bar 
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was charged with tris(2,2’-bipyridyl)ruthenium(II) chloride hexahydrate (0.7 mg, 1.0 
μmol), the corresponding alcohol 13 (22.1 mg, 0.100 mmol), carbon tetrabromide (66.3 
mg, 0.200 mmol) and DMF-d7 (1 mL, 99.5 atom% D, purchased from Sigma-Aldrich
®
) 
was added via syringe under nitrogen atmosphere. The mixture was degassed by the 
freeze-pump-thaw procedure (3 cycles), and placed in a 100 mL beaker with blue LEDs 
wrapped inside. After 4 h, the mixture was poured into a separatory funnel containing 15 
mL of Et2O and 15 mL of H2O. The layers were separated and the aqueous layer was 
extracted with Et2O (2 × 15 mL). The combined organic layers were washed with sat. 
Na2S2O3 solution, brine, dried (MgSO4) and concentrated in vacuo. The residue was 
purified by chromatography on SiO2 using petroleum ether/Et2O (4:1) as the eluent to 
afford 15.0 mg of the formate ester 41 (0.060 mmol, 60%, Figure 4.4). 
 
Figure 4.4 
1
H NMR spectrum of formate ester 41 
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Part B: Mechanistic Investigations into the Radical Pathway 
 
(4,4,4-Tribromobut-1-en-2-yl)benzene (43): A flame dried 5 mL round bottom 
flask with a rubber septum and magnetic stir bar was charged with 
tris(2,2’-bipyridyl)ruthenium(II) chloride hexahydrate (3.7 mg, 5.0 μmol), 
-methylstyrene (59.1 mg, 0.500 mmol), carbon tetrabromide (332 mg, 1.00 mmol), and 
DMF or CH3CN (5.0 mL) was added via syringe under nitrogen atmosphere. The mixture 
was degassed by the freeze-pump-thaw procedure (3 cycles), and placed in a 250 mL 
beaker with blue LEDs wrapped inside. After 12 h, the mixture was poured into a 
separatory funnel containing 50 mL of Et2O and 50 mL of H2O. The layers were 
separated and the aqueous layer was extracted with Et2O (2 × 50 mL). The combined 
organic layers were washed with brine, dried (MgSO4) and concentrated in vacuo. 
Analysis of the crude 
1
H NMR indicated that there was no dibromocyclopropane species 
44 generated in both reactions, as compared with an authentic sample of the cyclopropane 
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prepared independently. Exhaustive purification by chromatography on SiO2 to remove 
CBr4 impurities using petroleum ether as the eluent afforded 24.1 mg of compound 43. 
Rf (hexanes): 0.65; 
IR (neat): 3081, 3055, 3029, 1626, 1493, 1423, 1217, 949, 910, 781, 765, 698, 623 
cm
-1
;  
1
H NMR (CDCl3, 400 MHz): δ 7.44-7.25 (m, 5 H), 5.68 (s, 1 H), 5.58 (s, 1 H), 4.26 
(s, 2 H);  
13
C NMR (CDCl3, 100 MHz): δ 144.1, 141.1, 128.3, 127.7, 127.0, 122.4, 62.7, 39.4. 
 
Part C: Mechanistic Investigations of the Racemization  
1) Preparation of the Optically Enriched Alcohol  
 
(S)-1-Phenylbutan-2-ol (52): To a solution of racemic 1-phenylbutan-2-ol (1.00 g, 
6.67 mmol) in n-pentane (30 mL) was added Lipase AK Amano (1.00 g, purchased from 
Amano Enzyme Inc.) and vinyl acetate (1.23 mL, 13.3 mmol). The mixture was stirred at 
room temperature and monitored by 
1
H NMR. The lipase was filtered off and washed 
with n-pentane. The filtrate was concentrated in vacuo and the residue was purified by 
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chromatography on SiO2 using hexanes/ethyl acetate (gradient elution 10:1 to 3:1) as the 
eluent to afford 52 (0.420 g, 2.80 mmol, 42% yield, 99% ee) as a colorless oil. 
Rf (EtOAc/hexanes 1:3): 0.55; 
[𝛼]𝐷
20 = +28.7 (c 1.06, CHCl3);  
1
H NMR (CDCl3, 400 MHz): δ 7.35-7.29 (m, 2 H), 7.27-7.20 (m, 3 H), 3.80-3.72 
(m, 1 H), 2.85 (dd, J = 13.6, 4.4 Hz, 1 H), 2.66 (dd, J = 13.6, 8.4 Hz, 1 H), 1.62-1.49 (m, 
3 H), 1.01 (dt, J = 7.2, 1.6 Hz, 3 H). 
The enantiomeric excess was determined by HPLC using a ChiralCel OD column. 
Isocratic 5% isopropanol/hexanes at a flow rate of 1.0 mL/min (Figure 4.5). 
 
Figure 4.5 Chiral HPLC results of alcohol (S)-52 
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2) Racemization of Chiral Alcohol in Photocatalyzed Bromination  
 
(2-Bromobutyl)benzene (53): According to the general procedure A, (S)-52 (75.0 
mg, 0.500 mmol, 99% ee) was treated with tris(2,2 -´bipyridyl)ruthenium (II) chloride 
hexahydrate (3.7 mg, 5.0 μmol), carbon tetrabromide (332 mg, 1.00 mmol) and sodium 
bromide (103 mg, 1.00 mmol). After 12 h, the reaction mixture was subjected to the 
workup protocol and purified by chromatography on SiO2 using petroleum ether as the 
eluent to afford 85.0 mg (80% yield) of (2-bromobutyl)benzene 53. [𝛼]𝐷
20 of the product 
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was 0 (c=1.00, CHCl3) which indicates that racemization occurred to the product under 
this condition.  
Rf (hexanes): 0.23; 
IR (neat): 2964, 2932, 2855, 1454, 1172, 700 cm
-1
;  
1
H NMR (CDCl3, 400 MHz): δ 7.32-7.20 (m, 5 H), 4.21-4.13 (m, 1 H), 3.24-3.12 
(m, 2 H), 1.96-1.86 (m, 1 H), 1.84-1.72 (m, 1 H), 1.07 (t, J = 7.2 Hz, 3 H); 
13
C NMR (CDCl3, 100 MHz): δ 138.7, 129.2, 128.4, 126.7, 59.5, 45.4, 31.2, 12.1. 
 
3) Partial Racemization of the Bromination Reaction 
 
The experiment was carried out the same as above, but stopped after 5 h. Isolation 
and analysis of product 53 indicated that it was isolated in 90% ee after 35% conversion 
of the alcohol (S)-52.  
 
4) Isolation of the Reaction Intermediate  
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(S)-1-Phenylbutan-2-yl formate (54): A flame dried 5 mL round bottom flask with 
a rubber septum and magnetic stir bar was charged with tris(2,2’-bipyridyl)ruthenium(II) 
chloride hexahydrate (2.2 mg, 3.0 μmol), the corresponding alcohol (45.0 mg, 0.300 
mmol), carbon tetrabromide (99.5 mg, 0.300 mmol) and DMF (3.0 mL) was added via 
syringe under nitrogen atmosphere. The mixture was degassed by the freeze-pump-thaw 
procedure (3 cycles), and placed in a 250 mL beaker with blue LEDs wrapped inside. 
After 7 h, the mixture was poured into a separatory funnel containing 20 mL of Et2O and 
20 mL of H2O. The layers were separated and the aqueous layer was extracted with Et2O 
(2 × 20 mL). The combined organic layers were washed with brine, dried (MgSO4) and 
concentrated in vacuo. The residue was purified by flash chromatography using 
petroleum ether/Et2O (10:1) as the eluent to afford 3.40 mg of the formate ester 13 (99% 
ee).  
[𝛼]𝐷
24 = -2.0 (c 1.00, CHCl3); 
Rf (EtOAc/hexanes 1:10): 0.17; 
IR (neat): 2962, 2929, 1729, 1455, 760 cm
-1
;  
1
H NMR (CDCl3, 400 MHz): δ 8.02 (s, 1 H), 7.32-7.19 (m, 5 H), 5.17-5.11 (m, 1 
H), 2.94-2.82 (m, 2 H), 1.68-1.56 (m, 2 H), 0.94 (t, J = 7.4 Hz, 3 H);  
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13
C NMR (CDCl3, 100 MHz): δ 160.8, 137.2, 129.4, 128.4, 126.6, 76.1, 40.1, 26.4, 
9.6;  
The enantiomeric excess was determined by HPLC using a ChiralCel OD column on 
the alcohol 52 from hydrolysis of the formate ester 53 using K2CO3 in MeOH/H2O. 
Isocratic 5% isopropanol/hexanes at a flow rate of 1.0 mL/min (Figure 4.6). 
 
Figure 4.6 Chiral HPLC results of formate ester 54 after saponification 
 
The results indicate that the racemization does not accur to this step. 
5) Racemization of Chiral Bromide under Photocatalyzed Halogenation Condition  
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 According to the general procedure A, (R)-(2-bromobutyl)benzene 53 (130.0 mg, 
0.610 mmol, 99% ee) was treated with tris(2,2 -´bipyridyl)ruthenium (II) chloride 
hexahydrate (4.6 mg, 6.1 μmol), carbon tetrabromide (405 mg, 1.22 mmol) and sodium 
bromide (126 mg, 1.22 mmol) in DMF (6.0 mL). The reactions were running at 28 ̊C and 
34 ̊C, respectively. A portion of the reaction mixture was taken out after certain hours. 
After aqueous workup and evaporation of the solvent, the residue was purified by a 
pipette column. [𝛼]𝐷 was measured at 22 ̊C.  
[𝛼]𝐷
22 of (R)-53 was measured as ‒13.7 (c 1.02, CHCl3). 
Product of reaction at 28 ̊C: 
2 h, [𝛼]𝐷 =  −11.1, ee% = 81% 
7 h, [𝛼]𝐷 =  −7.69, ee% = 56% 
12 h, [𝛼]𝐷 =  −5.45, ee% = 40% 
Product of reaction at 34 ̊C: 
1 h, [𝛼]𝐷 =  −11.9, ee% = 87% 
4 h, [𝛼]𝐷 =  −7.69, ee% = 56% 
9 h, [𝛼]𝐷 =  −4.62, ee% = 34% 
12 h, [𝛼]𝐷 =  −3.48, ee% = 25% 
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Part D. Emission Quenching Experiments 
Emission intensities were recorded using a Jobin Yvon Horiba FluoroMax 3 
Fluorometer. Dry DMF was degassed with a stream of nitrogen overnight before using. 
All tris(2,2’-bipyridyl)ruthenium(II) chloride hexahydrate solutions were excited at 452 
nm and the emission intensity at 615 nm was observed. In a typical experiment, a 5.0 
μmol solution of tris(2,2’-bipyridyl)ruthenium(II) chloride hexahydrate in DMF was 
added to the appropriate amount of quencher in a 1.0 cm quartz cuvette and covered. 
After degassing with a stream of nitrogen for 10 minutes, the emission spectrum of the 
sample was collected (Figure 4.7). 
 
Figure 4.7 Emission quenching experiment of Ru(bpy)3Cl2 by CBr4 
 
I0 = Emission intensity of Ru(bpy)3
2+
 in the absence of quencher. I = Emission intensity of 
Ru(bpy)3
2+
 in the presence of quencher. 
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One-pot Deoxygenation on Flow 
 
Benzyl propylcarbamate (55): A flame dried 10 mL round bottom flask with a 
rubber septum and magnetic stir bar was charged with alcohol 17 (0.20 g, 1.0 mmol, 1.0 
equiv), triphenylphosphine (0.32 g, 1.2 mmol, 1.2 equiv), and imidazole (82 mg, 1.2 
mmol, 1.2 equiv) in MeCN (5.0 mL). The reaction mixture is cooled in an ice bath to 0 
ºC and iodine (0.30 g, 1.2 mmol, 1.2 equiv) was added in portions. The reaction was 
removed from the ice bath and stirred at room temperature overnight. 
N,N-Diisopropylethylamine (1.7 mL, 10 mmol, 10 equiv), methanol (0.2 mL), and 
fac-Ir(ppy)3 (1.6 mg, 0.0025 mmol, 0.0025 equiv) were added to the reaction mixture and 
stirred until a homogenous solution was formed. The reaction mixture was then pumped 
through the photoreactor at a flow rate to achieve a residence time of 18 min. The solvent 
was removed from the crude mixture in vacuo and was dissolved in a minimal amount of 
EtOAc before being passed through a bed of silica gel and eluted with diethyl ether. The 
filtrate was concentrated and the crude product was purified by chromatography on SiO2 
(95:5, hexanes/EtOAc) to afford the product 55 (0.16 g, 81%) as a colorless oil. 
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Rf (EtOAc/hexane 1:4): 0.42;  
1
H NMR (CDCl3, 400 MHz): δ 7.38-7.30 (m, 5 H), 5.10 (s, 2 H), 3.21-3.13 (m, 2 
H), 1.60-1.48 (m, 2 H), 0.93 (t, J = 7.4 Hz, 3 H). 
 
One-pot Deoxygenation Using Ir(ppy)2(dtb-bpy)PF6 
 
According to the general procedure A, the alcohol 17 (104 mg, 0.500 mmol) was 
treated with Ir(ppy)2(dtb-bpy)PF6 (4.6 mg, 5.0 μmol), carbon tetrabromide (199 mg, 
0.600 mmol, 1.2 equiv) and sodium bromide (61.8 mg, 0.600 mmol, 1.2 equiv) in DMF 
(2.5 mL). The reaction was stirred at room temperature for 12 h. Then 
N,N-Diisopropylethylamine (645 mg, 5.00 mmol, 10 equiv), NaHCO3 (84.0 mg, 1.00 
mmol, 2.0 equiv), MeCN (2.5 mL) and H2O (1.5 mL) were added to the reaction flask 
which was connected to the air via a needle. The reaction mixture was heated to 60 ̊C and 
stirred for 24 h. Then the reaction mixture was subjected to the workup protocol and 
purified by chromatography on SiO2 using hexane:EA (4:1) as the eluent to afford the 
desired product 55 (24.0 mg, 25% yield) as a colorless oil. 
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CHAPTER 5 
Syntheses of Anhydrides Using Oxidative Photocatalysis 
 
1 Introduction 
As discussed in Chapter 4, the Vilsmeier–Haack reagent can be generated in situ 
using light-mediated photocatalysis via oxidative quenching of Ru(bpy)3Cl2 by CBr4 in 
DMF. In the presence of a nucleophile, such as an alcohol in the previous case, the 
nucleophile will react with the Vilsmeier–Haack reagent and the carbon-oxygen bond of 
the alcohol was successfully activated toward nucleophilic substitution to provide the 
corresponding bromide or iodide. Inspired by this new means of activating molecules and 
bonds for chemical reactions, we sought to expand this method to the photocatalytic 
synthesis of anhydrides via activation of carbon-oxygen bonds in carboxylic acids by the 
in situ generated Vilsmeier–Haack reagent (Scheme 5.1). 
 
Scheme 5.1 Photocatalytic C-O bond activation using in situ generated Vilsmeier-Haack reagent 
 
180 
  
Carboxylic anhydrides have been mainly exploited as useful precursors to synthesize 
amides and esters and have been used in peptide synthesis (Figure 5.1). Among these 
examples, benzoic anhydrides and derivatives, such as 2-methyl-6-nitrobenzoic 
anhydride (1), have been utilized as powerful coupling reagents for the synthesis of 
carboxylic esters from carboxylic acids and alcohols.
191
 Meanwhile, asymmetric 
anhydrides, for example (1-naphthyl)(trifluoromethyl) O-carboxy anhydride (2), have 
been employed as chiral derivatizing agents.
192
 Recently, considerable attention has been 
paid to the functionalization of cyclic anhydrides due to their easy accessibility and 
potential to provide valuable building blocks. These compounds have found utility in 
polymer synthesis for drug delivery,
193,194
 thin polymeric film preparation
195,196
 and in 
other chemical transformations.
197 , 198 , 199
 Anhydrides have also been subjected to 
stereoselective ring opening which provides access to chiral carboxylic acids and their 
derivatives via desymmetrization.
200
 Moreover, natural products containing maleic 
anhydride moiety are known to possess useful biological activity as they can readily 
block amino acids in proteins and peptides, particularly the lysine residue.
201
 For 
examples, tautomycin (3) exhibits a strong inhibition of protein phosphatase, while 
phomoidride B (4) inhibits Ras farnesyl transferase and squalene synthase.
202
 Since 
carboxylic anhydrides form one of the most fundamentally useful classes of chemicals 
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and have numerous applications in both laboratory and industry, the development of 
efficient new approaches for the preparation of anhydrides remains a useful goal.  
 
Figure 5.1 Representative natural products with maleic anhydride moiety 
 
 
Various strategies for the synthesis of anhydrides from carboxylic acids have been 
reported (Table 5.1).
203
 The majority of methods currently available utilize carboxylic 
acids with dehydrating coupling agents, including phosgene,
204 , 205  
sulfonyl
206
 and 
thionyl chloride,
207 , 208 , 209
 phosphoranes,
210 , 211
 thiourea,
212
 carbodiimides,
213 , 214 
ethoxyacetylene,
215,216 ,217
 isocyanates,
218
 pyridazin-3(2H)-ones,
219,220  
1,3,5-triazines
221
 
and dicarbonate/Mg
2+
.
222
 Other approaches have centered around reactions of 
carboxylate salts with strong acylating agents such as acid chlorides
223,224,225
 or acid 
anhydrides.
226
 Among them, the Yamaguchi reagent (2,4,6-trichlorobenzoyl chloride) is 
one of the most widely used  
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Table 5.1 Representative reaction conditions for synthesis of anhydrides 
Entry Condition 
Reactive 
equivalent 
1 triphosgene, Et3N, rt 
 
2 TsCl, K2CO3 (excess amount), grinding 
 
3 SOCl2, Na2CO3, reflux 
 
4 
N-phenyl-phosphoramidochloride, or 
diphenyl phosphorochloride, Et3N, rt  
5 chlorosulfonyl isocyanate, Et3N, rt 
 
6 
, base, reflux  
7 
1,3,5-triazine reagents,  
N-methylmorpholine, 0 °C 
 
8 DIC, cat. DMAP, rt 
 
9 
N,N'-dicyclohexylthiourea,  
silver propionate, rt  
10 TMS-ethoxyacetylene, 60 °C 
 
11 Boc2O, cat. Mg(ClO4)2, rt 
 
12 
2,4,6-trichlorobenzoyl chloride, 
Et3N, rt   
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coupling reagents.
227,228
 More recently, polymer-supported cobalt phosphine complexes 
were reported for the ease of separation of products.
229
 
However, some of the coupling methods mentioned above suffer from harsh reaction 
conditions, while others require expensive coupling reagents or significant effort to 
prepare the reagents. Due to the relative instability of anhydrides, it is necessary to avoid 
chromatography and distillation for the purification of the products. Therefore, 
identifying mild and practical methods are crucial for this transformation. 
 
2 Aim of the Project 
We anticipated that by taking advantage of the mild reaction conditions of visible 
light-mediated photocatalysis and the efficiency of forming Vilsmeier–Haack reagents in 
situ, it should be possible to activate the carbon-oxygen bonds of carboxylic acids for 
nucleophilic additions leading to the production of anhydrides or other functionalized 
carboxylic acid derivatives. The purification of the products only requires an alkaline 
aqueous work-up, and continuous flow chemistry processing can also be employed, 
further exemplifying the efficiency of this approach.   
 
3 Development of Anhydride Syntheses Using Photoredox Catalysis 
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3.1 Optimization of the Reaction Conditions 
para-Methoxybenzoic acid (5) was used as the substrate for optimization of the 
reaction conditions. Initially, conditions used for photocatalyzed halogenation were 
applied to 5. By exposing the carboxylic acid to CBr4 and 2,6-lutidine in DMF, and under 
visible light irradiation (blue LEDs, λmax = 435 nm) in the presence of Ru(bpy)3Cl2 (1.0 
mol%) at 25 °C for 12 h, the corresponding anhydride 6 was isolated in 85% yield (Table 
5.2, entry 1). Increasing the temperature to 35 °C provided the product in a slightly 
decreased yield (entry 2). In both cases, we observed significant hydrolysis of the 
anhydride to the starting acid upon purification by chromatography (both neutral alumina 
and normal silica gel were tested). Therefore, we reasoned that lowering the amount of 
CBr4 from 2.0 equiv to 1.0 equiv and performing an alkaline aqueous work-up would 
allow for the isolation of analytically pure product without the need for further 
purification. Indeed, this new protocol led to the formation of the anhydride in 90% yield 
(entry 3). Additional control experiments were performed in the absence of the catalyst 
and careful exclusion of light, in which no reaction was observed, supporting the 
necessity of the photoredox catalyst and a light source (entries 4 and 5). As expected, 
excluding the oxidative quencher (CBr4) did not provide any of the desired product (entry 
6). Furthermore, the reaction was performed in the absence of a base, providing a mixture 
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of product and starting material in a 3:1 ratio (entry 7). In this case, lower conversion 
could be the result of an acid-mediated decomposition of the anhydride. 
 
Table 5.2 Optimization of reaction parameters 
 
Entry Catalyst 
Oxidative quencher 
(equiv) 
Base Yield
 a)
  
1
b)
 Ru(bpy)3Cl2 CBr4 (2.0) 2,6-lutidine 85% 
2
 b), e)
 Ru(bpy)3Cl2 CBr4 (2.0) 2,6-lutidine 79% 
3 Ru(bpy)3Cl2 CBr4 (1.0) 2,6-lutidine 90% 
4 None CBr4 (2.0) 2,6-lutidine NR 
5
 c)
 Ru(bpy)3Cl2 CBr4 (1.0) 2,6-lutidine NR 
6
 d)
 Ru(bpy)3Cl2 None 2,6-lutidine NR 
7
 d)
 Ru(bpy)3Cl2 CBr4 (1.0) None 77% 
a)
All reactions were performed on a 0.5 mmol scale and were rigorously degassed 
(freeze-pump-thaw). Yields (%) were obtained after aqueous work-up unless otherwise 
noted. 
b)Isolated yield (%) after purification by chromatography on SiO2. 
c)
Experiment was 
conducted in absence of light. 
d)
Conversion (%) was determined by crude 
1
HNMR. 
e)
Experiment was run at 35 °C.  
186 
  
3.2 Substrate Scope 
With the optimized reaction conditions in hand, a series of electronically diverse 
carboxylic acids were evaluated (Table 5.3). Aryl carboxylic acids bearing electron-rich 
substituents were readily accommodated and provided the corresponding anhydrides in 
greater than 90% yield (entries 2–9). The use of electron-withdrawing 
ortho-chlorobenzoic acid (entry 11) gave rise to the desired product in lower yield, 
presumably due to the decreased nucleophilicity of the acid or instability of the product. 
trans-Cinnamic acid provided the anhydride in excellent yield with no observation of   
the isomerization of the double bond (entry 10). Phthalic acid was also a viable substrate 
in this reaction, furnishing the intramolecular cyclization product in 99% yield (entry 12). 
Aliphatic carboxylic acids were also subjected to the reaction conditions and afforded the 
corresponding products in outstanding yields (entries 13 and 14). However, when 
α-amino acids or aryl carboxylic acids bearing strongly electron-withdrawing groups 
were utilized, less than 5% of the anhydrides were obtained (entries 15 and 16). 
 
3.3 Synthesis of Anhydrides on Large Scale 
In order to demonstrate the efficiency of the anhydride protocol on preparative scale, 
the reaction of 4-tert-butylbenzoic acid 26 was performed on a 2.5 gram scale with the 
catalyst loading lowered to 0.2 mol%. Gratifyingly, no significant loss of efficacy was 
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Table 5.3 Substrate scope* 
 
Entry Product Yield Entry Product Yield 
 
*
Reactions were performed on a 0.5 mmol scale and were degassed (freeze-pump-thaw). Yields 
(%) were obtained after aqueous work-up. 
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observed and the desired anhydride was obtained in 85% yield after work-up (Scheme 
5.2). 
 
Scheme 5.2 Large scale reaction 
 
 
3.4 Synthesis of Anhydrides in Flow Reactor 
The photoredox-catalyzed anhydride formation reaction was also conducted in a 
flow reactor using 4-tert-butylbenzoic acid 26, in which case the observed reaction time 
was significantly shortened.  
 
Scheme 5.3 Synthesis of anhydride in flow reactor 
 
 
As compared to the reaction in a batch reactor which requires 12 h of blue LEDs 
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irradiation for full conversion of 0.5 mmol of the starting material 26 (Table 5.3, entry 5), 
the same scale reaction in a flow reactor (the a residence time is 6.4 min), only required 
over 1 h to provide the product 13 in 97% yield (Scheme 5.3). 
 
3.5 Proposed Mechanism 
As proposed for the conversion of alcohols to halides, a mechanistic hypothesis for 
anhydride formation involves trapping of the electron-deficient CBr3 radical by DMF to 
form the Vilsmeier–Haack reagent 24. Subsequently, an attack by the carboxylic acid 7 
furnishes the iminium intermediate 25, followed by displacement by another carboxylic 
acid to provide the anhydride 8 and liberate DMF (Scheme 5.4). 
 
Scheme 5.4 Proposed mechanism 
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4 Further Application to Amide Formation 
With the success of activating carboxylic acids towards nucleophilic substitution via 
in situ generated Vilsmeier–Haack reagent, further application to the synthesis of amides 
was then studied. So far, the best condition was found to be a one-pot reaction with 
stepwise additions: photocatalyzed formation of Vilsmeier–Haack reagent was carried 
first, followed by addition of carboxylic acid 27 and pyridine, then addition of amine 28. 
The desired amide product was isolated in 60% yield.     
 
Scheme 5.5 Synthesis of amide 
 
 
5 Conclusion 
The first application of visible light-mediated photoredox catalysis for carboxylic 
carbon-oxygen bond activation and the synthesis of symmetric anhydrides was 
successfully demonstrated.
230
 Both aryl and aliphatic carboxylic acids were converted to 
the corresponding anhydrides in high yields, though aromatic substrates bearing 
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electron-withdrawing groups proved more challenging than the ones bearing 
electron-donating groups. This method is highlighted by the use of mild reaction 
conditions and isolation of analytically pure products after a simple aqueous work-up. 
Furthermore, the efficacy of this protocol is exemplified by performing both the scale-up 
and flow reactions, in which high yields of the anhydrides were obtained.  
 
6 Experimental Section 
General Information 
Chemicals were either used as received or purified according to Purification of 
Common Laboratory Chemicals. All reactions were performed using common dry, inert 
atmosphere techniques. NMR spectra were recorded on Varian Unity Plus 400, and 
Varian Mercury 500 spectrometers. Chemical shifts for 
1H NMR were reported as δ, parts 
per million, relative to the signal of residual CHCl3 in CDCl3 at 7.26 ppm. Chemical 
shifts for 
13C NMR were reported as δ, parts per million, relative to the center line signal 
of the CDCl3 triplet at 77.0 ppm. Proton and carbon assignments were established using 
spectral data of similar compounds. The abbreviations s, d, dd, t and m stand for the 
resonance multiplicity singlet, doublet, doublet of doublets, triplet and multiplet, 
respectively. Infrared spectra were recorded on a Nicolet Nexus 670 FT-IR with ATR 
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spectraphotometer. Absorptions are given in wavenumbers (cm
-1
). High resolution mass 
spectra were obtained on a Waters Q-Tof API-US with ESI high resolution mass 
spectrometer. HPLC analysis was performed on an Agilent 1100 series HPLC System 
with a diode array detector.  
Photoredox reactions were carried out under visible light irradiation by a 15 cm blue 
LED strip (available from http://www.creativelightings.com/, λmax = 435 nm) 
surrounding the reaction vessel. 
 
General Procedure For Visible light-Mediated Anhydride Fromation 
A 10 mL round bottom flask was equipped with a rubber septum and magnetic stir 
bar and was charged with carboxylic acid (0.5 mmol, 1.0 equiv), carbon tetrabromide (0.5 
mmol, 1.0 equiv), 2,6-lutidine (0.5 mmol, 2.0 equiv) and Ru(bpy)3Cl2 (5.0 mol, 0.010 
equiv). The flask was purged with a stream of argon and dry DMF (5.0 mL) was added 
with a syringe. The mixture was degassed by the freeze-pump-thaw procedure (three 
cycles). The homogenous mixture was then irradiated by a 1 W blue LED strip under an 
atmosphere of Ar for 12 h (the reaction reaches temperatures between 25 and 30 °C upon 
exposure to the blue LEDs). 
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After the reaction was complete, the mixture was poured into a separatory funnel 
containing 25 mL of Et2O and 25 mL of H2O. The layers were separated and the aqueous 
layer was extracted with Et2O (2  50 mL). The combined organic layers were washed 
with saturated NaHCO3, H2O, brine, dried (Na2SO4) and concentrated in vacuo to afford 
the desired anhydride.  
 
Compound Preparation and Characterization 
 
Benzoic anhydride,
220 
9 (Table 5.3, entry 1): According to General Procedure, 
benzoic acid (61.1 mg, 0.50 mmol), carbon tetrabromide (166 mg, 0.50 mmol), 
2,6-lutidine (117 L, 1.0 mmol) and Ru(bpy)3Cl2 (3.74 mg, 5.0 mol) in DMF (5.0 mL) 
afforded 9 (56.5 mg, 99%) as a light yellow solid.  
m.p.: 39-41 °C (Aldrich: 38-42 °C); 
IR (neat): 3071, 2918, 1782, 1723, 1210, 1172, 1037, 994 cm
-1
; 
1
H NMR (CDCl3, 500 MHz):  8.18–8.15 (m, 4 H), 7.70–7.67 (m, 2 H), 7.56–7.52 
(m, 4 H);  
13
C NMR (CDCl3, 125 MHz):  160.5, 133.4, 129.5, 127.9, 127.9. 
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4-Methylbenzoic anhydride,
231 
10 (Table 5.3, entry 2): According to General 
Procedure, 4-methylbenoic acid (68.1 mg, 0.50 mmol), carbon tetrabromide (166 mg, 
0.50 mmol), 2,6-lutidine (117 L, 1.0 mmol) and Ru(bpy)3Cl2 (3.74 mg, 5.0 mol) in 
DMF (5.0 mL) afforded 10 (62.8 mg, 98%) as a light yellow solid.  
m.p.: 88-40 °C (lit
219
: 89-90 °C); 
IR (neat): 3041, 2916, 1774, 1712, 1609, 1225, 1173, 1049, 1005, 750 cm-1; 
1
H NMR (CDCl3, 500 MHz):  8.05–8.03 (m, 4 H), 7.31 (d, J = 8.0 Hz, 4 H), 2.46 (s, 
6 H);  
13
C NMR (CDCl3, 125 MHz):  160.7, 144.1, 129.6, 128.6, 125.3, 23.7. 
 
 
 
2-Methylbenzoic anhydride,
231 
11 (Table 5.3, entry 3): According to General 
Procedure, 2-methylbenzoic acid (68.1 mg, 0.50 mmol), carbon tetrabromide (166 mg, 
0.50 mmol), 2,6-lutidine (117 L, 1.0 mmol) and Ru(bpy)3Cl2 (3.74 mg, 5.0 mol) in 
DMF (5.0 mL) afforded 11 (61.7 mg, 97%) as a light yellow solid.  
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m.p.: 37-39 °C (lit
232
: 38-39 °C); 
IR (neat): 2968, 2931, 1783, 1723, 1199, 983, 741 cm
-1
; 
1
H NMR (CDCl3, 400 MHz):  8.07–8.04 (m, 2 H), 7.53–7.49 (m, 2 H), 7.34–7.29 
(m, 4 H), 2.70 (s, 6 H); 
13
C NMR (CDCl3, 100 MHz):  162.9, 142.6, 133.6, 132.3, 131.4, 127.7, 126.1, 
22.0. 
 
 
 
4-Phenylbenzoic anhydride,
231 
12 (Table 5.3, entry 4): According to General 
Procedure, 4-phenylbenzoic acid (99.1 mg, 0.50 mmol), carbon tetrabromide (166 mg, 
0.50 mmol), 2,6-lutidine (117 L, 1.0 mmol) and Ru(bpy)3Cl2 (3.74 mg, 5.0 mol) in 
DMF (5.0 mL) afforded 12 (90.0 mg, 95%) as a light yellow solid.  
m.p.: 136-138 °C (lit
231
: 137-139 °C); 
IR (neat): 3030, 2927, 1778, 1717, 1605, 1226, 1175, 1055, 1002, 743 cm
-1
; 
1
H NMR (CDCl3, 500 MHz):  8.26–8.23 (m, 4 H), 7.77–7.75 (m, 4 H), 7.67–7.65 
(m, 4 H), 7.52–7.49 (m, 4 H), 7.45–7.42 (m, 2 H); 
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     13
C NMR (CDCl3, 125 MHz):  162.3, 147.3, 139.6, 131.1, 129.1, 128.6, 127.5 (two 
carbons overlapped), 127.4. 
 
 
 
4-(tert-Butyl)benzoic anhydride,
231 
13 (Table 5.3, entry 5): According to General 
Procedure, 4-(tert-butyl)benoic acid (89.1 mg, 0.50 mmol), carbon tetrabromide (166 mg, 
0.50 mmol), 2,6-lutidine (117 L, 1.0 mmol) and Ru(bpy)3Cl2 (3.74 mg, 5.0 mol) in 
DMF (5.0 mL) afforded 13 (83.7 mg, 99%) as a light yellow oil.  
m.p.: 75-77 °C (lit
233
: 78.7-79.0 °C); 
IR (neat): 2963, 2905, 2868, 1782, 1722, 1606, 1222, 1177, 1107, 1038, 993, 701 
cm
-1
; 
1
H NMR (CDCl3, 400 MHz):  8.08 (d, J = 8.8 Hz, 4 H), 7.54 (d, J = 8.8 Hz, 4 H), 
1.36 (s, 18 H); 
     13
C NMR (CDCl3, 100 MHz):  162.5, 158.5, 130.6, 126.1, 125.9, 35.3, 31.1. 
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2,6-Dimethylbenzoic anhydride, 14 (Table 5.3, entry 6): According to General 
Procedure, 2,6-dimethylbenoic acid (75.1 mg, 0.5 mmol), carbon tetrabromide (165.8 mg, 
0.5 mmol), 2,6-lutidine (116.5 L, 1.0 mmol) and Ru(bpy)3Cl2 (3.74 mg, 5.0 mol) in 
DMF (5.0 mL) afforded 14 (67.8 mg, 96%) as a light yellow solid.  
m.p.: 76-78 °C;  
IR (neat): 2926, 2359, 1798, 1738, 1595, 1466, 1201, 1166, 1093, 976, 780 cm
-1
; 
1
H NMR (CDCl3, 500 MHz):  7.26–7.23 (m, 3 H), 7.07–7.05 (d, J = 7.6 Hz, 3 H), 
2.41 (s, 12 H); 
      13
C NMR (CDCl3, 125 MHz):  163.2, 134.7, 130.7, 129.4, 127.0, 21.9; 
MS (ESI) m/z calcd for C18H18O3Na ([M + Na]
+
): 305.1154; found: 305.1157. 
 
 
 
2-Methoxybenzoic anhydride,
231
 15 (Table 5.3, entry 7): According to General 
Procedure, 2-methoxybenoic acid (76.1 mg, 0.50 mmol), carbon tetrabromide (166 mg, 
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0.5 mmol), 2,6-lutidine (117 L, 1.0 mmol) and Ru(bpy)3Cl2 (3.74 mg, 5.0 mol) in 
DMF (5.0 mL) afforded 15 (65.1 mg, 91%) as a light yellow solid.  
m.p.: 70-71 °C (lit
231
: 72-74 °C); 
IR (neat): 2918, 2848, 1781, 1730, 1600, 1489, 1256, 1199, 1020, 879, 756 cm
-1
; 
1
H NMR (CDCl3, 400 MHz):  8.02 (dd, J = 7.8, 1.8 Hz, 2 H), 7.55–7.51 (m, 2 H), 
7.03–6.97 (m, 4 H), 3.83 (s, 6 H); 
13
C NMR (CDCl3, 100 MHz):  161.9, 160.1, 135.3, 133.1, 120.3, 118.1, 112.1, 
55.9. 
 
 
 
4-Methoxybenzoic anhydride,
231
 6 (Table 5.3, entry 8): According to General 
Procedure, 4-methoxybenoic acid (76.1 mg, 0.50 mmol), carbon tetrabromide (166 mg, 
0.50 mmol), 2,6-lutidine (117 L, 1.0 mmol) and Ru(bpy)3Cl2 (3.74 mg, 5.0 mol) in 
DMF (5.0 mL) afforded 6 (64.1 mg, 90%) as a light yellow solid.  
m.p.: 94-96 °C (lit
221
: 97-98 °C); 
IR (neat): 2936, 2842, 1774, 1712, 1604, 1510, 1221, 1759, 1021, 991, 839 cm
-1
; 
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1
H NMR (CDCl3, 500 MHz):  8.11–8.09 (m, 4 H), 6.99–6.98 (m, 4 H), 3.90 (s, 6 
H); 
13
C NMR (CDCl3, 125 MHz):  162.6, 160.4, 131.7, 120.5, 113.6, 56.6. 
 
 
 
3-Methoxybenzoic anhydride,
231
 16 (Table 5.3, entry 9): According to General 
Procedure, 3-methoxybenoic acid (76.1 mg, 0.50 mmol), carbon tetrabromide (166 mg, 
0.50 mmol), 2,6-lutidine (117 L, 1.0 mmol) and Ru(bpy)3Cl2 (3.74 mg, 5.0 mol) in 
DMF (5.0 mL) afforded 16 (65.8 mg, 92%) as a light yellow solid.  
m.p.: 64-66 °C (lit
231
: 65-66 °C); 
IR (neat): 2918, 2849, 1787, 1724, 1600, 1585, 1261, 1194, 1021, 991, 748 cm
-1
; 
1
H NMR (CDCl3, 400 MHz):  7.67–7.64 (m, 2 H), 7.58–7.56 (m, 2 H), 7.34 (t, J = 
8.0 Hz, 2 H), 7.15 – 7.11 (m, 2 H), 3.79 (s, 6 H); 
13
C NMR (CDCl3, 100 MHz):  162.2, 159.9, 130.0, 129.9, 122.9, 121.1, 114.9, 
55.6. 
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trans-Cinnamic anhydride,
219
 17 (Table 5.3, entry 10): According to General 
Procedure, trans-cinnamic acid (74.1 mg, 0.50 mmol), carbon tetrabromide (166 mg, 0.50 
mmol), 2,6-lutidine (117 L, 1.0 mmol) and Ru(bpy)3Cl2 (3.74 mg, 5.0 mol) in DMF 
(5.0 mL) afforded 17 (62.8 mg, 90%) as a light yellow solid.  
m.p.: 134-136 °C (lit
234
: 135-136 °C); 
IR (neat): 3060, 3027, 2919, 2849, 1764, 1700, 1630, 1450, 1067, 959 cm
-1
; 
1
H NMR (CDCl3, 400 MHz):  7.86 (d, J = 15.9 Hz, 2 H), 7.60–7.58 (m, 4 H), 7.46–
7.43 (m, 6 H), 6.53 (d, J = 15.9 Hz, 2 H); 
13
C NMR (CDCl3, 125 MHz):  160.6, 147.1, 132.6, 130.2, 128.1, 127.6, 116.1. 
 
 
 
2-Chlorobenzoic anhydride,
231
 18 (Table 5.3, entry 11): According to General 
Procedure, 2-chlorobenzoic acid (78.3 mg, 0.50 mmol), carbon tetrabromide (166 mg, 
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0.50 mmol), 2,6-lutidine (117 L, 1.0 mmol) and Ru(bpy)3Cl2 (3.74 mg, 5.0 mol) in 
DMF (5.0 mL) afforded 18 (45.0 mg, 61%) as a light yellow oil.  
m.p.: 66-69 °C (lit
231
: 63-68 °C); 
IR (neat): 2955, 2913, 1794, 1697, 1589, 1437, 1207, 1075, 989, 742 cm
-1
; 
1
H NMR (CDCl3, 500 MHz):  8.03–8.02 (m, 2 H), 7.54–7.53 (m, 4 H), 4.41–7.38 
(m, 2 H); 
13
C NMR (CDCl3, 125 MHz):  158.6, 134.0, 133.1, 131.5, 130.6, 127.0, 126.0. 
 
 
Phthalic anhydride,
234,235
 19 (Table 5.3, entry 12): According to General Procedure, 
phthalic acid (83.1 mg, 0.50 mmol), carbon tetrabromide (166 mg, 0.50 mmol), 
2,6-lutidine (117 L, 1.0 mmol) and Ru(bpy)3Cl2 (3.74 mg, 5.0 mol) in DMF (5.0 mL) 
afforded 19 (36.9 mg, 99%) as a light yellow solid.  
m.p.: 130-132 °C (Aldrich: 131-134 °C); 
IR (neat): 2918, 2852, 1849, 1761, 1471, 1256, 1110, 905, 712 cm
-1
; 
1
H NMR (CDCl3, 500 MHz):  8.05–8.01 (m, 2 H), 7.93–7.90 (m, 2 H); 
13
C NMR (CDCl3, 100 MHz):  162.8, 136.1, 131.3, 125.8. 
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Cyclohexanecarboxylic anhydride,
236
 20 (Table 5.3, entry 13): According to 
General Procedure, cyclohexanecarboxylic acid (64.1 mg, 0.50 mmol), carbon 
tetrabromide (166 mg, 0.50 mmol), 2,6-lutidine (117 L, 1.0 mmol) and Ru(bpy)3Cl2 
(3.74 mg, 5.0 mol) in DMF (5.0 mL) afforded 20 (58.7 mg, 98%) as a light yellow 
liquid.  
IR (neat): 2932, 2856, 1808, 1741, 1451, 1082, 990, 895 cm
-1
; 
1
H NMR (CDCl3, 500 MHz):  2.40 (tt, J = 11.2, 3.7 Hz, 2 H), 1.97–1.93 (m, 4 H), 
1.80–1.77 (m, 4 H), 1.66–1.63 (m, 2 H), 1.52–1.43 (m, 4 H), 1.34–1.22 (m, 6 H); 
13
C NMR (CDCl3, 125 MHz):  169.7, 45.3, 30.1, 27.4, 27.0; 
MS (ESI) m/z calcd for C14H22O3Na ([M + Na]
+
): 261.1467; found: 261.1468. 
 
 
 
Lauric anhydride, 21 (Table 5.3, entry 14): According to General Procedure, lauric 
acid (100.16 mg, 0.50 mmol), carbon tetrabromide (166 mg, 0.50 mmol), 2,6-lutidine 
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(117 L, 1.0 mmol) and Ru(bpy)3Cl2 (3.74 mg, 5.0 mol) in DMF (5.0 mL) afforded 21 
(92.7 mg, 97%) as a light yellow solid.  
m.p.: 40-42 °C; 
IR (neat): 2924, 2854, 1818, 1746, 1466, 1035, 907, 731 cm
-1
; 
1
H NMR (CDCl3, 400 MHz):  2.43 (t, J = 7.4 Hz, 4 H), 1.68–1.62 (m, 4 H), 1.40–
1.18 (m, 32 H), 0.87 (t, J = 6.4 Hz, 6 H); 
13
C NMR (CDCl3, 100 MHz):  169.6, 35.3, 31.9, 29.6, 29.5, 29.4, 29.3, 29.2, 28.9, 
24.2, 22.7, 14.1;  
MS (ESI) m/z calcd for C24H46O3Na ([M + Na]
+
): 405.3345; found: 405.3331. 
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